{"meta":{"query_hash":"244635836ca0","filters":{"venue":"Clinical Breast Cancer"},"cohort_total":133,"direct_labels_cover":0,"predictions_cover":133,"exported":133,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/244635836ca0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Breast+Cancer"},"results":[{"id":"W1970601130","doi":"10.3816/cbc.2007.n.057","title":"National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Queen's University","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Exemestane; Breast cancer; Postmenopausal women; Cancer; Clinical trial; Oncology; Internal medicine; Gynecology; Aromatase","score_opus":0.05930763312104776,"score_gpt":0.4460798653727648,"score_spread":0.38677223225171703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970601130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80299234,0.060122393,0.0019717864,0.025012758,0.0031773846,0.010354296,0.04098812,0.000679671,0.054701302],"genre_scores_gemma":[0.8914506,0.021547468,0.0039036805,0.010156435,0.0015652875,0.007953974,0.0116159,0.00013654475,0.051670257],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995277,0.00028705888,0.00001453072,0.000037096226,0.00006197477,0.00007168449],"domain_scores_gemma":[0.999491,0.0001068139,0.000110411886,0.00004154166,0.000048382713,0.00020181066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009901493,0.0012161783,0.0026329649,0.0004489552,0.0006770558,0.0010896854,0.0009277306,0.0016222472,0.009206134],"category_scores_gemma":[0.0019919977,0.00042229507,0.0015105918,0.000553802,0.0006517094,0.00052190037,0.00038667338,0.0033480872,0.0012154098],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91730565,0.0029672114,0.0022063989,0.0015123831,0.0015745515,0.00015210903,0.00007051197,0.0007553537,0.003271159,0.0008312212,0.022711255,0.046642218],"study_design_scores_gemma":[0.9618536,0.018722136,0.008363935,0.000156523,0.00096692936,0.00010886876,0.000039827493,0.00045599713,0.0003913602,0.0006132061,0.0083002355,0.000027411721],"about_ca_topic_score_codex":0.021335352,"about_ca_topic_score_gemma":0.06734567,"teacher_disagreement_score":0.021335352,"about_ca_system_score_codex":0.001899549,"about_ca_system_score_gemma":0.003858502,"threshold_uncertainty_score":0.042422354},"labels":[],"label_agreement":null},{"id":"W1971954228","doi":"10.3816/cbc.2004.n.032","title":"Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Internal medicine; Anthracycline; Discontinuation; Progressive disease; Breast cancer; Chemotherapy; Phases of clinical research; Gastroenterology; Cancer; Surgery; Oncology; Colorectal cancer","score_opus":0.09835630191254444,"score_gpt":0.4714088183810935,"score_spread":0.3730525164685491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971954228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846502,0.004080276,0.0009835993,0.0014804639,0.00038374207,0.0025549792,0.0020823982,0.00014454809,0.00363988],"genre_scores_gemma":[0.980828,0.0034379126,0.0024798808,0.0014262015,0.0003617672,0.0018675142,0.0043319636,0.00008191607,0.0051848665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920446,0.00035761116,0.00004330408,0.00010575341,0.000070747374,0.00021808856],"domain_scores_gemma":[0.99868315,0.00030658685,0.000147354,0.00013120705,0.00009941653,0.00063226273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436473,0.0018538622,0.0034969721,0.000511072,0.0007533252,0.0012635328,0.0010745181,0.001663796,0.0033654594],"category_scores_gemma":[0.0019040257,0.0007591246,0.0018329482,0.00049633323,0.0012570746,0.0008630118,0.00035336515,0.0045553395,0.000926772],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73384947,0.10437173,0.0039255633,0.0008690778,0.002444356,0.0005508026,0.0004233499,0.004219171,0.038491555,0.000320446,0.009652217,0.10088238],"study_design_scores_gemma":[0.59091073,0.3903084,0.009126774,0.0000417736,0.0010193572,0.0002875904,0.000061994615,0.0007042479,0.0039306623,0.00019606052,0.0033761708,0.00003617059],"about_ca_topic_score_codex":0.002931191,"about_ca_topic_score_gemma":0.007303584,"teacher_disagreement_score":0.0034969721,"about_ca_system_score_codex":0.0011620035,"about_ca_system_score_gemma":0.0020111364,"threshold_uncertainty_score":0.012885451},"labels":[],"label_agreement":null},{"id":"W1973960663","doi":"10.3816/cbc.2008.n.035","title":"A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Locoregional Relapse of Breast Cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Radiation therapy; Hormonal therapy; Oncology; Mastectomy; Chemotherapy; Randomized controlled trial; Trastuzumab; Internal medicine; Adjuvant; Cancer; Adjuvant therapy; Randomization; Surgery","score_opus":0.05316196569667762,"score_gpt":0.37524060280148075,"score_spread":0.3220786371048031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973960663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996943,0.0021528872,0.00043477034,0.0012799015,0.0007663482,0.0024229556,0.0008550292,0.000073943316,0.0020447287],"genre_scores_gemma":[0.9842367,0.0016538686,0.0014395725,0.0014697473,0.00058731524,0.003509355,0.0015671899,0.000032062148,0.00550402],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99841464,0.0010524606,0.000060558803,0.00020042034,0.00006465562,0.00020727856],"domain_scores_gemma":[0.9976617,0.0007581923,0.0003503409,0.00029465335,0.00009744699,0.00083767466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031514452,0.0023496365,0.004437878,0.000530392,0.00054682815,0.0010897876,0.0013837809,0.0019327574,0.008659212],"category_scores_gemma":[0.0027647114,0.00090153614,0.0018393175,0.0005890684,0.0024426838,0.0011362382,0.0007380582,0.0037581015,0.0014152008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99377525,0.0023597283,0.00026613753,0.00005845401,0.00029484794,0.000007614114,0.000012967346,0.00014248547,0.0004565932,0.000056490044,0.00022572004,0.0023437785],"study_design_scores_gemma":[0.9631165,0.034685865,0.0008210135,0.000012069953,0.0004198673,0.000011211361,0.000018268327,0.00025566365,0.00020543503,0.00013850396,0.0003060462,0.0000095800515],"about_ca_topic_score_codex":0.0027805972,"about_ca_topic_score_gemma":0.004637061,"teacher_disagreement_score":0.008659212,"about_ca_system_score_codex":0.0013870457,"about_ca_system_score_gemma":0.0027640539,"threshold_uncertainty_score":0.028967977},"labels":[],"label_agreement":null},{"id":"W1981743837","doi":"10.3816/cbc.2007.n.028","title":"Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"NIH Clinical Center; National Cancer Institute; National Center for Research Resources; Genentech; European Society for Medical Oncology","keywords":"Medicine; Trastuzumab; Ejection fraction; Metastatic breast cancer; Heart failure; Internal medicine; Cardiotoxicity; Breast cancer; Regimen; Oncology; Cancer; Chemotherapy; Surgery; Cardiology","score_opus":0.03062241698754341,"score_gpt":0.34935280822758746,"score_spread":0.31873039124004404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981743837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933654,0.0001709103,0.00014588273,0.000037535487,0.000003681656,0.000013385631,0.000010505881,0.0000033641186,0.00027814409],"genre_scores_gemma":[0.99978024,0.000043395405,0.00007277031,0.000017949256,0.000006293731,0.0000061253354,0.0000122010415,0.0000012924586,0.000059765385],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998678,0.00006827569,0.00000527777,0.000019052002,0.000017300883,0.000022298318],"domain_scores_gemma":[0.9997851,0.000077729186,0.00005921942,0.000021757183,0.000012570147,0.000043642976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045264667,0.0001856508,0.00025219106,0.000084282154,0.00012613759,0.00030420147,0.00010343763,0.00018160985,0.00063680514],"category_scores_gemma":[0.0009087078,0.00009947263,0.00013987382,0.00010358322,0.00025880072,0.0002406665,0.00013117681,0.00039347916,0.00010538403],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14325725,0.0035907968,0.19524683,0.00024017457,0.00035858637,0.0012728616,0.00062926725,0.0043982984,0.465455,0.000836306,0.00083087286,0.1838837],"study_design_scores_gemma":[0.010506418,0.27483326,0.54255676,0.000060642124,0.0010407192,0.0037287863,0.00061952375,0.022267455,0.13874201,0.0006486172,0.00493979,0.000055958386],"about_ca_topic_score_codex":0.00043938824,"about_ca_topic_score_gemma":0.00057383016,"teacher_disagreement_score":0.00063680514,"about_ca_system_score_codex":0.00032772298,"about_ca_system_score_gemma":0.0002685983,"threshold_uncertainty_score":0.0023939013},"labels":[],"label_agreement":null},{"id":"W1989283938","doi":"10.1016/j.clbc.2012.01.002","title":"Experience of Young Women Diagnosed With Breast Cancer Who Undergo Fertility Preservation Consultation","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; CReATe Fertility Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Referral; Fertility preservation; Fertility; Family medicine; Breast cancer; Psychosocial; Gynecology; Cancer; Disease; Oocyte cryopreservation; Infertility; Internal medicine; Population; Pregnancy; Psychiatry","score_opus":0.053947994569379945,"score_gpt":0.3819651529906141,"score_spread":0.3280171584212342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989283938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932713,0.000829411,0.000076833865,0.0010382701,0.000068185254,0.00003472308,0.000102663995,0.000008836842,0.004569768],"genre_scores_gemma":[0.9953681,0.001328926,0.00016015695,0.0008645189,0.00005018541,0.000021479298,0.000098909986,0.000006542849,0.0021011787],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99967337,0.00009671467,0.0000177089,0.000018506878,0.0000502349,0.00014343041],"domain_scores_gemma":[0.9985916,0.00034275895,0.00017543316,0.000012784419,0.00008210453,0.000795184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004759541,0.00020170376,0.0002883512,0.00036267284,0.0028473458,0.0010908694,0.00025499208,0.00097177475,0.0041080248],"category_scores_gemma":[0.00265975,0.0002366603,0.00031121043,0.00033658888,0.0004898139,0.0005315289,0.0011278609,0.0010015897,0.00037147326],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064905046,0.0014260367,0.6868851,0.00027261933,0.00006328623,0.1423879,0.1194166,0.0003217522,0.0033532656,0.0011123208,0.008652323,0.035459705],"study_design_scores_gemma":[0.00010322377,0.0034038262,0.4036743,0.0003759786,0.00013994667,0.16067469,0.39238012,0.00048717417,0.0012481214,0.00058884587,0.036795627,0.00012814923],"about_ca_topic_score_codex":0.009197317,"about_ca_topic_score_gemma":0.020650048,"teacher_disagreement_score":0.009197317,"about_ca_system_score_codex":0.0008001183,"about_ca_system_score_gemma":0.0015930762,"threshold_uncertainty_score":0.0182876},"labels":[],"label_agreement":null},{"id":"W1992079963","doi":"10.3816/cbc.2009.n.020","title":"Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Endocrine system; Genitourinary system; Postmenopausal women; Oncology; Gynecology; Internal medicine; Cancer; Obstetrics; Hormone","score_opus":0.035752135160468934,"score_gpt":0.3954673185564606,"score_spread":0.3597151833959917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992079963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836403,0.00073007593,0.000016650225,0.00005581194,0.0000056716613,0.000006145637,0.00027417185,0.0000014348002,0.00054595905],"genre_scores_gemma":[0.9994266,0.0002634165,0.000018555675,0.000023379878,0.000009960414,0.00000308313,0.0001471378,5.294904e-7,0.0001072854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997187,0.00007738852,0.00004462481,0.000038245995,0.00006137042,0.000059729635],"domain_scores_gemma":[0.99892884,0.00022102658,0.0005201265,0.000032493805,0.00009715162,0.00020033377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034133883,0.00012488346,0.0003037575,0.0007722431,0.00030880523,0.000461043,0.00018655705,0.00040837663,0.0016621335],"category_scores_gemma":[0.0026699924,0.00018774318,0.0004051151,0.00093489885,0.00019660585,0.0003319672,0.0003681728,0.00037194244,0.000113348775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097596225,0.000020432557,0.9987362,0.000008660538,0.00002274138,0.000037700695,0.000050959243,0.000006615406,0.00012535167,0.000003880994,0.000030978666,0.00085885014],"study_design_scores_gemma":[0.0000019052907,0.000040216222,0.9996106,0.000002256245,0.000009341838,0.000117217,0.00014493125,0.000013923176,0.000008811007,0.0000034376537,0.00004633531,0.0000010922647],"about_ca_topic_score_codex":0.0065777088,"about_ca_topic_score_gemma":0.009538515,"teacher_disagreement_score":0.0065777088,"about_ca_system_score_codex":0.00021500394,"about_ca_system_score_gemma":0.00023597982,"threshold_uncertainty_score":0.013078809},"labels":[],"label_agreement":null},{"id":"W1997732467","doi":"10.3816/cbc.2008.n.061","title":"A BRCA1 Mutation Is Not Associated with Increased Indicators of Oxidative Stress","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Oxidative stress; Mutation; Breast cancer; Genetics; Internal medicine; Oncology; Cancer research; Cancer; Gene; Biology","score_opus":0.02346509766736525,"score_gpt":0.32887464314167764,"score_spread":0.30540954547431237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997732467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966614,0.00079181546,0.00015805554,0.00013414958,0.000022003802,0.000009612263,0.00026570915,0.000017560955,0.0019396559],"genre_scores_gemma":[0.9992331,0.000093568226,0.00006275945,0.000026747606,0.000011585872,0.0000033804868,0.00021220966,0.0000039057577,0.00035277056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999539,0.00010476855,0.000045527984,0.0000939485,0.00012225169,0.00009456009],"domain_scores_gemma":[0.9967801,0.00093425135,0.0011773136,0.00023707196,0.00028975835,0.00058146566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046277602,0.00042699845,0.000516703,0.0015791722,0.00041950948,0.0005756263,0.00046533372,0.00077693054,0.003879553],"category_scores_gemma":[0.0035035717,0.00020828427,0.00024327716,0.00086916075,0.0005246231,0.00034921567,0.00033077717,0.00066940056,0.0004386015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032997306,0.00015292411,0.94031703,0.00007666464,0.00011285266,0.0038582284,0.0001307625,0.00006696559,0.046948537,0.00016925363,0.00039589292,0.004471067],"study_design_scores_gemma":[0.000024510253,0.0006465183,0.97075576,0.00001764192,0.0000924442,0.015570954,0.0001700009,0.00023026932,0.011180001,0.00026731665,0.0010332944,0.000011240055],"about_ca_topic_score_codex":0.0010276532,"about_ca_topic_score_gemma":0.00060439995,"teacher_disagreement_score":0.003879553,"about_ca_system_score_codex":0.00027169962,"about_ca_system_score_gemma":0.00024612088,"threshold_uncertainty_score":0.012978375},"labels":[],"label_agreement":null},{"id":"W1997955685","doi":"10.3816/cbc.2006.n.038","title":"Molecular Predictive Factors in Patients Receiving Trastuzumab-Based Chemotherapy for Metastatic Disease","year":2006,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Medicine; Trastuzumab; Oncology; Metastatic breast cancer; Internal medicine; Breast cancer; Chemotherapy; Disease; Cancer","score_opus":0.04488971125718346,"score_gpt":0.41535157853292376,"score_spread":0.3704618672757403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997955685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967894,0.0010713377,0.00007835342,0.00030722364,0.000044066444,0.000008162909,0.00020067314,0.00000684313,0.0014938733],"genre_scores_gemma":[0.99897695,0.000264105,0.000056667253,0.00007240771,0.00007636606,0.000006455795,0.00020934688,0.0000030333401,0.00033481274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998036,0.00004790818,0.000019871966,0.00003114019,0.00004150586,0.000055978086],"domain_scores_gemma":[0.9986904,0.00051029393,0.00034132003,0.00005006094,0.000085337735,0.0003225792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003299312,0.00028385385,0.00044653838,0.0004221174,0.00040779056,0.00069120084,0.00034522227,0.000729827,0.0025069737],"category_scores_gemma":[0.0030285993,0.00018837972,0.00038705912,0.00086145906,0.00024304555,0.0004276235,0.00020235081,0.0010695257,0.00027165376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092007616,0.00007747918,0.9947149,0.000010854822,0.000052089134,0.00031406217,0.000027871974,0.00013302783,0.0005634765,0.000049538125,0.0003059858,0.002830771],"study_design_scores_gemma":[0.000048113532,0.00027462505,0.99681026,0.000008147959,0.000119582415,0.00096231286,0.000112768466,0.0006648535,0.00024676157,0.00011514098,0.0006307755,0.000006669021],"about_ca_topic_score_codex":0.0020914127,"about_ca_topic_score_gemma":0.0028638057,"teacher_disagreement_score":0.0025069737,"about_ca_system_score_codex":0.00034746487,"about_ca_system_score_gemma":0.00049713335,"threshold_uncertainty_score":0.008386672},"labels":[],"label_agreement":null},{"id":"W1998371653","doi":"10.3816/cbc.2003.n.042","title":"A Clinical Trial of Breast Radiation Therapy Versus Breast and Regional Radiation Therapy in Early-Stage Breast Cancer: The MA20 Trial","year":2003,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Queen's University; University of British Columbia; McMaster University; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Oncology; Stage (stratigraphy); Clinical trial; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.06298448628436581,"score_gpt":0.3882923112205548,"score_spread":0.325307824936189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998371653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699023,0.015534323,0.0007721602,0.0042355666,0.0009220007,0.00095952745,0.001410858,0.00013142613,0.0061318143],"genre_scores_gemma":[0.9766679,0.005627602,0.00097555073,0.003209927,0.0008809429,0.0013677271,0.0017810815,0.000053186865,0.009436164],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987973,0.0009167099,0.000028718594,0.00009320473,0.00004966327,0.00011439455],"domain_scores_gemma":[0.9983152,0.0006905715,0.0002498892,0.00013799693,0.000063155734,0.000543149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024650944,0.0019326609,0.0027507688,0.00041484312,0.00043020406,0.0008323602,0.0012057849,0.0022437228,0.008734201],"category_scores_gemma":[0.0030843504,0.00033489487,0.0017457654,0.00057639275,0.0010100958,0.0012180181,0.0005522528,0.003239743,0.001320159],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9479043,0.006581563,0.0014849649,0.00046032612,0.0013863317,0.00009112949,0.00006221109,0.00071047427,0.004294406,0.00054165465,0.0029782897,0.033504207],"study_design_scores_gemma":[0.7870944,0.19649483,0.00555315,0.00008962277,0.0014292563,0.00018731722,0.00006534694,0.00073085085,0.0013490153,0.0011141164,0.0058496986,0.000042448082],"about_ca_topic_score_codex":0.0006902283,"about_ca_topic_score_gemma":0.0015675938,"teacher_disagreement_score":0.008734201,"about_ca_system_score_codex":0.0005787712,"about_ca_system_score_gemma":0.0010241884,"threshold_uncertainty_score":0.029218793},"labels":[],"label_agreement":null},{"id":"W1999666422","doi":"10.3816/cbc.2000.n.005","title":"Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; BRCA2 Protein; Cancer; Gynecology; Mutation; Demography; Genetics; Gene; Germline mutation; Biology","score_opus":0.011861123139301166,"score_gpt":0.30441687057051,"score_spread":0.2925557474312088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999666422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990013,0.0011114322,0.000081194274,0.0007136254,0.000020093621,0.000028771092,0.0031438232,0.00001944838,0.0048686843],"genre_scores_gemma":[0.9973894,0.0006161611,0.00007257981,0.00016791974,0.000008896155,0.000008905798,0.0005449674,0.0000069258213,0.0011842233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990903,0.00006615874,0.000063299114,0.0001257862,0.00034284804,0.00031166547],"domain_scores_gemma":[0.9977412,0.00015426429,0.00037518874,0.00003095524,0.00087045226,0.00082800287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030301587,0.00025711377,0.0004981195,0.0021839526,0.002550393,0.0011949952,0.001234374,0.0006999146,0.0054696635],"category_scores_gemma":[0.0017067776,0.00047845778,0.00046337463,0.004132333,0.0007811949,0.0003635258,0.0006738597,0.0007426568,0.00041950692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040589155,0.000018002189,0.9968772,0.00001329348,0.00001681476,0.00015744008,0.00030250775,0.00003871574,0.000150718,0.00007601414,0.0005736943,0.0017349008],"study_design_scores_gemma":[0.0000063896355,0.00001749079,0.997521,0.000013761329,0.000015087884,0.0003429439,0.0013563997,0.00011043918,0.000052449726,0.000022695154,0.0005310421,0.000010146368],"about_ca_topic_score_codex":0.9800668,"about_ca_topic_score_gemma":0.984503,"teacher_disagreement_score":0.019933224,"about_ca_system_score_codex":0.014511092,"about_ca_system_score_gemma":0.015873166,"threshold_uncertainty_score":0.10528582},"labels":[],"label_agreement":null},{"id":"W2007037292","doi":"10.3816/cbc.2009.n.044","title":"TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Docetaxel; Medicine; Metastatic breast cancer; Ramucirumab; Placebo; Internal medicine; Oncology; Chemotherapy; Randomized controlled trial; Breast cancer; Phases of clinical research; Cancer; Pathology","score_opus":0.07878283885101223,"score_gpt":0.4425120655689957,"score_spread":0.36372922671798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007037292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218954,0.0041170297,0.0011299448,0.0012760282,0.0006967223,0.0048940107,0.0020755394,0.00045581555,0.0031652923],"genre_scores_gemma":[0.9695013,0.004887424,0.003139742,0.0022899534,0.0005868999,0.0078128725,0.0029763367,0.00013212906,0.008673413],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99938667,0.00032704213,0.000026631846,0.00009776798,0.000043866094,0.00011793171],"domain_scores_gemma":[0.9991159,0.00016439,0.00017573948,0.00006645752,0.000049738275,0.0004277034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002389866,0.0027081447,0.0038982523,0.0008484918,0.00075934996,0.0014926433,0.00166512,0.0022203603,0.0069390065],"category_scores_gemma":[0.0015669835,0.0012873092,0.0015840424,0.0008418346,0.0020816976,0.0015170332,0.0004980469,0.0058032167,0.0017819308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9403726,0.02620127,0.0007639128,0.0006352828,0.0009706594,0.00004449878,0.00011071475,0.0007378211,0.00647918,0.00022768659,0.002181647,0.021274555],"study_design_scores_gemma":[0.9291288,0.06824402,0.00088882423,0.00001598344,0.00027348616,0.00003157248,0.000025548065,0.00034031356,0.00044531343,0.00007327714,0.0005153041,0.000017549386],"about_ca_topic_score_codex":0.0019944638,"about_ca_topic_score_gemma":0.0055448636,"teacher_disagreement_score":0.0069390065,"about_ca_system_score_codex":0.0010255958,"about_ca_system_score_gemma":0.002351221,"threshold_uncertainty_score":0.023213267},"labels":[],"label_agreement":null},{"id":"W2009590627","doi":"10.3816/cbc.2005.n.016","title":"Phase II Study of Pemetrexed in Patients Pretreated with an Anthracycline, a Taxane, and Capecitabine for Advanced Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shaughnessy Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Neutropenia; Internal medicine; Breast cancer; Capecitabine; Taxane; Metastatic breast cancer; Oncology; Leukopenia; Phases of clinical research; Nausea; Cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin; Colorectal cancer","score_opus":0.03156877664350103,"score_gpt":0.4302681399291997,"score_spread":0.39869936328569866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009590627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950441,0.0010731085,0.00030819897,0.00043467575,0.0001279504,0.001187353,0.00051393954,0.00004335904,0.0012672246],"genre_scores_gemma":[0.9909739,0.0017165497,0.0008860901,0.0005924738,0.00022958049,0.0015302259,0.0013990846,0.000023935705,0.0026482085],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996277,0.00017291808,0.000014242809,0.00006548812,0.00002390644,0.000095646],"domain_scores_gemma":[0.9990422,0.000178161,0.0001172543,0.00007803583,0.00004143602,0.0005427914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011104029,0.0016159273,0.0032029627,0.00043468294,0.00052217825,0.0010228608,0.001043631,0.0013851798,0.004534827],"category_scores_gemma":[0.001214313,0.0007844469,0.0013028199,0.0004743053,0.0011845028,0.0012108057,0.00033649168,0.0046166074,0.0008749882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8515091,0.08345961,0.0023690977,0.00039364852,0.00085366005,0.0002045541,0.00023737471,0.001809151,0.02277244,0.00022728309,0.0018343894,0.034329657],"study_design_scores_gemma":[0.6649474,0.32476294,0.005789829,0.000018390265,0.00030358628,0.00014305188,0.000065561406,0.00078146515,0.0017518835,0.00012088838,0.0012966862,0.00001826167],"about_ca_topic_score_codex":0.001962854,"about_ca_topic_score_gemma":0.003792924,"teacher_disagreement_score":0.004534827,"about_ca_system_score_codex":0.0010582126,"about_ca_system_score_gemma":0.0018055437,"threshold_uncertainty_score":0.015170574},"labels":[],"label_agreement":null},{"id":"W2018810533","doi":"10.3816/cbc.2008.n.049","title":"Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions","year":2008,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase inhibitor; Oncology; Interim analysis; Anastrozole; Adjuvant therapy; Internal medicine; Exemestane; Adjuvant; Clinical trial; Randomized controlled trial; Cancer; Gynecology","score_opus":0.0269639738199417,"score_gpt":0.39009444971629276,"score_spread":0.36313047589635106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018810533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010818705,0.9990508,0.00010365464,0.00024136883,0.00014129534,0.00000223406,0.000008952712,0.0000037000018,0.0003397632],"genre_scores_gemma":[0.0007107187,0.99828196,0.00021944623,0.00023216945,0.00022883457,0.0000045880547,0.000020256157,9.16627e-7,0.00030103527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998079,0.000040220668,0.000030033187,0.00003489903,0.000065902444,0.000021102067],"domain_scores_gemma":[0.9994326,0.00033211193,0.000071156705,0.000013923671,0.00010363237,0.000046563015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011537249,0.00072533055,0.0018850636,0.00097565947,0.00019040151,0.0011530827,0.0010214146,0.0010975797,0.0033483447],"category_scores_gemma":[0.0011456836,0.00024336067,0.00042158374,0.0019105516,0.00051087525,0.0012547893,0.00060222036,0.0017131199,0.0013557579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002090317,0.000087383625,0.00033190008,0.0072863693,0.00007574606,0.00021755851,0.000030057834,0.00045518903,0.0010596521,0.0014632588,0.019446308,0.9693375],"study_design_scores_gemma":[0.00012689481,0.00026749587,0.0018204218,0.0034539227,0.00032283584,0.0020952467,0.00010189723,0.00021705139,0.0004030152,0.0022832649,0.9888831,0.000024979468],"about_ca_topic_score_codex":0.00093556545,"about_ca_topic_score_gemma":0.0024176075,"teacher_disagreement_score":0.0033483447,"about_ca_system_score_codex":0.0005615577,"about_ca_system_score_gemma":0.0011379035,"threshold_uncertainty_score":0.011201322},"labels":[],"label_agreement":null},{"id":"W2023764867","doi":"10.1016/j.clbc.2012.01.001","title":"Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; Genentech; National Institutes of Health; Mayo Clinic","keywords":"Vinorelbine; Capecitabine; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Cancer; Phases of clinical research; Chemotherapy; Colorectal cancer","score_opus":0.10161322086899631,"score_gpt":0.4580827344753126,"score_spread":0.3564695136063163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023764867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875683,0.002982839,0.000556266,0.0014796974,0.00029612173,0.0020517209,0.0015120804,0.00016191257,0.0033909734],"genre_scores_gemma":[0.9744966,0.0032036402,0.002552482,0.002721783,0.00044902693,0.0034080218,0.0037535091,0.00009657046,0.0093183825],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993894,0.00033404597,0.000015028907,0.00010620541,0.00003946414,0.0001158305],"domain_scores_gemma":[0.9990421,0.00016024895,0.00017613622,0.00008839852,0.000050462626,0.00048261354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021798739,0.0020489986,0.002667344,0.00049101224,0.0005346924,0.001053892,0.0014076252,0.0015502771,0.006602717],"category_scores_gemma":[0.001093781,0.00083891896,0.0016160797,0.0005247126,0.0016162827,0.0009531974,0.00041409323,0.003670716,0.001559979],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9105669,0.024694683,0.0026592647,0.00045234952,0.0011607057,0.00014710349,0.00020747173,0.0012571497,0.010283122,0.00035407968,0.0065846224,0.041632537],"study_design_scores_gemma":[0.91131145,0.08018943,0.0052102683,0.000023938439,0.00032369824,0.00010602826,0.00003164473,0.00048030537,0.00058858714,0.00013381145,0.0015837364,0.000017075154],"about_ca_topic_score_codex":0.005029526,"about_ca_topic_score_gemma":0.01781867,"teacher_disagreement_score":0.006602717,"about_ca_system_score_codex":0.0020788636,"about_ca_system_score_gemma":0.0032881955,"threshold_uncertainty_score":0.02208823},"labels":[],"label_agreement":null},{"id":"W2028929628","doi":"10.3816/cbc.2003.s.005","title":"Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Autologous stem-cell transplantation; Transplantation; Immune system; Immunology","score_opus":0.018533008153167323,"score_gpt":0.2724970796983422,"score_spread":0.25396407154517486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028929628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992761,0.0029953404,0.00035116932,0.0006218671,0.00012216921,0.000096225165,0.000054446347,0.000026940868,0.0029709735],"genre_scores_gemma":[0.9980216,0.0009009852,0.00029238858,0.00017264404,0.0000896361,0.000038886737,0.00006344584,0.0000029954392,0.0004175132],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997944,0.00009499575,0.000010471265,0.000024954268,0.00002215522,0.000052987176],"domain_scores_gemma":[0.9996705,0.00013991665,0.00005447713,0.000024040803,0.000015444963,0.00009565147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004622637,0.00028845377,0.0006975237,0.00022345727,0.00035379306,0.00036631303,0.00021520903,0.00038446905,0.0010554735],"category_scores_gemma":[0.0008874912,0.00015139506,0.00033852586,0.00026495708,0.00033925928,0.00021850232,0.00018451342,0.0008774762,0.00021940963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09671966,0.015719946,0.1657447,0.0007720803,0.00060434546,0.010716888,0.000843793,0.0053015165,0.09180316,0.0013231564,0.005355256,0.60509557],"study_design_scores_gemma":[0.014501639,0.40172184,0.44950902,0.00024444074,0.0015186496,0.028372163,0.0009148494,0.0067193424,0.067457706,0.0013506092,0.027605768,0.00008397444],"about_ca_topic_score_codex":0.0006447453,"about_ca_topic_score_gemma":0.0015420171,"teacher_disagreement_score":0.0010554735,"about_ca_system_score_codex":0.0004619296,"about_ca_system_score_gemma":0.0005329372,"threshold_uncertainty_score":0.0035309196},"labels":[],"label_agreement":null},{"id":"W2030801788","doi":"10.3816/cbc.2002.n.030","title":"Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial","year":2002,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Hôpital Saint-Luc; Lakeridge Health; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Docetaxel; Cyclophosphamide; Breast cancer; Oncology; Granulocyte colony-stimulating factor; Internal medicine; Cancer; Clinical trial; Neutropenia; Chemotherapy; Surgery","score_opus":0.08372146754036529,"score_gpt":0.3929917698684891,"score_spread":0.3092703023281238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030801788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707795,0.005171439,0.00041560142,0.0014571386,0.00036059518,0.0010660185,0.0012836364,0.0001772372,0.002990406],"genre_scores_gemma":[0.98508346,0.0032080985,0.001459226,0.0017864086,0.00034321242,0.0011929577,0.0026908165,0.00004691833,0.0041889423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995889,0.00024522797,0.000012616833,0.000055056164,0.00002869972,0.000069504844],"domain_scores_gemma":[0.9993587,0.00016316764,0.00012694692,0.00004359745,0.000033488337,0.0002740438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120332,0.0015289481,0.0024294804,0.0003366226,0.00036233215,0.00097137847,0.0010554986,0.0013134411,0.0036076135],"category_scores_gemma":[0.0014731418,0.0004200123,0.0013637046,0.0004296139,0.00083600025,0.0005995704,0.00030266508,0.0039110435,0.00075426983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92918396,0.0075910133,0.001319406,0.00041706717,0.0011349253,0.00007173372,0.00006628872,0.0010083342,0.006386945,0.0002310092,0.0035171947,0.049072124],"study_design_scores_gemma":[0.92957014,0.06304684,0.0037664266,0.000031182397,0.00050820847,0.00008423954,0.000027540236,0.00063588587,0.0007492609,0.00017516386,0.0013856939,0.000019490864],"about_ca_topic_score_codex":0.002623489,"about_ca_topic_score_gemma":0.00549819,"teacher_disagreement_score":0.0036076135,"about_ca_system_score_codex":0.0012187574,"about_ca_system_score_gemma":0.0016373408,"threshold_uncertainty_score":0.012068629},"labels":[],"label_agreement":null},{"id":"W2034693832","doi":"10.1016/j.clbc.2011.04.001","title":"Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Bevacizumab; Capecitabine; Breast cancer; Mucositis; Internal medicine; Oncology; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Regimen; Cancer; Surgery; Colorectal cancer","score_opus":0.07746102873287435,"score_gpt":0.44725440114429066,"score_spread":0.3697933724114163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034693832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930166,0.0021903396,0.00046285876,0.0005130709,0.00025994325,0.0011963765,0.00033901373,0.00008487905,0.0019369068],"genre_scores_gemma":[0.98995984,0.0023625507,0.0021077127,0.0005322781,0.00017902635,0.0011786501,0.00095004996,0.00003472342,0.0026951062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956256,0.00015717436,0.000024507175,0.000105333056,0.000049222217,0.00010120888],"domain_scores_gemma":[0.99941254,0.000102504644,0.00009569165,0.0000507041,0.000027167996,0.0003114893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014100604,0.0013478943,0.002242643,0.000684187,0.00042908758,0.0010127645,0.0010066576,0.0010179257,0.0033457724],"category_scores_gemma":[0.0010724426,0.00067245925,0.0009674306,0.0007484055,0.0009398284,0.001109065,0.00042224053,0.0030820991,0.000756008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7390078,0.05926314,0.0041555963,0.00073709874,0.0015632001,0.00012745583,0.00027870885,0.0050784783,0.02258904,0.00061792496,0.0032841088,0.16329752],"study_design_scores_gemma":[0.62992775,0.35147095,0.008540381,0.00006333165,0.0006133928,0.00019799269,0.00009027411,0.0026927195,0.00300188,0.00039029124,0.0029629115,0.000048201873],"about_ca_topic_score_codex":0.0030358804,"about_ca_topic_score_gemma":0.011825981,"teacher_disagreement_score":0.0033457724,"about_ca_system_score_codex":0.0012934709,"about_ca_system_score_gemma":0.0018441508,"threshold_uncertainty_score":0.011192679},"labels":[],"label_agreement":null},{"id":"W2035191914","doi":"10.1016/j.clbc.2014.07.006","title":"Cysteine Rhenium Colloid: A Novel Radiocolloid for Identifying Sentinel Lymph Nodes in Breast Cancer Surgery","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; London Health Sciences Centre; Lawson Health Research Institute; Sunnybrook Health Science Centre; Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"Medicine; Breast cancer; Sentinel node; Sentinel lymph node; Odds ratio; Lymph node; Lymph; Cancer; Axillary Lymph Node Dissection; Internal medicine; Oncology; Surgery; Radiology; Pathology","score_opus":0.04488594632235332,"score_gpt":0.3584862492876611,"score_spread":0.3136003029653078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035191914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990171,0.007863958,0.0010296128,0.00022488424,0.000039578492,0.000057933506,0.000021096032,0.000023283312,0.0005687138],"genre_scores_gemma":[0.9947507,0.0021203167,0.002729573,0.00006432578,0.000038617723,0.000020932952,0.00003843365,0.0000054570114,0.00023171736],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972254,0.00008474441,0.00002629025,0.000036557427,0.00011322062,0.000016616448],"domain_scores_gemma":[0.99951804,0.00012119151,0.00020660463,0.00002284789,0.00007057527,0.00006080053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007611862,0.00020419806,0.00020299606,0.00046415796,0.00014516589,0.00037620403,0.00027919895,0.00026652947,0.00048385505],"category_scores_gemma":[0.0012518544,0.00010578627,0.00015092605,0.00022647475,0.00038995908,0.0003024868,0.00025638845,0.00021577325,0.00013138687],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011198854,0.0015729957,0.44032118,0.0016688607,0.0003078048,0.0027775974,0.00039358303,0.0010178845,0.24673198,0.00032571788,0.0016992363,0.29198432],"study_design_scores_gemma":[0.002105534,0.053555477,0.63930064,0.00062714674,0.0010378584,0.04299678,0.0010153282,0.009289764,0.22807764,0.0003841364,0.021495966,0.00011363587],"about_ca_topic_score_codex":0.0011283449,"about_ca_topic_score_gemma":0.00255468,"teacher_disagreement_score":0.0011283449,"about_ca_system_score_codex":0.00046508337,"about_ca_system_score_gemma":0.00065415027,"threshold_uncertainty_score":0.0040255785},"labels":[],"label_agreement":null},{"id":"W2036145991","doi":"10.3816/cbc.2000.s.012","title":"Epirubicin in Breast Cancer: Present and Future","year":2000,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Breast cancer; Oncology; Trastuzumab; Taxane; Internal medicine; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Doxorubicin; Cancer; Pharmacology","score_opus":0.08241764795168283,"score_gpt":0.4870500193305227,"score_spread":0.4046323713788399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036145991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013374763,0.9982199,0.00013510845,0.00033656906,0.00025762193,0.000005571664,0.000014721579,0.000010256286,0.0008864361],"genre_scores_gemma":[0.0006764952,0.9975452,0.00021819203,0.0003414541,0.0002604912,0.000007318892,0.000020584326,0.0000014666317,0.00092873257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983346,0.00003449793,0.00002638709,0.00003492869,0.000054595963,0.000016209044],"domain_scores_gemma":[0.9996865,0.00011974438,0.00006907502,0.000009892572,0.000076555894,0.000038235863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007222762,0.0011685798,0.0020070777,0.0019634743,0.00025788174,0.0011273931,0.00084053166,0.0011246959,0.0049504023],"category_scores_gemma":[0.0007042241,0.00035109452,0.0004051972,0.0026908068,0.00053118553,0.0022603697,0.00062096474,0.0017516704,0.0025394051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019024819,0.00010321591,0.00016169547,0.009396407,0.00007335148,0.00017248772,0.000037314192,0.00038400127,0.0015479465,0.0016494525,0.030696958,0.9555869],"study_design_scores_gemma":[0.00009970878,0.00031058377,0.0010801569,0.0026147652,0.00022421233,0.0012553608,0.000067347726,0.00023610509,0.00045037258,0.0014248427,0.9922151,0.000021488726],"about_ca_topic_score_codex":0.0012238811,"about_ca_topic_score_gemma":0.004513909,"teacher_disagreement_score":0.0049504023,"about_ca_system_score_codex":0.0006433324,"about_ca_system_score_gemma":0.0011579512,"threshold_uncertainty_score":0.016560733},"labels":[],"label_agreement":null},{"id":"W2037157828","doi":"10.1016/j.clbc.2013.08.011","title":"Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Exemestane; Medicine; Everolimus; Breast cancer; Oncology; Internal medicine; Hormone receptor; Aromatase; Cancer; Gynecology","score_opus":0.009278835326357648,"score_gpt":0.29030447419732325,"score_spread":0.2810256388709656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037157828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858577,0.009256128,0.000090701964,0.0002423679,0.000078931094,0.00022565978,0.00045013125,0.000015753943,0.0010545637],"genre_scores_gemma":[0.9935725,0.0031927277,0.00035415206,0.0005838145,0.00015515005,0.00030045834,0.0010633979,0.0000065725217,0.0007713348],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960047,0.00017734965,0.00004626786,0.000075147575,0.000047017944,0.000053805008],"domain_scores_gemma":[0.9992817,0.00014541013,0.00025569287,0.000036647605,0.00002807475,0.00025245047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015548421,0.0004983817,0.0018181128,0.00032438265,0.00023970421,0.00079796766,0.00048828794,0.0006577671,0.0022006752],"category_scores_gemma":[0.0015336631,0.00031901375,0.0015344293,0.00034507122,0.0004307371,0.0007253655,0.0004437484,0.0015367505,0.00034625345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9318219,0.0049755033,0.012387465,0.0006041335,0.0017351,0.00011508546,0.00008391479,0.0008073614,0.006543196,0.000072450785,0.0007957037,0.040058333],"study_design_scores_gemma":[0.6227151,0.28468838,0.081766196,0.00022794874,0.0034799841,0.00039253567,0.00009028526,0.0011822217,0.0020913125,0.00018816492,0.0031304357,0.000047387213],"about_ca_topic_score_codex":0.00043660382,"about_ca_topic_score_gemma":0.0015082253,"teacher_disagreement_score":0.0022006752,"about_ca_system_score_codex":0.0007980281,"about_ca_system_score_gemma":0.00082190457,"threshold_uncertainty_score":0.008222938},"labels":[],"label_agreement":null},{"id":"W2040839197","doi":"10.3816/cbc.2008.n.028","title":"Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Lymphovascular invasion; Oncology; Lumpectomy; Internal medicine; Axilla; Progesterone receptor; Pathology; Lymph node; Cancer; Stage (stratigraphy); Immunohistochemistry; Biopsy; Estrogen receptor; Mastectomy; Metastasis; Biology","score_opus":0.021425438747411815,"score_gpt":0.32080971284967447,"score_spread":0.29938427410226265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040839197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787307,0.0008084366,0.00009155887,0.00008350033,0.000012581489,0.0000034495874,0.00021098372,0.0000046174537,0.0009117896],"genre_scores_gemma":[0.99900395,0.00023659556,0.000047609083,0.000026131871,0.000013930871,0.0000023198243,0.00019525773,0.0000023418481,0.0004719459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981874,0.0000741744,0.000015825826,0.00002630191,0.00003712005,0.000027930842],"domain_scores_gemma":[0.9990778,0.00029650598,0.00023225263,0.00009979444,0.00010291238,0.0001907456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043902255,0.00018449812,0.00038458087,0.00038889865,0.00024092385,0.0005746377,0.00022845635,0.00029811528,0.0025628093],"category_scores_gemma":[0.0017896105,0.00017267131,0.00036765088,0.0005589134,0.00016651936,0.00018420459,0.00012780401,0.0004771731,0.00033055365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006723118,0.000058107213,0.994665,0.000013826348,0.00006190857,0.000060225022,0.000031648582,0.00004383984,0.0016423517,0.00002015751,0.000095052164,0.0026355393],"study_design_scores_gemma":[0.0000068787676,0.000085404325,0.99907035,0.000002309006,0.000051026294,0.00022069199,0.00006034851,0.00005262827,0.00028730513,0.000025716106,0.00013614942,0.0000011828865],"about_ca_topic_score_codex":0.0031922506,"about_ca_topic_score_gemma":0.003391372,"teacher_disagreement_score":0.0031922506,"about_ca_system_score_codex":0.00022030389,"about_ca_system_score_gemma":0.00030977002,"threshold_uncertainty_score":0.0085734725},"labels":[],"label_agreement":null},{"id":"W2044133019","doi":"10.3816/cbc.2010.n.011","title":"A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Epirubicin; Trastuzumab; Breast cancer; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Cyclophosphamide; Clinical endpoint; Metastatic breast cancer; Febrile neutropenia; Anthracycline; Gastroenterology; Neutropenia; Cancer; Clinical trial","score_opus":0.01581447337146425,"score_gpt":0.3545481122868749,"score_spread":0.33873363891541064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044133019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413484,0.0010907844,0.0005224464,0.00050494244,0.00024313379,0.0014947109,0.00032543988,0.000077499295,0.0016061537],"genre_scores_gemma":[0.98941094,0.0016010962,0.0014762225,0.00053455983,0.00020773153,0.0023695808,0.00081090874,0.000047168913,0.003541784],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99942064,0.00027661887,0.000022678882,0.0000954295,0.000043500222,0.00014115583],"domain_scores_gemma":[0.99925,0.00015183115,0.000112813235,0.00011381293,0.000035493962,0.000336003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014472242,0.0017929323,0.0024172154,0.0005306274,0.0005669492,0.001036254,0.0009788376,0.0013435334,0.004150128],"category_scores_gemma":[0.0009165433,0.00079552067,0.0008639873,0.00060355,0.00163853,0.0012064242,0.00036816526,0.0034073112,0.0009835094],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79577935,0.10390861,0.0014898231,0.0004815229,0.00063385087,0.0001391934,0.00028139277,0.002588047,0.043682,0.0003431176,0.0022912452,0.04838184],"study_design_scores_gemma":[0.3963804,0.5904677,0.003478618,0.000024033454,0.00032262734,0.00012009658,0.000092740454,0.000840048,0.0062856986,0.00016680996,0.0017906093,0.000030696807],"about_ca_topic_score_codex":0.002379125,"about_ca_topic_score_gemma":0.005784775,"teacher_disagreement_score":0.004150128,"about_ca_system_score_codex":0.0012187051,"about_ca_system_score_gemma":0.0018926968,"threshold_uncertainty_score":0.013883531},"labels":[],"label_agreement":null},{"id":"W2048550637","doi":"10.1016/j.clbc.2011.07.006","title":"Routine Cardiac Evaluation in Patients With Early-Stage Breast Cancer Before Adjuvant Chemotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Adjuvant chemotherapy; Chemotherapy; Internal medicine; Adjuvant; Cancer","score_opus":0.023924683254184564,"score_gpt":0.31827265526639004,"score_spread":0.29434797201220547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048550637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952152,0.0027887814,0.000084288986,0.00012528099,0.000017961913,0.000030323321,0.000074799354,0.0000022689912,0.0016611684],"genre_scores_gemma":[0.9979808,0.0011701735,0.00013618317,0.00015651075,0.00005390421,0.000033770924,0.00015179152,0.0000015988937,0.00031527912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973494,0.00013541125,0.000023741004,0.000025078582,0.000026183061,0.00005461704],"domain_scores_gemma":[0.9989793,0.00042549046,0.00017206771,0.000037944606,0.000105970736,0.00027920667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046349343,0.0002665935,0.0005113883,0.00063122297,0.0004822051,0.00039508133,0.00016147511,0.0004685701,0.00079331663],"category_scores_gemma":[0.0020335722,0.00019017581,0.0001554631,0.00063616,0.00025812525,0.0002605218,0.00016141277,0.00051905075,0.00013774431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037252165,0.00040987562,0.983742,0.00007393267,0.000031272953,0.0007389327,0.00019608348,0.000055258643,0.0030836188,0.000039613857,0.0002127577,0.007691543],"study_design_scores_gemma":[0.00010364632,0.002667952,0.993845,0.000034734785,0.00005528225,0.0012699601,0.0003657652,0.00008134432,0.00080570515,0.00006205718,0.00070161815,0.0000069713938],"about_ca_topic_score_codex":0.0017726193,"about_ca_topic_score_gemma":0.002776867,"teacher_disagreement_score":0.0017726193,"about_ca_system_score_codex":0.0002959035,"about_ca_system_score_gemma":0.00046713228,"threshold_uncertainty_score":0.003524661},"labels":[],"label_agreement":null},{"id":"W2051872169","doi":"10.3816/cbc.2008.n.060","title":"Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Metformin; Breast cancer; Oncology; Internal medicine; Insulin; Cancer; Diabetes mellitus; Gynecology; Endocrinology","score_opus":0.011421107830951092,"score_gpt":0.28709030809243263,"score_spread":0.27566920026148156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051872169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834722,0.013656827,0.000063064836,0.00065778435,0.00012106607,0.000051407802,0.00016801148,0.000016230391,0.0017932825],"genre_scores_gemma":[0.99394435,0.00441083,0.00018004166,0.00036615637,0.00011670116,0.000028266526,0.00015391277,0.0000030054155,0.000796776],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99985456,0.00006644713,0.000014900791,0.000015167233,0.000021415293,0.000027448024],"domain_scores_gemma":[0.9996251,0.00014540351,0.00008128939,0.000012117763,0.000024153347,0.00011187401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004491765,0.0004228304,0.000980999,0.000296105,0.0002354656,0.00033458977,0.00022443371,0.00053244596,0.0014727756],"category_scores_gemma":[0.0017791239,0.00023275806,0.0005610275,0.00036870246,0.00011104415,0.00025030607,0.0001592772,0.00086164253,0.00009954466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40061742,0.010017354,0.24311548,0.0012059968,0.0020762833,0.0017118799,0.00037487168,0.00079868967,0.020771233,0.00020995752,0.0025803454,0.31652057],"study_design_scores_gemma":[0.0331029,0.05707955,0.89477026,0.0002156037,0.00338559,0.0012437406,0.0004488783,0.0010940288,0.003641548,0.00034137364,0.004620477,0.000056049914],"about_ca_topic_score_codex":0.00260639,"about_ca_topic_score_gemma":0.007221115,"teacher_disagreement_score":0.00260639,"about_ca_system_score_codex":0.0004360799,"about_ca_system_score_gemma":0.0004539962,"threshold_uncertainty_score":0.005182445},"labels":[],"label_agreement":null},{"id":"W2051878959","doi":"10.3816/cbc.2010.n.023","title":"Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Metastatic breast cancer; Capecitabine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Clinical endpoint; Cancer; Randomized controlled trial; Colorectal cancer","score_opus":0.08561982642156016,"score_gpt":0.46778926604650717,"score_spread":0.382169439624947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051878959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878011,0.004116989,0.000523755,0.00075778033,0.000139532,0.001412309,0.0011446016,0.000118554985,0.003985394],"genre_scores_gemma":[0.98596144,0.0044881715,0.0011950611,0.0008439315,0.00017527546,0.0012205391,0.00223301,0.000046862933,0.0038357924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999569,0.00023498439,0.000015205329,0.00003518447,0.000025380588,0.00012023778],"domain_scores_gemma":[0.9995808,0.00008838607,0.000074337375,0.00003387,0.000019749528,0.00020279117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012770449,0.0013163653,0.0020160319,0.00048930553,0.00038243827,0.0007077398,0.0008235851,0.000852509,0.0042443653],"category_scores_gemma":[0.00073037005,0.00046284354,0.0008533229,0.0006069237,0.00074862735,0.0006957249,0.00036675893,0.002405059,0.000974905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6452221,0.040849555,0.007992032,0.00089103746,0.0016489518,0.0003879968,0.00038164703,0.0047506616,0.051200867,0.0009820673,0.008560452,0.2371326],"study_design_scores_gemma":[0.5458852,0.4147562,0.022057164,0.000073052724,0.0007359301,0.0004982791,0.0001697589,0.0015739837,0.006048313,0.0005081262,0.0076552033,0.000038827733],"about_ca_topic_score_codex":0.0016448159,"about_ca_topic_score_gemma":0.006050619,"teacher_disagreement_score":0.0042443653,"about_ca_system_score_codex":0.00071812456,"about_ca_system_score_gemma":0.0010950033,"threshold_uncertainty_score":0.01419878},"labels":[],"label_agreement":null},{"id":"W2051989799","doi":"10.3816/cbc.2009.n.005","title":"Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Internal medicine; Metastatic breast cancer; Clinical trial; Surgery; Cancer","score_opus":0.08327100169660151,"score_gpt":0.4464181951761753,"score_spread":0.3631471934795738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051989799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9081692,0.047266535,0.010733758,0.015785405,0.001590501,0.0045903353,0.0025265308,0.000065158005,0.009272643],"genre_scores_gemma":[0.98466337,0.0028504117,0.0033925134,0.0021971017,0.0005781323,0.004679642,0.0010486629,0.000024383791,0.0005658153],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.93547976,0.05815732,0.0032493006,0.0015504704,0.00091931387,0.00064379605],"domain_scores_gemma":[0.9339685,0.05083475,0.0072048036,0.0031717815,0.002174783,0.0026454867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.076447725,0.000895384,0.0032771572,0.0006326456,0.0009937627,0.002007844,0.0011246525,0.001788598,0.0030351155],"category_scores_gemma":[0.101914026,0.00035652085,0.0023304294,0.0020026146,0.0017053807,0.0024081934,0.0016092897,0.002250153,0.00038987322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48988217,0.0030686166,0.29365918,0.00585345,0.014856877,0.0002521085,0.0010635644,0.0042465096,0.0014372389,0.008013665,0.005037411,0.17262915],"study_design_scores_gemma":[0.24615356,0.17995866,0.4420514,0.0041495883,0.03722662,0.00075103267,0.0021054696,0.01134097,0.0032107043,0.046877977,0.025846187,0.0003278335],"about_ca_topic_score_codex":0.000676593,"about_ca_topic_score_gemma":0.0016032181,"teacher_disagreement_score":0.076447725,"about_ca_system_score_codex":0.0014739409,"about_ca_system_score_gemma":0.0023395424,"threshold_uncertainty_score":0.40429902},"labels":[],"label_agreement":null},{"id":"W2061136852","doi":"10.1016/s1526-8209(11)70099-4","title":"Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; BRCA2 Protein; Male breast cancer; Gynecology; Internal medicine; Cancer; Mutation; Demography; Genetics; Germline mutation; Gene; Biology","score_opus":0.012467432172761314,"score_gpt":0.30934350909109176,"score_spread":0.29687607691833046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061136852","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010258787,0.0021842977,0.00005163834,0.9512195,0.04245523,0.000015335963,0.00058002316,0.000023360526,0.0024447793],"genre_scores_gemma":[0.0079831,0.0017918363,0.00009815504,0.95423096,0.030536935,0.00003764736,0.00017973027,0.0000262844,0.0051153535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957683,0.0006476217,0.0005835856,0.0005700723,0.0014892464,0.0009411465],"domain_scores_gemma":[0.97373295,0.009482499,0.0014376153,0.00029145685,0.011117382,0.0039381436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033603979,0.0006258648,0.0015346776,0.0013431509,0.005451428,0.0022501927,0.0032053567,0.027802274,0.0071419645],"category_scores_gemma":[0.02411019,0.00091013376,0.0016962448,0.002160221,0.0027775378,0.0014108274,0.0012490364,0.020944148,0.0023447145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000533281,0.0000063030825,0.0011751718,0.00009154726,0.000023720373,0.00023656746,0.00014395127,0.00003927131,0.000059668622,0.00045016236,0.9954769,0.0022434066],"study_design_scores_gemma":[0.00022050894,0.00006485603,0.016320853,0.0014470938,0.00024186155,0.0010162931,0.001842082,0.00035574,0.00036988675,0.0014296114,0.9765096,0.00018161246],"about_ca_topic_score_codex":0.57572794,"about_ca_topic_score_gemma":0.6521872,"teacher_disagreement_score":0.57572794,"about_ca_system_score_codex":0.015387628,"about_ca_system_score_gemma":0.02576117,"threshold_uncertainty_score":0.8535414},"labels":[],"label_agreement":null},{"id":"W2063413445","doi":"10.3816/cbc.2002.n.025","title":"Bisphosphonates: Biological Response Modifiers in Breast Cancer","year":2002,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bisphosphonate; Bone pain; Bone resorption; Osteonecrosis of the jaw; Breast cancer; Osteoclast; Internal medicine; Bone remodeling; Osteoporosis; Cancer; Oncology; Pharmacology; Endocrinology","score_opus":0.19873458699543295,"score_gpt":0.48398274573362987,"score_spread":0.2852481587381969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063413445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081273196,0.9993135,0.000064176296,0.00011784145,0.00010123635,0.0000044130175,0.000014715236,0.0000050768526,0.0002977733],"genre_scores_gemma":[0.0006510518,0.99846953,0.00016869677,0.0002503663,0.00012491632,0.0000064154674,0.00002431534,8.185823e-7,0.0003038941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996055,0.00007511156,0.0000885836,0.000070788046,0.00013108137,0.000029016248],"domain_scores_gemma":[0.9991917,0.00047562682,0.00015641787,0.000016999438,0.00012081193,0.00003848657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012482282,0.001189429,0.002665708,0.002702804,0.00027470075,0.0012076786,0.0010816101,0.0015886048,0.003731761],"category_scores_gemma":[0.0015538661,0.00046274712,0.0007823454,0.003599409,0.00052158977,0.0010949278,0.00052206457,0.0021082729,0.0017308127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030994465,0.00015516538,0.00022874294,0.024172446,0.00024504916,0.00018258035,0.000038491893,0.0004240477,0.001227172,0.0011957941,0.018532563,0.9532881],"study_design_scores_gemma":[0.00035044018,0.000610745,0.0026548158,0.008593117,0.0013709113,0.002104815,0.00008358709,0.00021224907,0.0008286621,0.0012663985,0.9818779,0.000046401987],"about_ca_topic_score_codex":0.0015036137,"about_ca_topic_score_gemma":0.0036536527,"teacher_disagreement_score":0.003731761,"about_ca_system_score_codex":0.0006982716,"about_ca_system_score_gemma":0.0012820929,"threshold_uncertainty_score":0.012483954},"labels":[],"label_agreement":null},{"id":"W2065575837","doi":"10.3816/cbc.2004.n.003","title":"Adjuvant Radiation Therapy After Breast-Conserving Surgery in Elderly Women with Early-Stage Breast Cancer: Controversy or Consensus?","year":2004,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Breast-conserving surgery; Population; Randomized controlled trial; Clinical trial; Disease; Stage (stratigraphy); Cancer; Oncology; Internal medicine","score_opus":0.03575336091794758,"score_gpt":0.3542707294309918,"score_spread":0.31851736851304424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065575837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091442795,0.99922895,0.000022072732,0.00039384817,0.00011883439,0.0000013767176,0.0000063210437,8.5150043e-7,0.00013623443],"genre_scores_gemma":[0.0011144439,0.99792284,0.00009062365,0.0005335098,0.00022353548,0.0000040742293,0.000015555106,6.157775e-7,0.00009479902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949026,0.00017019028,0.0001218185,0.00008118778,0.00010994129,0.000026634656],"domain_scores_gemma":[0.9986071,0.0009462933,0.00020260483,0.000025020254,0.00018212928,0.000036921865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023293477,0.00055457134,0.00347774,0.0010639238,0.00023693689,0.0011648762,0.0012937572,0.0015516129,0.0018721626],"category_scores_gemma":[0.0031821826,0.00024717866,0.0006876719,0.0020737415,0.0006882869,0.0010670171,0.00046596376,0.0014560568,0.0004782918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046461535,0.000048045466,0.0008952677,0.029839542,0.00037038905,0.00027821108,0.00007202897,0.00018678315,0.0004400673,0.0011062373,0.02396362,0.9423351],"study_design_scores_gemma":[0.0007129091,0.0005880533,0.009452608,0.053816747,0.003923074,0.0039285794,0.00056505576,0.00022755131,0.0006433249,0.0034902696,0.9225841,0.00006773253],"about_ca_topic_score_codex":0.0020042812,"about_ca_topic_score_gemma":0.005228727,"teacher_disagreement_score":0.00347774,"about_ca_system_score_codex":0.00081369764,"about_ca_system_score_gemma":0.0017486396,"threshold_uncertainty_score":0.012318909},"labels":[],"label_agreement":null},{"id":"W2066920175","doi":"10.1016/j.clbc.2013.09.001","title":"Contemporary Systemic Therapy for Male Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Medicine; Tamoxifen; Breast cancer; Internal medicine; Oncology; Trastuzumab; Male breast cancer; Aromatase; Population; Tolerability; Gynecology; Cohort; Adjuvant therapy; Cancer; Adverse effect","score_opus":0.09822054884637849,"score_gpt":0.4268114209734858,"score_spread":0.3285908721271073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066920175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07394286,0.8711916,0.00035979602,0.029087223,0.00059321406,0.000041527055,0.00030910168,0.000008962408,0.024465725],"genre_scores_gemma":[0.4855688,0.49524638,0.0004520746,0.011218428,0.00393773,0.00011761622,0.00032855113,0.000011160126,0.0031191898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898404,0.00068345154,0.00008072585,0.00006493324,0.00012485856,0.000061976636],"domain_scores_gemma":[0.9969066,0.002083012,0.0004947374,0.00014818036,0.00018019581,0.00018735345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017119307,0.000106773776,0.00033804856,0.0009538988,0.000441107,0.0008784818,0.00025806276,0.00042371,0.0068830703],"category_scores_gemma":[0.003579692,0.00007310724,0.00025129507,0.0029503678,0.0008589878,0.00070536527,0.00053126656,0.0007136117,0.00033562837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016007974,0.00038513084,0.04551063,0.0051192646,0.0003251845,0.0002272651,0.0014487164,0.00022852395,0.0019676103,0.024856482,0.024260426,0.89406997],"study_design_scores_gemma":[0.000801375,0.003542767,0.48328692,0.011930905,0.0014264979,0.0027781758,0.007051233,0.00034105306,0.0024037012,0.016954774,0.46942994,0.000052695905],"about_ca_topic_score_codex":0.0022603546,"about_ca_topic_score_gemma":0.006827902,"teacher_disagreement_score":0.0068830703,"about_ca_system_score_codex":0.0012007768,"about_ca_system_score_gemma":0.0016377004,"threshold_uncertainty_score":0.023026228},"labels":[],"label_agreement":null},{"id":"W2068559390","doi":"10.3816/cbc.2004.n.025","title":"Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Docetaxel; Medicine; Quality of life (healthcare); Nausea; Breast cancer; Internal medicine; Adverse effect; Oncology; Vomiting; Clinical trial; Cancer; Nursing","score_opus":0.0456254794329484,"score_gpt":0.42091801635756826,"score_spread":0.37529253692461984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068559390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331987,0.004438037,0.000035989517,0.00034016688,0.000028606104,0.000017353672,0.00023782231,0.0000026106122,0.001579453],"genre_scores_gemma":[0.9988613,0.000671141,0.000025412422,0.0000779483,0.000010391818,0.0000071980776,0.00011576145,5.0519543e-7,0.00023023099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998184,0.00007196449,0.000016149565,0.000017756221,0.000035062927,0.000040826206],"domain_scores_gemma":[0.9995572,0.000103817816,0.0001778801,0.000010565226,0.000043266602,0.00010725727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028261897,0.00013051255,0.00037949145,0.00021533917,0.00021807462,0.0004063439,0.00012521794,0.00022801678,0.0008884138],"category_scores_gemma":[0.0015718918,0.00009400882,0.0006256728,0.00043726375,0.00013392424,0.00018969987,0.00018374989,0.0003945854,0.00006480605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007944546,0.00090395624,0.9434919,0.00017882073,0.0008945575,0.00029905967,0.00037749042,0.00060026336,0.0010194798,0.00009112415,0.00096459524,0.04323429],"study_design_scores_gemma":[0.0002863071,0.0028051331,0.99475044,0.000025441439,0.00029183764,0.0002643568,0.00021177526,0.0002948146,0.000115300965,0.00005120618,0.0008955801,0.00000783814],"about_ca_topic_score_codex":0.0052866247,"about_ca_topic_score_gemma":0.009295277,"teacher_disagreement_score":0.0052866247,"about_ca_system_score_codex":0.00076999667,"about_ca_system_score_gemma":0.00031075507,"threshold_uncertainty_score":0.010511696},"labels":[],"label_agreement":null},{"id":"W2071269150","doi":"10.1016/j.clbc.2014.12.006","title":"Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"Canadian Cancer Society","keywords":"Medicine; Regimen; Randomized controlled trial; Placebo; Dry skin; Acute toxicity; Breast cancer; Clinical endpoint; Toxicity; Sunburn; Internal medicine; Dermatology; Cancer; Pathology","score_opus":0.06983728022871558,"score_gpt":0.3803238545652436,"score_spread":0.31048657433652804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071269150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548628,0.0089188805,0.0032683124,0.0028322744,0.0028810564,0.016268138,0.003855963,0.0006868303,0.0064257937],"genre_scores_gemma":[0.9525931,0.0043946914,0.0045343563,0.0038546566,0.0016968092,0.016670588,0.0019700825,0.00013438491,0.014151356],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989188,0.0005408885,0.00006868381,0.0001937594,0.00007698606,0.00020085515],"domain_scores_gemma":[0.9982514,0.0005383667,0.00032748785,0.00022549895,0.000117863245,0.0005394323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024168142,0.0023019002,0.006557775,0.0009453614,0.00080410123,0.0019240945,0.00196325,0.003538915,0.019308055],"category_scores_gemma":[0.0023032003,0.00097431714,0.0032661078,0.000833569,0.0022240628,0.0015928275,0.0008015102,0.005309903,0.0029130923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99008137,0.0035936146,0.00006392305,0.0002980028,0.0003313538,0.0000069937187,0.000017494815,0.00012621422,0.00082492095,0.000059810383,0.00028238728,0.0043140627],"study_design_scores_gemma":[0.9818425,0.017332433,0.00019934909,0.000012918479,0.00013783562,0.00000432953,0.000008078136,0.00010414773,0.00008497048,0.000081934115,0.0001860961,0.000005438891],"about_ca_topic_score_codex":0.0021754839,"about_ca_topic_score_gemma":0.0035548238,"teacher_disagreement_score":0.019308055,"about_ca_system_score_codex":0.0012186291,"about_ca_system_score_gemma":0.001618434,"threshold_uncertainty_score":0.064591885},"labels":[],"label_agreement":null},{"id":"W2072712535","doi":"10.3816/cbc.2008.s.014","title":"Basal and Triple-Negative Breast Cancers: Impact on Clinical Decision-Making and Novel Therapeutic Options","year":2008,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Subtyping; Triple negative; Oncology; Clinical decision making; Triple-negative breast cancer; Internal medicine; Bioinformatics; Cancer; Intensive care medicine; Biology","score_opus":0.08261093959511503,"score_gpt":0.4686493979078485,"score_spread":0.3860384583127334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072712535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006656173,0.9988977,0.00008034715,0.00047781583,0.00012618735,0.0000015549651,0.000009799839,0.0000024220915,0.00033761197],"genre_scores_gemma":[0.00059129816,0.99856085,0.0001909229,0.0002624855,0.00019949541,0.0000034523569,0.00001595127,7.8118234e-7,0.00017474616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996716,0.00009474515,0.00004341242,0.000053186814,0.00011221774,0.000024863317],"domain_scores_gemma":[0.99876654,0.00082512404,0.00011364965,0.00002368069,0.00021834273,0.000052669046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432892,0.00089157006,0.0025782483,0.0015456011,0.0002404947,0.0014760043,0.0011687268,0.0014519977,0.0022583737],"category_scores_gemma":[0.0019151671,0.00030247064,0.0005078072,0.0024971482,0.0007985161,0.001307086,0.0005795818,0.0022864593,0.0011803505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001588793,0.000064301115,0.00033327297,0.008767406,0.00012343585,0.00020150242,0.000032682266,0.0003509589,0.00056003546,0.002813214,0.030774321,0.9558199],"study_design_scores_gemma":[0.00009698497,0.00016307112,0.0022413603,0.007769608,0.00042591832,0.0023841858,0.00016622002,0.00024333957,0.0005283074,0.004942419,0.98099774,0.000040843785],"about_ca_topic_score_codex":0.0015425752,"about_ca_topic_score_gemma":0.0032757714,"teacher_disagreement_score":0.0025782483,"about_ca_system_score_codex":0.0010651767,"about_ca_system_score_gemma":0.0015212796,"threshold_uncertainty_score":0.0077284575},"labels":[],"label_agreement":null},{"id":"W2076902557","doi":"10.3816/cbc.2000.n.013","title":"Internet Usage Among Women with Breast Cancer: An Exploratory Study","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Grey Nuns Community Hospital","funders":"Hope Foundation","keywords":"The Internet; Medicine; Breast cancer; Family medicine; Cancer; Medical information; Internet access; Internal medicine; World Wide Web","score_opus":0.0735965495379866,"score_gpt":0.39662678512393285,"score_spread":0.32303023558594623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076902557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868613,0.00013952582,0.00002038943,0.000036445068,0.000002770595,0.000048140813,0.00018867872,0.0000011670833,0.00087687164],"genre_scores_gemma":[0.9980952,0.00040897584,0.00009755536,0.00014102295,0.000018436509,0.00012922839,0.0003135933,0.0000029016164,0.00079307106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993304,0.00032293802,0.00007410049,0.0000666095,0.00009449673,0.000111486],"domain_scores_gemma":[0.99761677,0.0010960302,0.0005683196,0.00010697741,0.00026632048,0.00034566436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008172702,0.0004157537,0.0005843942,0.0021768545,0.001813457,0.0012359592,0.00037831534,0.0009935668,0.004188719],"category_scores_gemma":[0.0034318718,0.00054864207,0.00057983113,0.002431349,0.000584736,0.0015870798,0.0010305641,0.0009091175,0.0009385049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044921378,0.002120905,0.9849262,0.000084931686,0.00005950946,0.00037492078,0.0071844333,0.000017205195,0.00049964944,0.00005624933,0.00013626879,0.0040904097],"study_design_scores_gemma":[0.000053048625,0.0025836695,0.9684743,0.000031177377,0.00009185783,0.0007569189,0.027052233,0.00008736844,0.00013903108,0.00004881968,0.00066587364,0.000015596535],"about_ca_topic_score_codex":0.005521959,"about_ca_topic_score_gemma":0.0069499793,"teacher_disagreement_score":0.005521959,"about_ca_system_score_codex":0.00047693626,"about_ca_system_score_gemma":0.0004641577,"threshold_uncertainty_score":0.014012635},"labels":[],"label_agreement":null},{"id":"W2077037832","doi":"10.1016/j.clbc.2013.10.016","title":"Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck","keywords":"Medicine; Capecitabine; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Colorectal cancer","score_opus":0.020141642534631344,"score_gpt":0.34714416053795083,"score_spread":0.3270025180033195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077037832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98278826,0.004852342,0.0008905178,0.0014350453,0.0013425187,0.0035663815,0.0011678574,0.00014206156,0.0038149685],"genre_scores_gemma":[0.9832023,0.0029693914,0.0016929702,0.0015425256,0.00059547863,0.0031598394,0.00135162,0.000041945434,0.005443934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999443,0.00029490734,0.000026476891,0.00010607597,0.000028292468,0.000101287435],"domain_scores_gemma":[0.99894434,0.0003129264,0.0001841065,0.00008773196,0.00004984193,0.00042104034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015164757,0.0018867248,0.0035472582,0.00046860828,0.00048751893,0.001286798,0.0010153508,0.0014163974,0.008457474],"category_scores_gemma":[0.0019442183,0.00090815686,0.0014160434,0.000515894,0.001629685,0.0013235252,0.00049503363,0.0039281263,0.0011762308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.984235,0.0037387991,0.0002471939,0.0002649607,0.00035036338,0.00002166089,0.000027167858,0.0003939369,0.0013696143,0.00013561473,0.0005429303,0.00867278],"study_design_scores_gemma":[0.9643609,0.033846516,0.0005256326,0.000014527851,0.00017130689,0.000018951305,0.00001624707,0.00029802663,0.00016721574,0.00014096173,0.00043191342,0.000007782311],"about_ca_topic_score_codex":0.0020712821,"about_ca_topic_score_gemma":0.005411176,"teacher_disagreement_score":0.008457474,"about_ca_system_score_codex":0.0015108638,"about_ca_system_score_gemma":0.0016277405,"threshold_uncertainty_score":0.028293073},"labels":[],"label_agreement":null},{"id":"W2081331508","doi":"10.3816/cbc.2005.s.003","title":"Evaluating Bone Mass and Bone Quality in Patients with Breast Cancer","year":2005,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Bone remodeling; Bone mineral; Osteoporosis; Cancellous bone; Bone density; Internal medicine; Endocrinology; Cortical bone; Breast cancer; Cancer; Pathology","score_opus":0.21201654103952186,"score_gpt":0.5646748522907314,"score_spread":0.3526583112512096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081331508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016670606,0.9994541,0.000039128652,0.00009507841,0.000043356846,0.0000036553865,0.000019516869,0.00000227014,0.00017619996],"genre_scores_gemma":[0.0020687107,0.9972609,0.00020888825,0.00020294548,0.000096194075,0.000007114398,0.000035159643,7.9065904e-7,0.0001191654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994486,0.00009550482,0.000133465,0.000092879745,0.00020882885,0.000020714373],"domain_scores_gemma":[0.99852294,0.0009708812,0.00022623956,0.000017489416,0.00022922468,0.00003314448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010261886,0.00089766557,0.004237137,0.0033127218,0.00016869843,0.0007647492,0.0009921031,0.0010588771,0.0016273863],"category_scores_gemma":[0.0026496537,0.0004638649,0.0010675133,0.0036773433,0.00048169887,0.00073079334,0.0004842491,0.0010840157,0.00048112636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026661655,0.000085509164,0.0027558901,0.04178031,0.001020976,0.00015202267,0.000040346316,0.00020365455,0.0004481167,0.0003828516,0.009898674,0.942965],"study_design_scores_gemma":[0.0010147943,0.0015247212,0.08851317,0.09873698,0.020119026,0.010436136,0.00066144014,0.0011500036,0.002215719,0.004513472,0.7708526,0.0002619083],"about_ca_topic_score_codex":0.004428321,"about_ca_topic_score_gemma":0.011288665,"teacher_disagreement_score":0.004428321,"about_ca_system_score_codex":0.0005870635,"about_ca_system_score_gemma":0.0011228123,"threshold_uncertainty_score":0.008805096},"labels":[],"label_agreement":null},{"id":"W2081584264","doi":"10.3816/cbc.2004.n.030","title":"Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Docetaxel; Capecitabine; Medicine; Chemotherapy; Internal medicine; Oncology; Vinorelbine; Hazard ratio; Randomized controlled trial; Breast cancer; Surgery; Cancer; Confidence interval; Colorectal cancer; Cisplatin","score_opus":0.06626576878013078,"score_gpt":0.4365959759552752,"score_spread":0.3703302071751444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081584264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855359,0.007010443,0.00091606006,0.0010257118,0.0004336506,0.002135501,0.0010606041,0.00008683523,0.0017953204],"genre_scores_gemma":[0.98908615,0.0026576712,0.0015112248,0.0008720278,0.00045290674,0.0020518226,0.001420279,0.00003996383,0.0019078737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99659365,0.0024175318,0.00012278011,0.0004335706,0.0001348468,0.00029760788],"domain_scores_gemma":[0.9960544,0.0019383811,0.0006818418,0.00035783564,0.000120126904,0.0008473633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062192287,0.002560821,0.0053303647,0.0005796454,0.0006490889,0.0016362274,0.0013187992,0.002007926,0.005171392],"category_scores_gemma":[0.004908537,0.00083440344,0.004332125,0.0008164389,0.0024561503,0.0019482371,0.0006909947,0.0056835837,0.000827093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9883145,0.0016983591,0.0005493524,0.00016636035,0.0010087985,0.00001931411,0.000029200393,0.00039218398,0.0008547325,0.0000607368,0.0003099206,0.006596596],"study_design_scores_gemma":[0.9409628,0.05409096,0.0019908696,0.00003028603,0.0015597781,0.000032879976,0.00001977929,0.00046344436,0.00026531692,0.00021647269,0.0003524522,0.000014998093],"about_ca_topic_score_codex":0.0010305415,"about_ca_topic_score_gemma":0.0021362281,"teacher_disagreement_score":0.0062192287,"about_ca_system_score_codex":0.001559077,"about_ca_system_score_gemma":0.0017605325,"threshold_uncertainty_score":0.032890797},"labels":[],"label_agreement":null},{"id":"W2091553548","doi":"10.1016/j.clbc.2014.03.003","title":"Juvenile Papillomatosis: A Case Report and Literature Review","year":2014,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queensway-Carleton Hospital; Ottawa Hospital","funders":"","keywords":"Papillomatosis; Medicine; Apocrine; Atypia; Papilloma; Metaplasia; Pathology; Dermatology; Duct (anatomy)","score_opus":0.059216333683049426,"score_gpt":0.4315251327352076,"score_spread":0.3723087990521582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091553548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067694103,0.988052,0.0004454246,0.0007987737,0.00029721338,0.000029493205,0.0001885141,0.00004219235,0.0033769496],"genre_scores_gemma":[0.027104678,0.9679156,0.0012325112,0.00109017,0.0008055772,0.0000198204,0.0002813016,0.000012747413,0.0015375598],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99957186,0.00004525127,0.00016397625,0.00007848826,0.00008734397,0.000053078955],"domain_scores_gemma":[0.9992181,0.0003044118,0.00027305234,0.000026705122,0.0000908931,0.00008683873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033682818,0.0011184604,0.0013794414,0.0068358774,0.0007454498,0.0018251705,0.0011269851,0.0016773487,0.0038048956],"category_scores_gemma":[0.0011673155,0.0005208513,0.0007704279,0.005142333,0.0011208496,0.0030146297,0.0013491412,0.0011755314,0.0012118759],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020072296,0.000249435,0.01790311,0.03918097,0.00047445265,0.36158714,0.001432503,0.00074785063,0.006111689,0.002117066,0.046563104,0.523432],"study_design_scores_gemma":[0.000021920652,0.00006321712,0.008564124,0.007816996,0.0007500396,0.7273105,0.001315982,0.00013463123,0.00071310584,0.0010920033,0.25212833,0.00008914473],"about_ca_topic_score_codex":0.0015710434,"about_ca_topic_score_gemma":0.0034603344,"teacher_disagreement_score":0.0068358774,"about_ca_system_score_codex":0.0006734726,"about_ca_system_score_gemma":0.0013734414,"threshold_uncertainty_score":0.0127286315},"labels":[],"label_agreement":null},{"id":"W2096797962","doi":"10.1016/j.clbc.2014.09.002","title":"Comparison of Toxicity Experienced by Older Versus Younger Patients Enrolled in Breast Cancer Clinical Trials","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Discontinuation; Clinical trial; Internal medicine; Adverse effect; Hormonal therapy; Chemotherapy; Cancer; Toxicity; Geriatric oncology; Hormone therapy; Clinical endpoint; Oncology; Radiation therapy","score_opus":0.08454920997608419,"score_gpt":0.47579596784393613,"score_spread":0.39124675786785196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096797962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239725,0.006225214,0.00016434534,0.00007146802,0.000022674454,0.00004976489,0.00019303654,0.0000026323617,0.0008735523],"genre_scores_gemma":[0.9979373,0.0011327986,0.00007756244,0.00014641794,0.000053497854,0.000041640058,0.00030539758,0.0000031000902,0.0003023008],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99813443,0.0012164015,0.0002437351,0.0001448191,0.00013451168,0.00012627145],"domain_scores_gemma":[0.9941093,0.0029025718,0.0019338736,0.00027975376,0.00024210737,0.00053240085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035908972,0.00020409841,0.0010515077,0.00033533448,0.00017839849,0.0005726243,0.00020088557,0.000421598,0.001736649],"category_scores_gemma":[0.0054998402,0.00010357196,0.0016138355,0.00062960584,0.00021924108,0.0005304539,0.00031389252,0.0005191544,0.000106984444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47104502,0.0013583493,0.41491705,0.001442933,0.010210643,0.00036824436,0.00040032747,0.001704692,0.011284207,0.0005216867,0.00088571996,0.085861094],"study_design_scores_gemma":[0.0187091,0.12940805,0.83315545,0.0001990031,0.007644916,0.0007468933,0.00043222538,0.0009442422,0.0027101527,0.0007159171,0.0052856426,0.000048444723],"about_ca_topic_score_codex":0.00027699274,"about_ca_topic_score_gemma":0.00053505815,"teacher_disagreement_score":0.0035908972,"about_ca_system_score_codex":0.0003284186,"about_ca_system_score_gemma":0.00027689373,"threshold_uncertainty_score":0.018990695},"labels":[],"label_agreement":null},{"id":"W2103707992","doi":"10.3816/cbc.2009.n.019","title":"Phase I Study of Nonpegylated Liposomal Doxorubicin plus Trastuzumab in Patients with HER2-Positive Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Doxorubicin; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.037202716011297425,"score_gpt":0.43187942971137866,"score_spread":0.3946767137000812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103707992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940904,0.0013647965,0.0005290977,0.0004544946,0.00014020054,0.0014034149,0.00046379142,0.00007267047,0.0014812176],"genre_scores_gemma":[0.9928687,0.0015353325,0.0008144056,0.00040959794,0.00013023757,0.0012567707,0.0008591996,0.000026039788,0.0020996698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968386,0.00012899774,0.000011387164,0.000060159666,0.00002178043,0.000093721545],"domain_scores_gemma":[0.9995116,0.00009813847,0.00006484838,0.00005090566,0.000026578286,0.0002479722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009597369,0.0014148456,0.0021721686,0.0003620526,0.0004035021,0.0008954812,0.0008902429,0.0009555148,0.0032479635],"category_scores_gemma":[0.0008118559,0.0006176093,0.0008958396,0.00042017087,0.0010566964,0.0008512865,0.0003372491,0.0027634245,0.00082410075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7805521,0.07637088,0.00382308,0.0007223137,0.001099524,0.00028356406,0.00039550866,0.0031799055,0.04231743,0.00046372061,0.003454903,0.087337136],"study_design_scores_gemma":[0.59472734,0.39251477,0.005564243,0.000020313113,0.00036613658,0.00016061266,0.00007314795,0.0010879474,0.0034466702,0.00014480975,0.0018705403,0.000023498384],"about_ca_topic_score_codex":0.0018683181,"about_ca_topic_score_gemma":0.003366312,"teacher_disagreement_score":0.0032479635,"about_ca_system_score_codex":0.0010664328,"about_ca_system_score_gemma":0.0016296679,"threshold_uncertainty_score":0.010865569},"labels":[],"label_agreement":null},{"id":"W2106968573","doi":"10.1016/j.clbc.2012.07.006","title":"Treatment and Outcomes of Primary Breast Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Medicine; Breast cancer; Lymphoma; Stage (stratigraphy); Internal medicine; Univariate analysis; Chemotherapy; Surgery; Radiation therapy; Population; Aggressive lymphoma; Oncology; Cancer; Multivariate analysis; Rituximab","score_opus":0.04203916915508224,"score_gpt":0.36359237589206034,"score_spread":0.32155320673697807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106968573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874473,0.006059812,0.00006930115,0.0009822837,0.000049653376,0.000010912946,0.00061409624,0.000008323473,0.0047581727],"genre_scores_gemma":[0.9982817,0.0006608185,0.000013343451,0.000114186,0.00005727965,0.000004127849,0.00050645164,0.0000030558278,0.00035906478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991248,0.00027767575,0.00007981456,0.000087880966,0.0001301564,0.00029966896],"domain_scores_gemma":[0.996748,0.0007767104,0.001518222,0.00011527706,0.00024896878,0.0005929112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724374,0.00014440107,0.0004140139,0.0005218942,0.00040385465,0.00089607143,0.0004186817,0.0005676616,0.0031150854],"category_scores_gemma":[0.006019278,0.00015087683,0.00075406965,0.000947346,0.00030635932,0.00074186106,0.0005206041,0.00089346303,0.00029453504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014926747,0.00026542222,0.98540515,0.000046652334,0.0002125207,0.00031115513,0.00008665562,0.00018711509,0.00021951979,0.0001241134,0.0007191602,0.010929805],"study_design_scores_gemma":[0.000034282697,0.00023986984,0.9979658,0.000018099598,0.00010067514,0.0005804222,0.00022213018,0.00011943458,0.00006206558,0.00016152671,0.00048968033,0.000006115181],"about_ca_topic_score_codex":0.0046633496,"about_ca_topic_score_gemma":0.006061402,"teacher_disagreement_score":0.0046633496,"about_ca_system_score_codex":0.0009325267,"about_ca_system_score_gemma":0.000613953,"threshold_uncertainty_score":0.010420978},"labels":[],"label_agreement":null},{"id":"W2108152062","doi":"10.1016/j.clbc.2015.09.006","title":"A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Alberta","funders":"Indiana Clinical and Translational Sciences Institute; National Institutes of Health; Alberta Cancer Foundation; Pfizer","keywords":"Epirubicin; Medicine; Internal medicine; Gastroenterology; Breast cancer; Toxicity; Single-nucleotide polymorphism; Oncology; Genotype; Endocrinology; Cancer; Biology; Genetics","score_opus":0.046572645488112414,"score_gpt":0.3573558239700384,"score_spread":0.310783178481926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108152062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913555,0.0003549704,0.00006214596,0.00007027167,0.0000093260605,0.0000019952856,0.00007308624,0.0000031237557,0.00028967185],"genre_scores_gemma":[0.9994399,0.00008542254,0.00003563935,0.000028433657,0.0000116613055,0.0000019021332,0.00010227037,0.0000037359707,0.0002909455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998547,0.0000476171,0.000012556942,0.000026990083,0.000020049372,0.000038110753],"domain_scores_gemma":[0.9993754,0.00018536711,0.00023411334,0.000038697635,0.00005139547,0.00011513405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023530515,0.00027737065,0.0003259059,0.00027966866,0.00022422709,0.00053642184,0.00021998504,0.0004567154,0.001874098],"category_scores_gemma":[0.0011128824,0.00017236682,0.0003240513,0.00042706498,0.0001897639,0.0002007795,0.00017533115,0.000597088,0.00022760409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019914312,0.00013315635,0.98560494,0.000018530907,0.00019859965,0.00030720432,0.000043042695,0.000108621025,0.0066127223,0.00007713329,0.0002353908,0.004669354],"study_design_scores_gemma":[0.000045050754,0.00029465614,0.9960873,0.000010798177,0.00020743356,0.0007452977,0.00009972752,0.0006203924,0.0012834164,0.00014286631,0.00045601907,0.000006991135],"about_ca_topic_score_codex":0.0015311262,"about_ca_topic_score_gemma":0.001748216,"teacher_disagreement_score":0.001874098,"about_ca_system_score_codex":0.00022648381,"about_ca_system_score_gemma":0.00017938885,"threshold_uncertainty_score":0.006269455},"labels":[],"label_agreement":null},{"id":"W2118299978","doi":"10.3816/cbc.2005.n.043","title":"The Global Breast Cancer Burden: Variations in Epidemiology and Survival","year":2005,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi","keywords":"Medicine; Breast cancer; Epidemiology; Oncology; Internal medicine; Cancer","score_opus":0.27353927788110155,"score_gpt":0.5376905810052716,"score_spread":0.26415130312417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118299978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008905356,0.99941707,0.000037554342,0.00019886585,0.00006490076,0.0000021344001,0.000040131396,0.0000033465144,0.00014703552],"genre_scores_gemma":[0.00055930484,0.99911827,0.00007338719,0.00008864823,0.000068758156,0.0000023218406,0.000031229287,6.113191e-7,0.000057610563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994885,0.000092270035,0.000101630605,0.000091133414,0.00019928845,0.000027121985],"domain_scores_gemma":[0.9985935,0.0007157297,0.00028074966,0.000021856498,0.00033077746,0.00005741295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013499678,0.0009777928,0.002885933,0.0039828923,0.00019927468,0.0012022537,0.0009023856,0.000979159,0.0021368505],"category_scores_gemma":[0.002940536,0.00043690126,0.000996574,0.009350482,0.00039156017,0.0012749989,0.00062610174,0.0010643252,0.0006112573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000985367,0.000024529667,0.0017470772,0.03077194,0.0004771051,0.000070641836,0.000057105022,0.0004330429,0.00022294179,0.0008681556,0.026488358,0.93874055],"study_design_scores_gemma":[0.0000918974,0.0001895563,0.030696027,0.038271673,0.0031337356,0.0020848738,0.00040605446,0.0003886621,0.00034245118,0.0024087706,0.92190254,0.00008369669],"about_ca_topic_score_codex":0.010121665,"about_ca_topic_score_gemma":0.017343404,"teacher_disagreement_score":0.010121665,"about_ca_system_score_codex":0.0013590346,"about_ca_system_score_gemma":0.0027641065,"threshold_uncertainty_score":0.020125508},"labels":[],"label_agreement":null},{"id":"W2123478677","doi":"10.3816/cbc.2007.n.030","title":"Method of Detection of New Contralateral Primary Breast Cancer in Younger Versus Older Women","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sudbury Regional Hospital","funders":"","keywords":"Medicine; Mammography; Breast cancer; Cancer; Estrogen receptor; Cohort; Primary tumor; Internal medicine; Oncology; Gynecology; Metastasis","score_opus":0.020521899953217522,"score_gpt":0.36803155380513236,"score_spread":0.34750965385191485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123478677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685724,0.0048671304,0.0026581297,0.00010769152,0.000113056776,0.00018587225,0.0009513556,0.00002787136,0.0042317323],"genre_scores_gemma":[0.99292654,0.0011655743,0.0025191305,0.00011301076,0.00005454732,0.0002337492,0.00041263967,0.00001515516,0.0025595054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747473,0.0013609263,0.00018736819,0.00037881118,0.00045037566,0.00014767947],"domain_scores_gemma":[0.9946203,0.0026836912,0.00094572117,0.0005000027,0.00095300085,0.0002972759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00419001,0.00035648397,0.0005541502,0.001842611,0.00035651762,0.0006769332,0.0005377198,0.00046664051,0.0028288094],"category_scores_gemma":[0.010448947,0.00028815033,0.0003613166,0.00072374515,0.00027759073,0.00029238465,0.00038939703,0.0003217548,0.00055720675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056925802,0.00017567152,0.95902896,0.00020052161,0.0001658196,0.00012316334,0.0004096633,0.00005018895,0.0072217076,0.00016723605,0.00028950052,0.026475165],"study_design_scores_gemma":[0.00015716448,0.002859552,0.9825335,0.00006146954,0.00028071625,0.0017211697,0.0005096431,0.00029087192,0.008068165,0.00012592887,0.0033671767,0.000024657144],"about_ca_topic_score_codex":0.0035395438,"about_ca_topic_score_gemma":0.0035222084,"teacher_disagreement_score":0.00419001,"about_ca_system_score_codex":0.00050598994,"about_ca_system_score_gemma":0.00051557936,"threshold_uncertainty_score":0.02215916},"labels":[],"label_agreement":null},{"id":"W2126279489","doi":"10.3816/cbc.2009.n.027","title":"A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and Correlation With Biomarkers","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Bristol-Myers Squibb","keywords":"Medicine; Breast cancer; Oncology; Regimen; Internal medicine; Neoadjuvant therapy; Correlation; Cancer","score_opus":0.020551854772295167,"score_gpt":0.35169779561455955,"score_spread":0.3311459408422644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126279489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961456,0.0010285882,0.00030230475,0.00036012632,0.00009824081,0.0007344923,0.00057068956,0.000032098073,0.0007278027],"genre_scores_gemma":[0.99062145,0.0012691772,0.0011978222,0.0005502714,0.00020370628,0.0017607056,0.0021955068,0.00003043097,0.0021709264],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99913365,0.0005197626,0.000037360533,0.000124267,0.00006087019,0.0001240864],"domain_scores_gemma":[0.99830496,0.00036593337,0.0003235603,0.00029384936,0.00008471105,0.0006269102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021146457,0.0013462341,0.002815819,0.00062069943,0.0005814379,0.0009790233,0.00081051554,0.0013069498,0.0027892722],"category_scores_gemma":[0.0017771883,0.00043721,0.001017738,0.00078341935,0.0014045795,0.0012113156,0.00046359547,0.0025615043,0.00064306444],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88503575,0.035317667,0.011286426,0.00022590133,0.0008035962,0.00012992008,0.00016259536,0.001198294,0.019337874,0.00012102517,0.0012962128,0.045084663],"study_design_scores_gemma":[0.3748779,0.58746254,0.029158002,0.000029221255,0.00067996647,0.00030862336,0.00012041676,0.00082129857,0.0045631723,0.00022880173,0.0017074625,0.000042558007],"about_ca_topic_score_codex":0.0011131581,"about_ca_topic_score_gemma":0.0024547614,"teacher_disagreement_score":0.002815819,"about_ca_system_score_codex":0.0009903428,"about_ca_system_score_gemma":0.0014507585,"threshold_uncertainty_score":0.011183441},"labels":[],"label_agreement":null},{"id":"W2140679483","doi":"10.3816/cbc.2007.n.055","title":"Delayed Resolution of Jaundice in the Arm of a Patient with Impaired Lymphatic Drainage: A Case Report","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Jaundice; Lymphatic system; Lymphedema; Dissection (medical); Lymph node; Surgery; Axillary Lymph Node Dissection; Radiology; Breast cancer; Internal medicine; Pathology; Cancer; Sentinel lymph node","score_opus":0.04481662897447928,"score_gpt":0.4205379081652171,"score_spread":0.3757212791907378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140679483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96625024,0.00730864,0.004462136,0.005481715,0.0009380381,0.0002760358,0.0003769197,0.00034329094,0.014562876],"genre_scores_gemma":[0.99306047,0.0014009805,0.0014539474,0.0009938001,0.0018807047,0.000044707274,0.000107424166,0.000037316015,0.0010207345],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987036,0.0001582986,0.0001472136,0.00029285188,0.00014685914,0.00055100565],"domain_scores_gemma":[0.99438334,0.0019479729,0.00092565553,0.00086627447,0.00029142716,0.0015853196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008285863,0.0039713434,0.0028495074,0.0041025877,0.0041471887,0.0035425762,0.003481968,0.0126404185,0.0028037867],"category_scores_gemma":[0.010277751,0.0026924605,0.0029926924,0.0029024016,0.0036014977,0.004373958,0.0026231883,0.00714783,0.0016762504],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038094495,0.00003058793,0.002183933,0.00001602799,0.0000051453567,0.9970728,0.000045597404,0.000030267342,0.00019590533,0.000045777568,0.000055909317,0.0002799745],"study_design_scores_gemma":[0.000023920249,0.00009366211,0.0023367598,0.0000075797925,0.000014004897,0.9967163,0.000085896165,0.00015604374,0.0003085503,0.000084577296,0.0001601689,0.0000124052485],"about_ca_topic_score_codex":0.0015313632,"about_ca_topic_score_gemma":0.0016663483,"teacher_disagreement_score":0.0126404185,"about_ca_system_score_codex":0.0023587986,"about_ca_system_score_gemma":0.0012372873,"threshold_uncertainty_score":0.017114341},"labels":[],"label_agreement":null},{"id":"W2141987768","doi":"10.1016/j.clbc.2015.09.005","title":"Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Demography; Ethnic group; Cancer; Population; Cancer registry; Estrogen receptor; Confidence interval; Health equity; Gynecology; Oncology; Internal medicine; Public health; Pathology; Environmental health","score_opus":0.026106701322343513,"score_gpt":0.3310841974471355,"score_spread":0.304977496124792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141987768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789953,0.00027680618,0.000073316056,0.000090800604,0.000004798576,0.0000132191535,0.00064142514,0.0000039064266,0.0009962748],"genre_scores_gemma":[0.99811435,0.00021891111,0.00007956066,0.00008980453,0.0000026128264,0.000012659137,0.0003759814,0.0000062315535,0.0010998774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990669,0.00017990834,0.000081306775,0.00021379278,0.00020457996,0.00025343962],"domain_scores_gemma":[0.9987336,0.00015193239,0.00016478458,0.00008745343,0.0005586948,0.00030350982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007117355,0.00027736192,0.0005169311,0.0017660722,0.0026932622,0.0011521681,0.0011748598,0.0004573957,0.0020477362],"category_scores_gemma":[0.001903589,0.00037680738,0.00034830743,0.0039978013,0.00073922094,0.0003145015,0.0008078349,0.0006316139,0.00033564935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001849088,0.000073126044,0.99085534,0.00001887842,0.00009391002,0.00019449313,0.00236223,0.00006238598,0.0008686323,0.00011139995,0.0007681833,0.0044066235],"study_design_scores_gemma":[0.0000063696916,0.000015959997,0.99727076,0.000014271276,0.000028915532,0.00007418404,0.001940627,0.000116823125,0.000064933316,0.000027768838,0.0004324712,0.0000068297722],"about_ca_topic_score_codex":0.9345509,"about_ca_topic_score_gemma":0.9587903,"teacher_disagreement_score":0.06544912,"about_ca_system_score_codex":0.0050524687,"about_ca_system_score_gemma":0.003962927,"threshold_uncertainty_score":0.13166904},"labels":[],"label_agreement":null},{"id":"W2153242757","doi":"10.3816/cbc.2004.n.010","title":"Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case Histories","year":2004,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Roche (Canada); St. Boniface Hospital; Lions Gate Hospital; Ottawa Regional Cancer Foundation; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Regimen; Oncology; Internal medicine; Vinorelbine; Taxane; Metastatic breast cancer; Breast cancer; Chemotherapy; Cardiotoxicity; Cancer; Surgery; Cisplatin","score_opus":0.3380781820358026,"score_gpt":0.5386034532522701,"score_spread":0.20052527121646752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153242757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20248513,0.7913946,0.0006891155,0.00064197934,0.00006712859,0.000027667185,0.00045780977,0.000018591101,0.004217974],"genre_scores_gemma":[0.4848013,0.5124043,0.0007850423,0.0004842817,0.000096841424,0.000021810121,0.000700436,0.000015209461,0.00069069926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991704,0.00016765729,0.00023939194,0.00017921544,0.00017905398,0.00006429735],"domain_scores_gemma":[0.9961994,0.0021850334,0.00090539426,0.00022714435,0.00038512333,0.00009782567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007582078,0.00027087762,0.0006215521,0.0021295433,0.00025949674,0.0008844972,0.0006194291,0.00047516872,0.000958059],"category_scores_gemma":[0.005195558,0.00022045727,0.00037449438,0.003325878,0.00037957012,0.00074685627,0.0003307775,0.0003622408,0.00040813882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045105774,0.000106655556,0.47234562,0.006387965,0.00062312075,0.06496121,0.0024916155,0.0002361349,0.0041247085,0.0006417093,0.0063878642,0.44124237],"study_design_scores_gemma":[0.000027460987,0.00017582484,0.44315967,0.0048681824,0.0026153126,0.4532767,0.0031790766,0.00016790848,0.0027626858,0.0004753219,0.089236036,0.00005578525],"about_ca_topic_score_codex":0.0016917904,"about_ca_topic_score_gemma":0.0030600068,"teacher_disagreement_score":0.0021295433,"about_ca_system_score_codex":0.00037942198,"about_ca_system_score_gemma":0.00077781687,"threshold_uncertainty_score":0.0040097833},"labels":[],"label_agreement":null},{"id":"W2169656388","doi":"10.3816/cbc.2011.n.005","title":"Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Public Health Ontario; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Breast cancer; Confidence interval; Odds ratio; Internal medicine; Population; Oncology; Cancer; Surgery; Gynecology","score_opus":0.298111550154427,"score_gpt":0.4710066680358696,"score_spread":0.17289511788144263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169656388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885905,0.00019246164,0.00008811486,0.000028156433,0.00000701602,0.00004078804,0.00053518784,0.0000038449457,0.00024526234],"genre_scores_gemma":[0.99855727,0.0001298227,0.00020552939,0.00004467246,0.0000067707883,0.000034313227,0.00065585534,0.0000052740406,0.00036053287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997593,0.00039046517,0.0001482551,0.00065142947,0.0005481387,0.0006687268],"domain_scores_gemma":[0.99668163,0.00056295184,0.0006400744,0.00038041713,0.0010396519,0.0006953318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023976464,0.001067167,0.0011069725,0.0014854493,0.0031164864,0.0016102828,0.0028225563,0.0013711785,0.0013622844],"category_scores_gemma":[0.0047629443,0.0011482468,0.0013241317,0.0028113734,0.001608265,0.00055664167,0.00090850523,0.0011562598,0.00018006114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013808622,0.00022306664,0.995415,0.000027910084,0.00041905767,0.00014233387,0.0005863758,0.00006756344,0.00059683947,0.00007761138,0.00021543878,0.0008478315],"study_design_scores_gemma":[0.00012415226,0.00021976784,0.99806076,0.000008016295,0.00023338188,0.00012719381,0.0006137487,0.00027525317,0.00008161438,0.000023342629,0.00021314246,0.000019609224],"about_ca_topic_score_codex":0.92667556,"about_ca_topic_score_gemma":0.91195846,"teacher_disagreement_score":0.07332444,"about_ca_system_score_codex":0.011711556,"about_ca_system_score_gemma":0.011571973,"threshold_uncertainty_score":0.1475125},"labels":[],"label_agreement":null},{"id":"W2175411741","doi":"10.1016/j.clbc.2015.11.002","title":"Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Cancer; Stage (stratigraphy); Proportional hazards model; Univariate analysis; Confidence interval; Gynecology; Estrogen receptor; Oncology; Multivariate analysis","score_opus":0.023392160818099545,"score_gpt":0.33617740940609486,"score_spread":0.31278524858799533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175411741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390715,0.003250867,0.000116889816,0.00007583531,0.00003749533,0.000010508162,0.0005607026,0.0000096853555,0.0020308793],"genre_scores_gemma":[0.99799913,0.000500448,0.000030883202,0.000043446144,0.00004079679,0.0000050795743,0.00045082695,0.0000018542562,0.00092750625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997094,0.00008535079,0.00002389793,0.000055858378,0.000036051126,0.000089322064],"domain_scores_gemma":[0.99875474,0.0003604367,0.00040167363,0.00012819309,0.000080045196,0.00027496193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065809913,0.00027668366,0.0004795305,0.0005966637,0.00035902538,0.00042028064,0.0003007018,0.0005244466,0.0024107252],"category_scores_gemma":[0.0020197644,0.00016945098,0.001041629,0.00057511305,0.00015167972,0.0002367998,0.00024351779,0.00067424675,0.00016282129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036230555,0.00011971281,0.9894264,0.000068627305,0.00032009353,0.00027790325,0.000056330176,0.00012192501,0.0006065764,0.00007032172,0.00030182285,0.0050071557],"study_design_scores_gemma":[0.000056668952,0.00049121905,0.997888,0.000012114923,0.00024753966,0.0004923655,0.0000661435,0.00012131185,0.00013668105,0.000039899543,0.00044235904,0.0000056405856],"about_ca_topic_score_codex":0.011147924,"about_ca_topic_score_gemma":0.009445002,"teacher_disagreement_score":0.011147924,"about_ca_system_score_codex":0.00028239164,"about_ca_system_score_gemma":0.000502799,"threshold_uncertainty_score":0.022166073},"labels":[],"label_agreement":null},{"id":"W2207044386","doi":"10.1016/j.clbc.2015.06.011","title":"Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Angiosarcoma; Medicine; Breast cancer; Breast carcinoma; Radiation therapy; Malignancy; Lymphedema; Oncology; Internal medicine; Radiology; Cancer","score_opus":0.04476189011112873,"score_gpt":0.32511362420605894,"score_spread":0.2803517340949302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207044386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772127,0.0033827361,0.0034790263,0.0027163504,0.00043192157,0.0002936253,0.000494107,0.00028248012,0.011707013],"genre_scores_gemma":[0.9940758,0.0011659123,0.0013256187,0.0006643506,0.0011354259,0.00003087978,0.00017531263,0.000045920784,0.0013807988],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992311,0.00009546101,0.00008049854,0.00023695696,0.00009642355,0.0002595929],"domain_scores_gemma":[0.9972882,0.0007755514,0.0005065646,0.0002541123,0.00014294514,0.0010326948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003825586,0.0024002027,0.0012905096,0.003287369,0.0029324328,0.0020663727,0.0017380989,0.0059561348,0.0036758953],"category_scores_gemma":[0.0037529904,0.0018781456,0.0018527709,0.0017622019,0.0018137756,0.0020893854,0.0017597676,0.0028677846,0.0016806305],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035179353,0.00003342778,0.0051222136,0.000011141035,0.000005409555,0.99380565,0.00005974208,0.000022892757,0.00039578133,0.000035477053,0.00010333449,0.00036968518],"study_design_scores_gemma":[0.000007136913,0.000052906118,0.0043122037,0.0000049118553,0.000017197015,0.9949403,0.000092837276,0.000108921435,0.00024336744,0.000045169785,0.00016590094,0.000009201652],"about_ca_topic_score_codex":0.002320079,"about_ca_topic_score_gemma":0.002746795,"teacher_disagreement_score":0.0059561348,"about_ca_system_score_codex":0.001182437,"about_ca_system_score_gemma":0.0008325033,"threshold_uncertainty_score":0.0122971535},"labels":[],"label_agreement":null},{"id":"W2442066587","doi":"10.1016/j.clbc.2016.06.004","title":"Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer","year":2016,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Breast cancer; Hormone; Blockade; Internal medicine; Oncology; Cancer; Hormone receptor; Gynecology; Endocrinology; Receptor","score_opus":0.07345930812789521,"score_gpt":0.42714991484241327,"score_spread":0.3536906067145181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442066587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048598365,0.99872714,0.00004447146,0.00015665499,0.000082034196,0.0000051226207,0.000032458567,0.0000026514467,0.00046343796],"genre_scores_gemma":[0.0050470745,0.99390715,0.00015169442,0.0003963054,0.00011164868,0.000008776172,0.000068499336,0.0000016763345,0.00030725313],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998653,0.000035889057,0.000026616106,0.000026126432,0.00003312744,0.000013005098],"domain_scores_gemma":[0.99972945,0.0001918769,0.000038324033,0.0000044262706,0.000025178184,0.0000106518655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052149734,0.00047514247,0.0018787588,0.000668994,0.00007135822,0.00055896456,0.00051042694,0.00043515305,0.0036150855],"category_scores_gemma":[0.0007946902,0.00013720436,0.0008533522,0.00069687323,0.0001632608,0.00047516034,0.00026507408,0.0011011484,0.0005217213],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011855352,0.000082508945,0.00044606425,0.04995608,0.0013079011,0.00013706536,0.00003412331,0.00026029095,0.0022720082,0.0012365518,0.01435353,0.92872834],"study_design_scores_gemma":[0.0023334909,0.0018412374,0.010993179,0.033883244,0.0084363585,0.0029172169,0.00020630007,0.00028312937,0.002363897,0.003136386,0.9335336,0.00007197624],"about_ca_topic_score_codex":0.0004050892,"about_ca_topic_score_gemma":0.0016203091,"teacher_disagreement_score":0.0036150855,"about_ca_system_score_codex":0.00028317972,"about_ca_system_score_gemma":0.0003673909,"threshold_uncertainty_score":0.012093663},"labels":[],"label_agreement":null},{"id":"W2471052102","doi":"10.1016/j.clbc.2016.07.001","title":"Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Breast cancer; Osteoporosis; Cancer; Disease; Aromatase; Population; Oncology; Surgery; Internal medicine","score_opus":0.023615177021308494,"score_gpt":0.35394680532502676,"score_spread":0.33033162830371826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471052102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913931,0.0030616864,0.0010399736,0.0003052249,0.000092969196,0.00004512031,0.00017781994,0.000016554854,0.0038675023],"genre_scores_gemma":[0.9978497,0.00093647034,0.00050806405,0.000054376243,0.000126814,0.000005465905,0.000236577,0.000007369039,0.0002750866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866426,0.00023669812,0.00024715732,0.000106925836,0.0004191425,0.00032580836],"domain_scores_gemma":[0.9967573,0.0012570155,0.0009883257,0.00023562132,0.00043351654,0.0003282043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011461835,0.00052882935,0.0005189063,0.0030994716,0.0007451984,0.0009973518,0.0010499156,0.0013190887,0.0025247075],"category_scores_gemma":[0.009414902,0.0005300953,0.0009072951,0.0015175584,0.00092448114,0.00076596567,0.00080923334,0.00089438,0.0005989333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027152672,0.00004250488,0.9762955,0.000028697308,0.000027162318,0.015649145,0.0001239105,0.00011784165,0.00057444285,0.00022954945,0.00017263668,0.006467134],"study_design_scores_gemma":[0.000023361179,0.0003095841,0.8293799,0.00008891219,0.00007907878,0.16348298,0.0018519646,0.0012800163,0.0016917789,0.000873929,0.00091395015,0.00002458999],"about_ca_topic_score_codex":0.0021544595,"about_ca_topic_score_gemma":0.00269731,"teacher_disagreement_score":0.0030994716,"about_ca_system_score_codex":0.00053022464,"about_ca_system_score_gemma":0.0010225163,"threshold_uncertainty_score":0.008445978},"labels":[],"label_agreement":null},{"id":"W2494806904","doi":"10.1016/j.clbc.2016.07.014","title":"Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Radiation therapy; Oncology; MEDLINE; Observational study; Chemotherapy; Systematic review; Prospective cohort study; Cancer; Surgery","score_opus":0.05572311220088244,"score_gpt":0.41747822756101355,"score_spread":0.3617551153601311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494806904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005259779,0.99906856,0.00004554007,0.00008982363,0.00004237367,0.00003687367,0.00008754577,0.0000021302158,0.00010112934],"genre_scores_gemma":[0.010284882,0.9888853,0.00030560332,0.0003066982,0.000049012782,0.000048457845,0.00007700975,0.0000015063359,0.000041566385],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986272,0.00040089796,0.0005640454,0.00015363307,0.00019923523,0.000055007702],"domain_scores_gemma":[0.99666226,0.0022857431,0.0007381147,0.000035921876,0.00021907243,0.000058988135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017098051,0.0008494516,0.0048261685,0.0028903533,0.00030350508,0.0013576652,0.001183118,0.0012241366,0.0034519401],"category_scores_gemma":[0.01038069,0.000657648,0.004970542,0.0034554047,0.00041564254,0.0012977448,0.0007793122,0.001083535,0.00020031426],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047820085,0.00004587603,0.0014373489,0.8727688,0.016372738,0.0001108198,0.00012786411,0.00023645928,0.00018073636,0.00022283611,0.0025260202,0.10549221],"study_design_scores_gemma":[0.0013270077,0.00053821085,0.010270999,0.73543704,0.20726438,0.00078261393,0.00044376866,0.00025919318,0.00024748384,0.0008700688,0.042460237,0.000099072815],"about_ca_topic_score_codex":0.0067869066,"about_ca_topic_score_gemma":0.025963677,"teacher_disagreement_score":0.0067869066,"about_ca_system_score_codex":0.0013369801,"about_ca_system_score_gemma":0.0032416496,"threshold_uncertainty_score":0.01349479},"labels":[],"label_agreement":null},{"id":"W2495043549","doi":"10.1016/j.clbc.2016.07.008","title":"Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab; Docetaxel; Epirubicin; Breast cancer; Internal medicine; Oncology; Cyclophosphamide; Neoadjuvant therapy; Regimen; Ejection fraction; Chemotherapy; Cancer; Heart failure","score_opus":0.028574340506992785,"score_gpt":0.38939238070556553,"score_spread":0.3608180401985728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495043549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132544,0.0029933632,0.00042520053,0.000381392,0.000178672,0.0011584639,0.00043350086,0.00006704994,0.0030368678],"genre_scores_gemma":[0.99014837,0.002137141,0.0013014731,0.00047372756,0.00009682561,0.0008934578,0.0010671809,0.000021314945,0.0038607426],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99949145,0.00023799538,0.000023748195,0.000086518565,0.000039364644,0.00012100975],"domain_scores_gemma":[0.9996537,0.000058455036,0.000049935006,0.000030319596,0.000012972076,0.00019462986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011866858,0.00095358666,0.0014498361,0.0006636379,0.00033576408,0.00077247195,0.0007078245,0.0008781612,0.003405746],"category_scores_gemma":[0.00074802723,0.00044242846,0.0006675085,0.000592193,0.0006835646,0.0007811241,0.00031365143,0.0020213316,0.0005482526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74930423,0.049902707,0.004364059,0.0005089906,0.0012888286,0.0001672425,0.00015803546,0.002768927,0.022618696,0.0007370579,0.002902544,0.16527867],"study_design_scores_gemma":[0.53848296,0.42775872,0.0147153735,0.00008144259,0.0006747985,0.00033432228,0.00007356328,0.001507334,0.00965751,0.00032050157,0.006350176,0.00004332918],"about_ca_topic_score_codex":0.0024076265,"about_ca_topic_score_gemma":0.0098780785,"teacher_disagreement_score":0.003405746,"about_ca_system_score_codex":0.0009007951,"about_ca_system_score_gemma":0.0014912338,"threshold_uncertainty_score":0.011393368},"labels":[],"label_agreement":null},{"id":"W2533756834","doi":"10.1016/j.clbc.2016.10.005","title":"Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Ductal carcinoma; Radiation therapy; Internal medicine; Breast cancer; Multivariate analysis; Oncology; Confidence interval; Carcinoma; Cancer; Urology","score_opus":0.03366775043726564,"score_gpt":0.36463582402644734,"score_spread":0.3309680735891817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533756834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633447,0.026112797,0.0049963742,0.00045304364,0.00012800064,0.00007354336,0.00009949913,0.000067647874,0.0047244127],"genre_scores_gemma":[0.99410015,0.003047877,0.0013619203,0.00011252699,0.000078391255,0.00001814923,0.000094169416,0.000022635148,0.0011641568],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997993,0.00009984375,0.000011485705,0.0000261831,0.000038926926,0.000024217323],"domain_scores_gemma":[0.99982077,0.00008112925,0.00003546827,0.000035253055,0.000012270723,0.00001509699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006401772,0.00016619844,0.00037876933,0.00032107852,0.00019895914,0.0002967553,0.00035408593,0.00019652226,0.0020643794],"category_scores_gemma":[0.0006101034,0.00008002182,0.00033022638,0.00041910922,0.00032874063,0.0003836901,0.00019217307,0.00048789615,0.00013048569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062282506,0.0022957807,0.031321406,0.0012063879,0.0005566383,0.00032578548,0.00056264544,0.004948438,0.40473136,0.0037472066,0.001012586,0.48700926],"study_design_scores_gemma":[0.0042660907,0.13578916,0.52094024,0.00042246422,0.0018390298,0.004270658,0.00074942474,0.004787501,0.2599248,0.004444508,0.062445194,0.00012094065],"about_ca_topic_score_codex":0.00078711257,"about_ca_topic_score_gemma":0.001429026,"teacher_disagreement_score":0.0020643794,"about_ca_system_score_codex":0.00024146726,"about_ca_system_score_gemma":0.00032005925,"threshold_uncertainty_score":0.0069060326},"labels":[],"label_agreement":null},{"id":"W2576774687","doi":"10.1016/j.clbc.2017.01.002","title":"Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Robarts Clinical Trials; University of British Columbia; Queen's University","funders":"National Cancer Institute; University of British Columbia","keywords":"Medicine; Breast cancer; Lymphovascular invasion; Tamoxifen; Oncology; Internal medicine; Cancer; Cohort; Estrogen receptor; Progesterone receptor; Metastasis","score_opus":0.0250787222093636,"score_gpt":0.33822091961903855,"score_spread":0.31314219740967497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576774687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468297,0.0011164333,0.000084804946,0.00020449543,0.000011228172,0.000007955546,0.0026064145,0.000008372112,0.0012772656],"genre_scores_gemma":[0.997297,0.00035371745,0.000042874468,0.000051604446,0.0000106284115,0.000007927229,0.0014319022,0.000005004267,0.0007994224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936837,0.0001555968,0.000049608283,0.00013928891,0.00010337066,0.00018383875],"domain_scores_gemma":[0.99805415,0.0003321787,0.000477797,0.00030870672,0.00038966545,0.0004374976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736657,0.0003190235,0.0006662285,0.00077512395,0.00095152063,0.0009305377,0.0010364939,0.0006677525,0.0024275226],"category_scores_gemma":[0.0025447456,0.00045677266,0.00085650483,0.0017358128,0.00031897787,0.00027068733,0.00059662614,0.0010784782,0.00022057103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012839349,0.000037581238,0.9943316,0.000029408136,0.00050055183,0.000118777076,0.000119120225,0.00020796087,0.00048343636,0.00015579753,0.0010007805,0.0017310203],"study_design_scores_gemma":[0.000045251287,0.000061709,0.997795,0.000021536453,0.0002455503,0.0001247804,0.00029979166,0.00068159495,0.00006426177,0.00008769313,0.0005585942,0.000014368182],"about_ca_topic_score_codex":0.63826096,"about_ca_topic_score_gemma":0.6969146,"teacher_disagreement_score":0.63826096,"about_ca_system_score_codex":0.0020477069,"about_ca_system_score_gemma":0.0025119747,"threshold_uncertainty_score":0.72773874},"labels":[],"label_agreement":null},{"id":"W25997855","doi":"10.1016/j.clbc.2015.04.004","title":"Representation de la peur dans le roman de premiere lecture au Quebec de 1995 a 2005 : nouvelles identites masculines ou statu quo?","year":2007,"lang":"en","type":"dissertation","venue":"Clinical Breast Cancer","topic":"Themes in Literature Analysis","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Status quo; Inscribed figure; Psychology; Narrative; Masculinity; Identity (music); Field (mathematics); Restructuring; Psychoanalysis; Humanities; Social psychology; Sociology; Art; Aesthetics; Literature; Political science","score_opus":0.017069072522762123,"score_gpt":0.36539843309412157,"score_spread":0.34832936057135944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W25997855","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33889785,0.13530137,0.0018443451,0.27121943,0.0058367196,0.00015283779,0.0038760835,0.00009209719,0.24277924],"genre_scores_gemma":[0.8667281,0.040442836,0.001023463,0.008445789,0.0004994296,0.00007796918,0.00076196704,0.000084605446,0.08193583],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970577,0.00079187204,0.00014669778,0.00022610821,0.0010378663,0.00073976297],"domain_scores_gemma":[0.99041945,0.002539591,0.001006231,0.0001689155,0.0042193313,0.0016463738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005615261,0.0002602398,0.00035700007,0.004878264,0.0089633595,0.005734342,0.0007144511,0.0009188302,0.00933654],"category_scores_gemma":[0.010530695,0.0002536057,0.00024880114,0.010007791,0.005676547,0.0020617368,0.00188246,0.002216222,0.0006830547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002070916,0.000053424243,0.03319207,0.0016693772,0.00005487355,0.0020845733,0.4451605,0.00033576493,0.001460576,0.120597996,0.17547505,0.21970867],"study_design_scores_gemma":[0.00000781586,0.00002822723,0.07483709,0.0019430879,0.000019236599,0.0003252746,0.17874816,0.00013256782,0.00042160955,0.0013344082,0.74216104,0.000041542018],"about_ca_topic_score_codex":0.89690316,"about_ca_topic_score_gemma":0.94560194,"teacher_disagreement_score":0.10309684,"about_ca_system_score_codex":0.07923864,"about_ca_system_score_gemma":0.091670774,"threshold_uncertainty_score":0.5749192},"labels":[],"label_agreement":null},{"id":"W2683062180","doi":"10.1016/j.clbc.2017.06.007","title":"A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Physiotherapy Association; McGill University; Jewish General Hospital","funders":"McGill University","keywords":"Medicine; Range of motion; Physical therapy; Randomized controlled trial; Breast cancer; Grip strength; Axilla; Physical medicine and rehabilitation; Surgery; Cancer","score_opus":0.02015011080360156,"score_gpt":0.3397694685597378,"score_spread":0.3196193577561362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2683062180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849939,0.002576735,0.00053633447,0.00059451006,0.00076622225,0.008489808,0.0007569593,0.000085886626,0.0011996476],"genre_scores_gemma":[0.97885805,0.0022001609,0.0025216672,0.00089793233,0.00055878976,0.012150292,0.0008801852,0.00001568419,0.0019171879],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99902844,0.00047197708,0.00010431246,0.00017619683,0.00006525186,0.00015379244],"domain_scores_gemma":[0.99794704,0.0008224633,0.00032158865,0.00014409957,0.00016173115,0.00060315646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020235241,0.0015847915,0.0037862363,0.0005008078,0.00072766887,0.0007792193,0.0010722873,0.0020809982,0.008733508],"category_scores_gemma":[0.0030807501,0.0007420198,0.0023215704,0.0006159651,0.0013435917,0.00097546197,0.0006865217,0.003333005,0.00069540244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9799615,0.012664969,0.00029122844,0.00048531542,0.00055167795,0.000028076789,0.0000361147,0.0001098646,0.00066585303,0.000039992025,0.00019244364,0.004972961],"study_design_scores_gemma":[0.94038,0.057717014,0.0012865774,0.000024456614,0.0002963788,0.000006389943,0.000017124314,0.00009302079,0.000058881036,0.000026673253,0.00008888998,0.0000045276925],"about_ca_topic_score_codex":0.0041696723,"about_ca_topic_score_gemma":0.0053873034,"teacher_disagreement_score":0.008733508,"about_ca_system_score_codex":0.0007315114,"about_ca_system_score_gemma":0.0017946032,"threshold_uncertainty_score":0.029216528},"labels":[],"label_agreement":null},{"id":"W2766893338","doi":"10.1016/j.clbc.2017.10.009","title":"Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Ontario Institute for Cancer Research; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Calcitriol receptor; Medicine; Vitamin D and neurology; Internal medicine; Aromatase inhibitor; vitamin D deficiency; Subclinical infection; Endocrinology; Cytokine; Single-nucleotide polymorphism; Aromatase; Immunology; Genotype; Breast cancer; Cancer; Biology","score_opus":0.020924641065252034,"score_gpt":0.32332005447400325,"score_spread":0.3023954134087512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766893338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986198,0.00048000782,0.00015669149,0.000079326994,0.0000126384475,0.000009657722,0.0002464936,0.0000050283106,0.0003903923],"genre_scores_gemma":[0.99932075,0.00006974379,0.000077177625,0.000030253474,0.000016063726,0.000009112893,0.000138079,0.0000042890874,0.0003344747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935824,0.0002257509,0.00006431569,0.00014091594,0.000095347954,0.00011550732],"domain_scores_gemma":[0.9990815,0.0003162638,0.00021595514,0.0000867168,0.00010038777,0.00019921032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042710142,0.00058683415,0.000508117,0.00089812116,0.0005982698,0.0005359018,0.00049238646,0.0006642349,0.0037395537],"category_scores_gemma":[0.0014339575,0.0002951141,0.0010775806,0.0011506007,0.00032080835,0.00018897414,0.00026991087,0.0007113446,0.0003873186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002604065,0.00016905402,0.9847003,0.000025534102,0.00058525364,0.0011113066,0.00021570602,0.00010668095,0.007441276,0.00008181048,0.00029324187,0.0026657777],"study_design_scores_gemma":[0.000053769836,0.00022720332,0.99745065,0.000009840381,0.0003375918,0.0006470078,0.00010980455,0.00037362945,0.00038726025,0.000041066352,0.00035476437,0.0000074467257],"about_ca_topic_score_codex":0.01125813,"about_ca_topic_score_gemma":0.009333267,"teacher_disagreement_score":0.01125813,"about_ca_system_score_codex":0.00034442442,"about_ca_system_score_gemma":0.00036676135,"threshold_uncertainty_score":0.02238518},"labels":[],"label_agreement":null},{"id":"W2770903255","doi":"10.1016/j.clbc.2017.11.012","title":"Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Oncology; Hazard ratio; Proportional hazards model; Genotype; Cancer; Gynecology; Confidence interval","score_opus":0.06898295181947652,"score_gpt":0.4281602336921043,"score_spread":0.3591772818726278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770903255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938095,0.00020458671,0.000018619277,0.00003844217,0.0000067646347,0.0000018286464,0.00008633937,0.0000013502342,0.00026108188],"genre_scores_gemma":[0.9995067,0.00006766451,0.000016234588,0.000026387173,0.000011616297,0.0000024687279,0.00012054614,0.0000015157177,0.00024690034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997451,0.00007389633,0.000030157811,0.00005750153,0.000032246608,0.00006103775],"domain_scores_gemma":[0.999356,0.00020884213,0.00019851867,0.00004565716,0.000046991252,0.00014408011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032406987,0.00024097165,0.00036241158,0.00034775335,0.00029358576,0.0005163709,0.00023570235,0.00047309723,0.001881389],"category_scores_gemma":[0.0011192727,0.0002559835,0.00056179485,0.0005976389,0.00022885771,0.0003420995,0.00020712198,0.0006308645,0.00020124523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009862547,0.00007423464,0.9969379,0.0000063165608,0.00015138205,0.00010899003,0.000030410682,0.000042850163,0.00071138644,0.000013021262,0.00006362245,0.00087372866],"study_design_scores_gemma":[0.000027069642,0.00011687068,0.9989924,0.000002421187,0.00009960156,0.00017600037,0.00007997602,0.00025746625,0.00009698718,0.000026497732,0.000120702854,0.000003936306],"about_ca_topic_score_codex":0.0024843225,"about_ca_topic_score_gemma":0.0026832523,"teacher_disagreement_score":0.0024843225,"about_ca_system_score_codex":0.00024820573,"about_ca_system_score_gemma":0.0002199083,"threshold_uncertainty_score":0.006293893},"labels":[],"label_agreement":null},{"id":"W2781545660","doi":"10.1016/j.clbc.2017.12.013","title":"Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Socioeconomic status; Stage (stratigraphy); Family medicine; Ductal carcinoma; Radiation therapy; Cancer; Gynecology; Oncology; Internal medicine; Population","score_opus":0.20667500051181822,"score_gpt":0.47552711425279326,"score_spread":0.26885211374097506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781545660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012416787,0.9980426,0.000055974426,0.000120687255,0.00006457989,0.00008702681,0.00028362876,0.0000036959154,0.000100196965],"genre_scores_gemma":[0.023339752,0.97496593,0.00047974943,0.00070980645,0.000060198134,0.0001710999,0.000174334,0.000004932625,0.00009416253],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99632484,0.001151005,0.0015492802,0.00040702918,0.00041309034,0.00015479031],"domain_scores_gemma":[0.98801327,0.008856755,0.002298283,0.00011564236,0.0005537512,0.00016226972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004108665,0.0012534938,0.0073459586,0.0038736134,0.000429285,0.0019429586,0.0014687246,0.0017461253,0.0057935216],"category_scores_gemma":[0.022477841,0.0010856392,0.009655246,0.005682188,0.00061031565,0.0014214151,0.0013104897,0.0016658914,0.00027195047],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056532177,0.00003412096,0.002287937,0.9278606,0.04405155,0.00009536153,0.0001853113,0.00009735984,0.00013084243,0.00010194986,0.0012822193,0.023307469],"study_design_scores_gemma":[0.0011962494,0.00031171556,0.012109235,0.5402551,0.43042076,0.0003453098,0.00040127308,0.00010047673,0.00012346951,0.00026136902,0.014402667,0.00007247559],"about_ca_topic_score_codex":0.015505395,"about_ca_topic_score_gemma":0.05796978,"teacher_disagreement_score":0.015505395,"about_ca_system_score_codex":0.0025774352,"about_ca_system_score_gemma":0.006072884,"threshold_uncertainty_score":0.030830324},"labels":[],"label_agreement":null},{"id":"W2790548769","doi":"10.1016/j.clbc.2018.03.008","title":"Prospective Study of Breast Radiation Dermatitis","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Adverse effect; Dermatology; Radiation therapy; Prospective cohort study; Toxicity; Regimen; Internal medicine; Surgery; Cancer","score_opus":0.01885744899582218,"score_gpt":0.3806932599921902,"score_spread":0.361835810996368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790548769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700326,0.0007546739,0.00019647354,0.00003233401,0.000014974391,0.00004928942,0.0005299171,0.00000780264,0.0014111984],"genre_scores_gemma":[0.99675024,0.00034726417,0.0001258653,0.00006466897,0.000021860453,0.000037051403,0.00065612927,0.00000819291,0.001988769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991186,0.00034831295,0.00007731833,0.00017883413,0.00011799513,0.00015887948],"domain_scores_gemma":[0.9985506,0.00026708326,0.00034934428,0.0002544097,0.00024258146,0.00033589976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083069626,0.0005644791,0.0005017579,0.0009383628,0.001238313,0.00087834784,0.0004673777,0.000795758,0.0042952886],"category_scores_gemma":[0.0017261393,0.0010213227,0.0005728553,0.001147437,0.00042342013,0.000497783,0.0006123684,0.00080321217,0.0014704431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018611692,0.000626291,0.9935586,0.00003221597,0.00014217009,0.00038790912,0.00023494649,0.00003729882,0.0008655386,0.00004849343,0.00017238416,0.0020329666],"study_design_scores_gemma":[0.000083076855,0.0013710565,0.99563223,0.000012729233,0.00010625722,0.00088567834,0.0003774599,0.000045929042,0.00025687768,0.000036634592,0.0011836911,0.000008325146],"about_ca_topic_score_codex":0.0035263079,"about_ca_topic_score_gemma":0.004422596,"teacher_disagreement_score":0.0042952886,"about_ca_system_score_codex":0.0003454626,"about_ca_system_score_gemma":0.0005267567,"threshold_uncertainty_score":0.01436919},"labels":[],"label_agreement":null},{"id":"W2791226420","doi":"10.1016/j.clbc.2018.02.008","title":"Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Avon Foundation for Women","keywords":"Medicine; Confidence interval; Breast cancer; Reliability (semiconductor); Range of motion; Physical therapy; Upper limb; Physical medicine and rehabilitation; Cancer; Internal medicine","score_opus":0.047050581797090034,"score_gpt":0.34363248896369897,"score_spread":0.2965819071666089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791226420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877375,0.00018109995,0.00016840335,0.000062366606,0.000027253907,0.000019196192,0.00008800253,0.0000027699134,0.00067707256],"genre_scores_gemma":[0.9993383,0.00009061062,0.00019887066,0.00002694604,0.00001645236,0.000017789518,0.0001605088,0.0000018555512,0.00014851788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975477,0.0011607271,0.00032784147,0.00020998328,0.0004931514,0.00026062853],"domain_scores_gemma":[0.99109554,0.005148752,0.0015791816,0.00055379537,0.0012991828,0.0003235285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051234253,0.0003633891,0.00046890584,0.0014451899,0.00044424253,0.00083636446,0.0005694781,0.00075378583,0.0005374941],"category_scores_gemma":[0.023103507,0.0004264192,0.0007633406,0.0009044472,0.00073000405,0.00054079504,0.0009731353,0.00072264904,0.00021571422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007694513,0.000039900147,0.9978841,0.0000063366806,0.000052121308,0.000013880874,0.00018138334,0.000060222097,0.000078386074,0.000014724348,0.00005601402,0.0015359035],"study_design_scores_gemma":[0.000010311916,0.00016940614,0.99824476,0.000010737258,0.00004307225,0.00007052301,0.00047431042,0.0006310728,0.00008962503,0.000038006998,0.00021315226,0.0000050381036],"about_ca_topic_score_codex":0.0060718046,"about_ca_topic_score_gemma":0.007938689,"teacher_disagreement_score":0.0060718046,"about_ca_system_score_codex":0.0005879491,"about_ca_system_score_gemma":0.00066119566,"threshold_uncertainty_score":0.027095556},"labels":[],"label_agreement":null},{"id":"W2799541018","doi":"10.1016/j.clbc.2018.05.001","title":"Early Local Recurrence in a Patient With Encapsulated Papillary Carcinoma of the Breast","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Myoepithelial cell; Papillary carcinoma; Breast cancer; Capsule; Carcinoma; Breast carcinoma; Ductal carcinoma; Pathology; Oncology; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.020328493702090476,"score_gpt":0.2993965439465933,"score_spread":0.2790680502445028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799541018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258995,0.0013858351,0.0005990285,0.0007526737,0.000077092845,0.000046968114,0.000119096,0.00006919158,0.0043601],"genre_scores_gemma":[0.9982844,0.00036270721,0.00019697307,0.00025184735,0.00016591573,0.000008486774,0.00007249863,0.000013845582,0.0006432895],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999663,0.000041736814,0.000042599142,0.000067203335,0.000044088618,0.00014143168],"domain_scores_gemma":[0.9986412,0.00050436775,0.00022098,0.00014649605,0.00006874911,0.0004182492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003373205,0.0011114675,0.001005537,0.0014536926,0.0016015726,0.0010968732,0.0009663283,0.0030288242,0.0018919323],"category_scores_gemma":[0.0033266607,0.00091541355,0.000979835,0.000957548,0.0011600842,0.0011126397,0.0009236641,0.0016006816,0.0007970208],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015163528,0.000060143284,0.041520737,0.000033813954,0.0000140872335,0.9551707,0.0002702217,0.00011647933,0.0011008129,0.0000756222,0.00016739465,0.0013184978],"study_design_scores_gemma":[0.00003293632,0.00024767395,0.047851868,0.000014465242,0.000051486375,0.95020914,0.00031521395,0.0002779913,0.0005162998,0.00009941878,0.0003610057,0.00002246754],"about_ca_topic_score_codex":0.0024600483,"about_ca_topic_score_gemma":0.0028049187,"teacher_disagreement_score":0.0030288242,"about_ca_system_score_codex":0.00094468344,"about_ca_system_score_gemma":0.0005076489,"threshold_uncertainty_score":0.006854236},"labels":[],"label_agreement":null},{"id":"W2802874188","doi":"10.1016/j.clbc.2018.04.013","title":"Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Oncology; Cohort; Population; Internal medicine; Survival analysis; Triple negative; Cancer; Gynecology; Environmental health","score_opus":0.025369665966971794,"score_gpt":0.4156564737991756,"score_spread":0.3902868078322038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802874188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822825,0.00082099636,0.0002548119,0.000042550822,0.000016991145,0.0000073192464,0.00040514691,0.0000066983894,0.00021720206],"genre_scores_gemma":[0.9991665,0.00016675997,0.00010070104,0.000021254962,0.000013009426,0.000007318116,0.00028783796,0.000008139305,0.00022860154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752516,0.00096010073,0.00021669046,0.0007100946,0.0002451024,0.00034293995],"domain_scores_gemma":[0.99443,0.0017342619,0.0014212709,0.001467744,0.00050660834,0.00044000856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036650333,0.00060485606,0.0007451235,0.0008631274,0.0007487176,0.001473567,0.00085841626,0.00101004,0.0020765834],"category_scores_gemma":[0.006421695,0.00070412643,0.0026575604,0.0012353678,0.00050673686,0.0008265348,0.00074718695,0.001231611,0.00025992436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015829861,0.00007417944,0.9947621,0.00001715654,0.0014017004,0.000083050014,0.00010460549,0.0000581973,0.00040353768,0.00002786838,0.00012803923,0.0013565717],"study_design_scores_gemma":[0.00005260373,0.00039296362,0.99691355,0.000010947609,0.0013841424,0.00022060906,0.00024528758,0.00034554492,0.00013175419,0.000052034873,0.00023696467,0.000013564169],"about_ca_topic_score_codex":0.0115977395,"about_ca_topic_score_gemma":0.010981348,"teacher_disagreement_score":0.0115977395,"about_ca_system_score_codex":0.00039748906,"about_ca_system_score_gemma":0.0005411658,"threshold_uncertainty_score":0.0230605},"labels":[],"label_agreement":null},{"id":"W2807780575","doi":"10.1016/j.clbc.2018.05.010","title":"A Systematic Review of Heart Dose in Breast Radiotherapy","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Dosimetry; Heart disease; Heart rate; Breathing; Nuclear medicine; Cardiology; Internal medicine; Cancer; Blood pressure; Anesthesia","score_opus":0.04167221562212159,"score_gpt":0.4238226244999446,"score_spread":0.38215040887782303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807780575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030621028,0.9991522,0.000051531995,0.00009162912,0.000049572773,0.000034535795,0.00019684201,0.0000027765234,0.00011461323],"genre_scores_gemma":[0.005660766,0.9933316,0.00027551045,0.00041592726,0.00005821656,0.00006263357,0.00011611028,0.0000031583363,0.00007610016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99641895,0.0011555448,0.0014415095,0.00038441055,0.0005019878,0.00009762037],"domain_scores_gemma":[0.9908059,0.0068331636,0.0016485656,0.0001473112,0.00047825155,0.00008686813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044530556,0.0011652574,0.0061905426,0.0051219305,0.00032587888,0.0016727486,0.0015501884,0.0014520737,0.0051734243],"category_scores_gemma":[0.019347552,0.0008289192,0.005980829,0.0065154457,0.0006438246,0.0012356279,0.0013839654,0.0011011505,0.00030525288],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002450173,0.000015005493,0.00084311626,0.9193121,0.014294882,0.00006242822,0.00010903989,0.00015637098,0.00015966634,0.00021988989,0.0025445705,0.062037926],"study_design_scores_gemma":[0.00059909484,0.0003549648,0.008305231,0.7352319,0.18959777,0.00058669323,0.00025243266,0.0001009902,0.0002379222,0.0006831042,0.06397643,0.000073541196],"about_ca_topic_score_codex":0.0098692905,"about_ca_topic_score_gemma":0.02953574,"teacher_disagreement_score":0.0098692905,"about_ca_system_score_codex":0.0020096668,"about_ca_system_score_gemma":0.0053672707,"threshold_uncertainty_score":0.023550272},"labels":[],"label_agreement":null},{"id":"W2809807627","doi":"10.1016/j.clbc.2018.06.015","title":"Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Randomized controlled trial; Incidence (geometry); Dermatology; Cancer; Systematic review; Internal medicine; MEDLINE; Oncology","score_opus":0.07297618904876768,"score_gpt":0.4552145097670153,"score_spread":0.3822383207182476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809807627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012273168,0.99810284,0.0000929596,0.00007186315,0.000055843277,0.0001354072,0.00019845154,0.000004768443,0.00011054892],"genre_scores_gemma":[0.021075198,0.97734046,0.0005549086,0.0004988842,0.000064670116,0.00018646027,0.00017326456,0.0000050632784,0.00010117049],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961971,0.0013107386,0.0014369114,0.00046413115,0.00046239555,0.0001287069],"domain_scores_gemma":[0.99053687,0.0067521366,0.001982194,0.0001483718,0.00045780992,0.00012258554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046709403,0.0016690047,0.00901606,0.0030019372,0.00041100036,0.0018477724,0.0017193534,0.0017521065,0.0046024234],"category_scores_gemma":[0.0191379,0.000916559,0.011287973,0.0043165875,0.0006247938,0.0015326644,0.0011971251,0.001669692,0.00021794056],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014449563,0.00003555314,0.0011545108,0.9106094,0.05878156,0.00006767918,0.00008010465,0.00018268205,0.00019517676,0.00010653118,0.0009117023,0.02643002],"study_design_scores_gemma":[0.0035478347,0.0009790773,0.008737683,0.324186,0.645452,0.00043231162,0.0002493205,0.00014891398,0.00028261793,0.0005482031,0.015355589,0.000080544494],"about_ca_topic_score_codex":0.00462985,"about_ca_topic_score_gemma":0.015218064,"teacher_disagreement_score":0.00901606,"about_ca_system_score_codex":0.0018395843,"about_ca_system_score_gemma":0.0032295971,"threshold_uncertainty_score":0.024702549},"labels":[],"label_agreement":null},{"id":"W2884297513","doi":"10.1016/j.clbc.2018.07.016","title":"Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Proportional hazards model; Univariate analysis; Supraclavicular lymph nodes; Internal medicine; Oncology; Stage (stratigraphy); Axilla; Multivariate analysis; Survival analysis; Randomized controlled trial; Cancer; Surgery","score_opus":0.18284313137461775,"score_gpt":0.48569050990991464,"score_spread":0.30284737853529686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884297513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69530785,0.292762,0.003570749,0.000566867,0.0005513569,0.00050793035,0.0036722736,0.000079749356,0.002981177],"genre_scores_gemma":[0.9822412,0.013644046,0.0007879788,0.00049480586,0.00025857065,0.00023392751,0.0016840132,0.000034371427,0.0006211404],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9900866,0.0068080523,0.0010196196,0.0012101986,0.00051625335,0.00035921394],"domain_scores_gemma":[0.99113643,0.0052966014,0.0020373513,0.000902343,0.00038334145,0.00024403127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010705488,0.0019498838,0.005968346,0.00085759506,0.00033941827,0.0021093586,0.0007886524,0.0015463156,0.0017343501],"category_scores_gemma":[0.013218381,0.0007325219,0.018032849,0.001448832,0.0006626368,0.0009526954,0.001050686,0.0017423931,0.00020991873],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19399749,0.0001760738,0.05792293,0.009419134,0.71365994,0.00017282966,0.0001103821,0.002869237,0.0018252474,0.00019375359,0.00089741853,0.0187556],"study_design_scores_gemma":[0.028138084,0.0076540834,0.095847495,0.0008656471,0.8624554,0.00022166727,0.00012519937,0.0010600149,0.00077567913,0.0006537314,0.0021209621,0.00008203277],"about_ca_topic_score_codex":0.0017125272,"about_ca_topic_score_gemma":0.0034545232,"teacher_disagreement_score":0.010705488,"about_ca_system_score_codex":0.0006608016,"about_ca_system_score_gemma":0.0005802676,"threshold_uncertainty_score":0.056616724},"labels":[],"label_agreement":null},{"id":"W2884344149","doi":"10.1016/j.clbc.2018.07.019","title":"Clinical Outcomes of Single Versus Double Hormone Receptor–Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Confidence interval; Odds ratio; Univariate analysis; Oncology; Chemotherapy; Logistic regression; Cancer; Gastroenterology; Multivariate analysis","score_opus":0.028335911381362194,"score_gpt":0.347683456628805,"score_spread":0.3193475452474428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884344149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974721,0.0010777392,0.000031067393,0.00006323916,0.00001803062,0.000010258529,0.00019447107,0.0000011142829,0.0011319007],"genre_scores_gemma":[0.9989826,0.00024348064,0.000017710508,0.000046568734,0.000023971917,0.000010276905,0.00038621624,0.0000010413661,0.00028812967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996686,0.00013381672,0.000039876846,0.000051680818,0.000038377657,0.0000675668],"domain_scores_gemma":[0.99900275,0.00033244875,0.00030925483,0.0000480272,0.00007511397,0.00023241287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046795813,0.0001459693,0.00051004934,0.00028664956,0.00019381006,0.00044044942,0.00014275954,0.0002782232,0.0015617805],"category_scores_gemma":[0.0019420091,0.00008695799,0.00041629368,0.0004079556,0.00025498186,0.00033966216,0.00023615449,0.00035603924,0.00018047332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053462747,0.0005935718,0.91765636,0.00011101946,0.00045331524,0.00032036574,0.00017318543,0.000373848,0.0038666944,0.00012764146,0.0005305147,0.022330623],"study_design_scores_gemma":[0.00046999136,0.0067757904,0.98948693,0.000027371654,0.000352468,0.00043944633,0.00028503267,0.00026238785,0.00060814875,0.00011499481,0.0011610354,0.000016499342],"about_ca_topic_score_codex":0.0007275871,"about_ca_topic_score_gemma":0.0013564128,"teacher_disagreement_score":0.0015617805,"about_ca_system_score_codex":0.00041158395,"about_ca_system_score_gemma":0.00027049024,"threshold_uncertainty_score":0.0052247047},"labels":[],"label_agreement":null},{"id":"W2884986199","doi":"10.1016/j.clbc.2018.07.018","title":"Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Cancer Society; Cancer Care Ontario","keywords":"Medicine; Ductal carcinoma; In situ; Breast cancer; Oncology; Carcinoma in situ; Internal medicine; Mastectomy; Radiology; Cancer","score_opus":0.07834848226788581,"score_gpt":0.3749532434243623,"score_spread":0.2966047611564765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884986199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077077,0.001875535,0.0126624275,0.0012205734,0.00045040515,0.00006615203,0.0016289112,0.00018146593,0.001143751],"genre_scores_gemma":[0.99570614,0.00027635798,0.001890283,0.00007042791,0.00019924005,0.000048873113,0.000948605,0.00002556799,0.0008343967],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997771,0.0012892643,0.00017194138,0.0003228378,0.00017744729,0.00026743268],"domain_scores_gemma":[0.99162346,0.0057484563,0.00052307727,0.00062686385,0.00079536706,0.0006827821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008007273,0.0015297468,0.001348422,0.0015962275,0.00061193376,0.001842833,0.0017446339,0.0010843566,0.0027589959],"category_scores_gemma":[0.01097717,0.0005173619,0.0032865503,0.0011854825,0.0003132074,0.0010551809,0.00086576527,0.0025634104,0.0005903246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026352385,0.00042437768,0.96958894,0.00009129384,0.0028043208,0.00018994165,0.00010010119,0.0073663555,0.00073511194,0.00026588392,0.001437204,0.014361237],"study_design_scores_gemma":[0.00055056706,0.0030684453,0.60028857,0.0001822925,0.011909798,0.00082172605,0.00057069206,0.37263158,0.0022505634,0.002318916,0.005277133,0.00012969063],"about_ca_topic_score_codex":0.0060507134,"about_ca_topic_score_gemma":0.0063581034,"teacher_disagreement_score":0.008007273,"about_ca_system_score_codex":0.00036561736,"about_ca_system_score_gemma":0.002011409,"threshold_uncertainty_score":0.042347014},"labels":[],"label_agreement":null},{"id":"W2887856562","doi":"10.1016/j.clbc.2018.07.007","title":"Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Pfizer (Canada); Ottawa Hospital","funders":"MedImmune; AbbVie; Puma Biotechnology; Novartis; Pfizer; Eli Lilly and Company","keywords":"Palbociclib; Medicine; Letrozole; Neutropenia; Metastatic breast cancer; Breast cancer; Adverse effect; Internal medicine; Oncology; Febrile neutropenia; Expanded access; Fulvestrant; Cancer; Estrogen receptor; Chemotherapy; Tamoxifen","score_opus":0.03019194093956165,"score_gpt":0.38807140220821973,"score_spread":0.3578794612686581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887856562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753613,0.0030052501,0.00029165755,0.000616867,0.0002547179,0.0011118498,0.002750022,0.00010516708,0.004328311],"genre_scores_gemma":[0.98475677,0.0020708241,0.00059059705,0.0011402527,0.00032835957,0.0010476947,0.0035815085,0.00004396085,0.0064400453],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993311,0.0002905365,0.000031388117,0.00011456489,0.00007922279,0.00015331252],"domain_scores_gemma":[0.9994079,0.00010740654,0.000068657435,0.00006278881,0.00004249322,0.00031074818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011154494,0.0011637721,0.0028047827,0.00060531945,0.00043556868,0.0012217636,0.0007652872,0.0012326227,0.010123137],"category_scores_gemma":[0.0012227613,0.00053923565,0.001386423,0.0005194036,0.00069951947,0.001412325,0.00051467447,0.003146084,0.0019088583],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94073486,0.018623147,0.0033904046,0.0002407082,0.0016229701,0.00018059633,0.000067517845,0.00038689387,0.0052407356,0.00009828455,0.0016162973,0.02779764],"study_design_scores_gemma":[0.77475286,0.1958709,0.02011507,0.000046707682,0.0020486503,0.00019221654,0.00009252065,0.000683754,0.0010852283,0.00022308038,0.004844135,0.00004479817],"about_ca_topic_score_codex":0.0025796094,"about_ca_topic_score_gemma":0.006334886,"teacher_disagreement_score":0.010123137,"about_ca_system_score_codex":0.0009103084,"about_ca_system_score_gemma":0.0012204691,"threshold_uncertainty_score":0.033865273},"labels":[],"label_agreement":null},{"id":"W2888237016","doi":"10.1016/j.clbc.2018.08.002","title":"Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Cancer Care South East","funders":"","keywords":"Medicine; Breast cancer; Axilla; Axillary Lymph Node Dissection; Sentinel node; Sentinel lymph node; Radiation therapy; Clinical trial; Randomized controlled trial; Oncology; Biopsy; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.09273697392234953,"score_gpt":0.4358140334634458,"score_spread":0.3430770595410963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888237016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065137465,0.9995946,0.000035852114,0.00011376742,0.00004029335,0.000007225751,0.000037410937,0.0000018036129,0.00010378982],"genre_scores_gemma":[0.00078222173,0.9986039,0.00015595343,0.000273527,0.00006602256,0.000012606648,0.00004983045,0.000001287009,0.000054612196],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992279,0.00020779845,0.00023087164,0.00012619514,0.00016442224,0.000042869447],"domain_scores_gemma":[0.9965918,0.0025757325,0.00044434125,0.000051689378,0.00026671524,0.00006974816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024850932,0.0010150293,0.003604021,0.002429322,0.00027435002,0.0014828099,0.0015397136,0.0012287924,0.004172869],"category_scores_gemma":[0.0056601283,0.0004478654,0.0022115295,0.0032645403,0.00042793975,0.0012859177,0.0007779651,0.0016383976,0.00055360777],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083684124,0.00010030342,0.00073099334,0.211792,0.0020497295,0.00010772331,0.00007094773,0.00039570167,0.0008320669,0.0010015673,0.014983365,0.7670988],"study_design_scores_gemma":[0.00082339667,0.001190535,0.0067483922,0.24866667,0.022933273,0.0018734873,0.00031706723,0.00035033195,0.001117741,0.003616428,0.712222,0.00014075752],"about_ca_topic_score_codex":0.001313391,"about_ca_topic_score_gemma":0.0040508066,"teacher_disagreement_score":0.004172869,"about_ca_system_score_codex":0.0007971913,"about_ca_system_score_gemma":0.0021311955,"threshold_uncertainty_score":0.013959587},"labels":[],"label_agreement":null},{"id":"W2889734568","doi":"10.1016/j.clbc.2018.08.012","title":"Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Ottawa Hospital","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Radiation therapy; Internal medicine; Adjuvant; Endocrine system; Adjuvant therapy; Adjuvant radiotherapy; Cancer; Gynecology; Hormone","score_opus":0.04168327726248598,"score_gpt":0.3778543600038195,"score_spread":0.3361710827413335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889734568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986721,0.0003346094,0.00003521655,0.000097596014,0.000005341762,0.0000043763193,0.00025582485,0.0000016298043,0.00059317384],"genre_scores_gemma":[0.999345,0.00015113203,0.000057025507,0.000049031238,0.000007970887,0.0000030006672,0.00016473864,8.378306e-7,0.00022118825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996088,0.00020760071,0.00003950451,0.00004570313,0.00004792512,0.00005045707],"domain_scores_gemma":[0.9973483,0.00090251025,0.0011808743,0.000056281908,0.00017650647,0.00033543503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043075395,0.0000930883,0.0001693284,0.0005089986,0.00023098962,0.00025364416,0.000111639994,0.00033402216,0.0012770339],"category_scores_gemma":[0.0032083045,0.00013445296,0.000162197,0.00082209957,0.00010394873,0.00019489747,0.00013207535,0.00028875066,0.00016603926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018909079,0.000051733557,0.9984401,0.000008018547,0.000013975503,0.00003610775,0.00007627983,0.000030089162,0.0001406751,0.0000060686175,0.000070279035,0.0009376188],"study_design_scores_gemma":[0.000006372916,0.00019633342,0.99907625,0.0000032776566,0.000011783387,0.00013302232,0.00023473085,0.000055344066,0.000057244986,0.0000041366893,0.00021979076,0.0000017961943],"about_ca_topic_score_codex":0.010953144,"about_ca_topic_score_gemma":0.015428839,"teacher_disagreement_score":0.010953144,"about_ca_system_score_codex":0.00032334586,"about_ca_system_score_gemma":0.00035945003,"threshold_uncertainty_score":0.021778822},"labels":[],"label_agreement":null},{"id":"W2904914229","doi":"10.1016/j.clbc.2018.12.005","title":"Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Cancer registry; Proportional hazards model; Cancer; Odds ratio; Confidence interval; Population; Comorbidity; Mastectomy; Oncology","score_opus":0.03877624950441126,"score_gpt":0.3948362463287303,"score_spread":0.35605999682431905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904914229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863523,0.00038879283,0.0000688227,0.000059532693,0.000007190384,0.000008950465,0.00056908897,0.000002568421,0.0002597334],"genre_scores_gemma":[0.99923515,0.00014408771,0.000037430236,0.00003727809,0.000011794651,0.000008268798,0.00047644018,0.0000012548677,0.00004827512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992415,0.00025251394,0.00007818669,0.00021012189,0.00009508892,0.00012267387],"domain_scores_gemma":[0.99852884,0.00026802355,0.0006313791,0.00017429586,0.00012846844,0.0002689702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006771288,0.00037043093,0.0005745898,0.0007212826,0.00054275786,0.00093743386,0.00042158313,0.00083648,0.0010682192],"category_scores_gemma":[0.0027264045,0.00038257608,0.0010141515,0.0016656638,0.00044440027,0.00081396045,0.000728345,0.0010085165,0.00017382303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018859403,0.000060460257,0.9988721,0.000010644254,0.00017465184,0.000046336732,0.00003510921,0.000026585054,0.00007248162,0.000010765565,0.00006486365,0.0004373224],"study_design_scores_gemma":[0.00001289658,0.00011990176,0.99924254,0.000004333479,0.000081710314,0.00013701324,0.00018549967,0.000101478654,0.000013389989,0.00001961371,0.000077244484,0.0000044799503],"about_ca_topic_score_codex":0.006938737,"about_ca_topic_score_gemma":0.009487814,"teacher_disagreement_score":0.006938737,"about_ca_system_score_codex":0.0005061841,"about_ca_system_score_gemma":0.00041314948,"threshold_uncertainty_score":0.013796687},"labels":[],"label_agreement":null},{"id":"W2907792903","doi":"10.1016/j.clbc.2019.01.001","title":"Comparison of Radioactive Seed Localized Excision and Wire Localized Excision of Breast Lesions: A Community Hospital’s Experience","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; North York General Hospital; University of Toronto","funders":"","keywords":"Medicine; Surgical excision; Breast cancer; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.03508224849894968,"score_gpt":0.39261687460153416,"score_spread":0.35753462610258446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907792903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844223,0.0002674557,0.000102592414,0.00008197279,0.0000054730017,0.000016672564,0.000017657194,0.0000020860102,0.0010639764],"genre_scores_gemma":[0.9985709,0.00039809782,0.00019872838,0.00008076129,0.000015813761,0.000009062462,0.000051691757,0.0000050649637,0.0006698038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992605,0.0003369485,0.000042175492,0.00009729265,0.00012661987,0.00013644299],"domain_scores_gemma":[0.99859077,0.00052111136,0.00015241289,0.00010839691,0.00027378072,0.00035351352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096468866,0.0002485619,0.00020807981,0.0007288807,0.0011726359,0.0005578224,0.0005087941,0.0005401547,0.0017283865],"category_scores_gemma":[0.002470473,0.00023473286,0.00019440435,0.000874631,0.00085466396,0.00029437558,0.00078634825,0.0004200291,0.00022789136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056260847,0.0065700365,0.7948123,0.00032842066,0.00010176821,0.01834304,0.013562498,0.00085211033,0.022193165,0.000773,0.001241063,0.1355966],"study_design_scores_gemma":[0.00035204127,0.02232514,0.90189517,0.00008612822,0.000120615536,0.029442426,0.022336053,0.000597902,0.011108776,0.0002847711,0.011325974,0.00012492825],"about_ca_topic_score_codex":0.0059597124,"about_ca_topic_score_gemma":0.015093752,"teacher_disagreement_score":0.0059597124,"about_ca_system_score_codex":0.0009464064,"about_ca_system_score_gemma":0.0011219275,"threshold_uncertainty_score":0.011850059},"labels":[],"label_agreement":null},{"id":"W2914403239","doi":"10.1016/j.clbc.2019.01.003","title":"Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Society for Medical Oncology","keywords":"Medicine; Mammography; Breast cancer; Radiology; Asymptomatic; Cancer; Malignancy; Nuclear medicine; Medical physics; Internal medicine","score_opus":0.01734164103829911,"score_gpt":0.3408402520503995,"score_spread":0.32349861101210037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914403239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98387617,0.006000641,0.0007281565,0.001184685,0.00006767596,0.000030621875,0.00051676953,0.000041520314,0.0075537465],"genre_scores_gemma":[0.99706656,0.0013307866,0.00050341856,0.00017916258,0.00008041775,0.0000074898453,0.00024697924,0.000006625733,0.000578609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966383,0.00015111179,0.00002658497,0.000034566467,0.00007070103,0.000053299274],"domain_scores_gemma":[0.9972474,0.00082443573,0.0013089323,0.00014995216,0.00019449698,0.0002748047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032640249,0.0002440822,0.00031869792,0.00058562536,0.00031257202,0.00058308366,0.00025225358,0.00051986973,0.0027723112],"category_scores_gemma":[0.0046259975,0.00014629241,0.00036795772,0.00078625797,0.00015116672,0.00032012395,0.0002499705,0.0007266084,0.00020165395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002441646,0.000107052525,0.9835759,0.000041436804,0.000071284005,0.00023271545,0.000047686237,0.00010516903,0.0005877869,0.000079582984,0.00046566446,0.014441504],"study_design_scores_gemma":[0.00000767651,0.00029024397,0.9964132,0.000043336207,0.00010661759,0.0010032674,0.000121493744,0.0003148217,0.00036528317,0.00022779316,0.0011007914,0.000005644972],"about_ca_topic_score_codex":0.0028258357,"about_ca_topic_score_gemma":0.0032494043,"teacher_disagreement_score":0.0028258357,"about_ca_system_score_codex":0.00028493244,"about_ca_system_score_gemma":0.0004144449,"threshold_uncertainty_score":0.009274244},"labels":[],"label_agreement":null},{"id":"W2921234713","doi":"10.1016/j.clbc.2019.03.002","title":"Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Immunohistochemistry; Breast cancer; Sentinel node; Sentinel lymph node; Cohort; Pathology; Oncology; Lymph node; Internal medicine; Cancer","score_opus":0.010948372823360811,"score_gpt":0.27797298712294627,"score_spread":0.26702461429958546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921234713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912375,0.00020893205,0.0001142605,0.0000105993595,0.0000042622783,0.0000071407844,0.00029759613,0.0000022188688,0.00023121244],"genre_scores_gemma":[0.99916077,0.00011186354,0.000052312716,0.0000132397245,0.0000063444495,0.000009631793,0.00039462734,0.000004296158,0.0002470471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992136,0.00016647593,0.00006246951,0.00028434175,0.000121877965,0.00015131534],"domain_scores_gemma":[0.9986505,0.00026644216,0.00037141782,0.0003022723,0.00020056887,0.00020874129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006554608,0.00040832974,0.00048726433,0.0009053443,0.00069119525,0.0009078229,0.0007184692,0.0005316609,0.0017812517],"category_scores_gemma":[0.0019360661,0.0005202856,0.0005570589,0.0010988435,0.00039020096,0.0005299162,0.0007926249,0.00069637265,0.00040270726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038345944,0.00004479052,0.99670535,0.000008975651,0.00009932881,0.00015701204,0.0001180449,0.00002493938,0.0013697158,0.000019513358,0.000072732706,0.0009961051],"study_design_scores_gemma":[0.000013089592,0.00018520198,0.9978892,0.000004575429,0.00010467805,0.00059537316,0.0003900927,0.000104386156,0.00037064267,0.00002943061,0.00030746058,0.0000058045453],"about_ca_topic_score_codex":0.0051367544,"about_ca_topic_score_gemma":0.006129023,"teacher_disagreement_score":0.0051367544,"about_ca_system_score_codex":0.00037477384,"about_ca_system_score_gemma":0.00046305446,"threshold_uncertainty_score":0.010213733},"labels":[],"label_agreement":null},{"id":"W2945204224","doi":"10.1016/j.clbc.2019.05.007","title":"Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Joey and Mary Furfari Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Anxiety; Breast cancer; Quality of life (healthcare); Depression (economics); Physical therapy; Hospital Anxiety and Depression Scale; Cancer; Stepwise regression; Internal medicine; Psychiatry","score_opus":0.029791024623103138,"score_gpt":0.39234177196101305,"score_spread":0.36255074733790993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945204224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990452,0.00021062949,0.0000255334,0.00006485812,0.000008172944,0.0000050229028,0.00011307294,0.0000011582329,0.00052626064],"genre_scores_gemma":[0.9995603,0.00007546169,0.000026870694,0.00002320365,0.000006615405,0.0000032175822,0.00015982006,6.343606e-7,0.00014385596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979717,0.0000625172,0.00002019057,0.000020168842,0.000048980502,0.000051058203],"domain_scores_gemma":[0.99906975,0.00028261286,0.00034378128,0.000023824086,0.00009108507,0.00018888444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039801747,0.0002220411,0.00028404582,0.00048031966,0.00027210196,0.000520298,0.00028595544,0.00039355044,0.0015343466],"category_scores_gemma":[0.0026207604,0.0001322885,0.0004953827,0.00067221315,0.00026022093,0.00032756806,0.00049067655,0.0005346312,0.00010223178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010368628,0.000040436495,0.9983146,0.0000056892354,0.000035637233,0.000033059096,0.000050249222,0.00008146971,0.00009776105,0.0000086464615,0.00007495285,0.001153823],"study_design_scores_gemma":[0.0000052270675,0.00005387356,0.9994729,0.0000043696405,0.000018374729,0.000046015113,0.00015001144,0.00015633124,0.00002232487,0.000011906097,0.00005633971,0.000002418935],"about_ca_topic_score_codex":0.006038758,"about_ca_topic_score_gemma":0.011308988,"teacher_disagreement_score":0.006038758,"about_ca_system_score_codex":0.00037426525,"about_ca_system_score_gemma":0.00044905598,"threshold_uncertainty_score":0.0120072365},"labels":[],"label_agreement":null},{"id":"W2947085112","doi":"10.1016/j.clbc.2019.05.002","title":"Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; NOSM University; Laurentian University","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Immune system; Oncology; Metastatic breast cancer; Internal medicine; Peripheral; Peripheral blood; Cancer; Immunology","score_opus":0.010271630282281561,"score_gpt":0.2735510560594746,"score_spread":0.26327942577719304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947085112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877936,0.00027547052,0.000056420693,0.00004052695,0.000005761181,0.0000033254937,0.00016511194,0.0000052124133,0.0006687403],"genre_scores_gemma":[0.9994523,0.00007761399,0.000034084485,0.000021975367,0.000013039732,0.0000034771938,0.00019627008,0.0000017750879,0.00019951913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984527,0.000036101785,0.0000132750765,0.00003223982,0.000023814582,0.000049251776],"domain_scores_gemma":[0.9989993,0.00028933035,0.000404788,0.00005077661,0.00007643203,0.00017931602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016472755,0.00014904753,0.00027609893,0.0004036468,0.0002771679,0.0004815074,0.00021038779,0.00034354834,0.0020141762],"category_scores_gemma":[0.0015792006,0.00014170034,0.00018066994,0.00057731534,0.00020049595,0.00031312887,0.00021949668,0.00043725857,0.00024478507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042293247,0.00002656227,0.99722075,0.000004221714,0.000020753447,0.00007119233,0.000018099561,0.00004010366,0.0006119486,0.000010008634,0.00008061603,0.0014728201],"study_design_scores_gemma":[0.000008474246,0.00015079162,0.9989472,0.000002632625,0.000020096557,0.00039120056,0.000051602365,0.00015561476,0.00013674238,0.000021167634,0.00011231238,0.0000022815675],"about_ca_topic_score_codex":0.0010320762,"about_ca_topic_score_gemma":0.0013781085,"teacher_disagreement_score":0.0020141762,"about_ca_system_score_codex":0.00020648408,"about_ca_system_score_gemma":0.00017050609,"threshold_uncertainty_score":0.0067381263},"labels":[],"label_agreement":null},{"id":"W2950065662","doi":"10.1016/j.clbc.2019.05.020","title":"Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Waterloo; BC Cancer Agency","funders":"AbbVie","keywords":"Medicine; Breast cancer; Oncology; Neoadjuvant therapy; Chemotherapy; Endocrine system; Internal medicine; Prospective cohort study; Cancer; Hormone","score_opus":0.023558056259878144,"score_gpt":0.34408901428048977,"score_spread":0.3205309580206116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950065662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928596,0.0013141464,0.000061787476,0.00009864669,0.0000073917736,0.00003449841,0.0051143616,0.000003676736,0.00050601194],"genre_scores_gemma":[0.9918258,0.0005325983,0.00010570099,0.00011685202,0.000018959947,0.00005418444,0.007202416,0.0000057131874,0.00013791544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954052,0.0022606042,0.0007760118,0.00077940425,0.00045734426,0.00032141016],"domain_scores_gemma":[0.9875673,0.0044261143,0.005858943,0.00079938676,0.0006309417,0.00071738445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031971086,0.0003127142,0.00091282034,0.0011070025,0.00045706684,0.0012577262,0.0008761908,0.0005692038,0.0016455271],"category_scores_gemma":[0.009354763,0.00029746146,0.0011566685,0.003726857,0.00047503397,0.00090835855,0.0008633038,0.00048623595,0.00024877622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026032834,0.00011433546,0.9947338,0.000061665305,0.0006284401,0.00002254727,0.000050841016,0.0000878144,0.00009386153,0.000023783094,0.00024608272,0.001333542],"study_design_scores_gemma":[0.00023250488,0.00034826278,0.9978212,0.000025767959,0.000571225,0.00010520633,0.00020990027,0.00013216634,0.00013037953,0.00002122003,0.00039319688,0.000008918443],"about_ca_topic_score_codex":0.0068528294,"about_ca_topic_score_gemma":0.010232822,"teacher_disagreement_score":0.0068528294,"about_ca_system_score_codex":0.0009796531,"about_ca_system_score_gemma":0.0010898717,"threshold_uncertainty_score":0.01690811},"labels":[],"label_agreement":null},{"id":"W2956139542","doi":"10.1016/j.clbc.2019.05.013","title":"Effect of Exercise on Taxane Chemotherapy–Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Taxane; Breast cancer; Randomized controlled trial; Oncology; Peripheral neuropathy; Internal medicine; Chemotherapy; Cancer; Physical therapy; Endocrinology; Diabetes mellitus","score_opus":0.011403874610716057,"score_gpt":0.355187699852125,"score_spread":0.34378382524140894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956139542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97780675,0.012590171,0.0007771736,0.0010575559,0.0011008888,0.0036460583,0.0007862814,0.00009319774,0.0021418226],"genre_scores_gemma":[0.98526114,0.005739993,0.0009896111,0.0011235151,0.0007351445,0.0030708106,0.0005556395,0.000014606099,0.0025095742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992292,0.00038941958,0.000064613094,0.00016162203,0.000041998137,0.000113199836],"domain_scores_gemma":[0.9989504,0.00040084915,0.00023012597,0.000082387895,0.00006680144,0.00026951885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013645678,0.0017318414,0.0035908972,0.00043359553,0.00063334784,0.00091686606,0.0009899782,0.0026753866,0.008346002],"category_scores_gemma":[0.002300141,0.0008342309,0.0025532076,0.0005718711,0.0014743353,0.0010592297,0.00058371143,0.003227607,0.0007465311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9873246,0.0037520686,0.00045337965,0.0008549724,0.0014342775,0.000021102296,0.000023693729,0.00010741945,0.0005323418,0.000039040144,0.00020992351,0.00524722],"study_design_scores_gemma":[0.9586309,0.037185732,0.0018896353,0.00008018869,0.0015540434,0.000012106531,0.000024894469,0.00016116309,0.00009389055,0.000078209014,0.000278629,0.000010625378],"about_ca_topic_score_codex":0.0019133223,"about_ca_topic_score_gemma":0.0028941184,"teacher_disagreement_score":0.008346002,"about_ca_system_score_codex":0.000673815,"about_ca_system_score_gemma":0.00083925563,"threshold_uncertainty_score":0.027920127},"labels":[],"label_agreement":null},{"id":"W2962460569","doi":"10.1016/j.clbc.2019.06.007","title":"Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?","year":2019,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University Medical Centre","funders":"Pfizer Canada; Roche; Novartis; AstraZeneca","keywords":"Medicine; Breast cancer; Incidence (geometry); Oncology; Internal medicine; Metastatic breast cancer; Cancer","score_opus":0.1126630097334715,"score_gpt":0.4602386974483536,"score_spread":0.3475756877148821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962460569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005719758,0.9995788,0.000016973941,0.00015187457,0.000052350275,7.9408926e-7,0.000024231129,0.0000017511506,0.000116026145],"genre_scores_gemma":[0.00093665265,0.99864954,0.000049928392,0.0001684264,0.00011197341,0.0000017544501,0.000025043184,6.8990465e-7,0.000055952303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955946,0.00009048489,0.00010497042,0.00008946552,0.00012595573,0.000029630948],"domain_scores_gemma":[0.9985984,0.00081974856,0.0003169434,0.00001994016,0.0002026715,0.000042248805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087497145,0.00064178545,0.0026595474,0.0025776657,0.00012984869,0.0010785296,0.00092409673,0.0010215729,0.0029687523],"category_scores_gemma":[0.003039076,0.00031965948,0.0012095154,0.0033192192,0.0005451501,0.0009740874,0.00047711335,0.0014258539,0.00052384357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017458537,0.000030244299,0.0017717672,0.045274727,0.00066746114,0.00008892346,0.000042885826,0.0003519754,0.0001947544,0.0013428995,0.02284292,0.92721695],"study_design_scores_gemma":[0.0002407353,0.00059153576,0.032097608,0.10930638,0.0073384778,0.004167886,0.00039472795,0.00055901794,0.00042233407,0.004787071,0.8399369,0.00015725807],"about_ca_topic_score_codex":0.0058198986,"about_ca_topic_score_gemma":0.009718485,"teacher_disagreement_score":0.0058198986,"about_ca_system_score_codex":0.00083604094,"about_ca_system_score_gemma":0.0016338923,"threshold_uncertainty_score":0.011572003},"labels":[],"label_agreement":null},{"id":"W2969651887","doi":"10.1016/j.clbc.2019.06.013","title":"Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract–Level Socioeconomic Database","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Socioeconomic status; Breast cancer; Hazard ratio; Proportional hazards model; Demography; Epidemiology; Confidence interval; Cancer registry; Cohort; Cancer; Multivariate analysis; Oncology; Gynecology; Gerontology; Internal medicine; Population; Environmental health","score_opus":0.09886965925997132,"score_gpt":0.4275932679825297,"score_spread":0.3287236087225584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969651887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896277,0.0003318631,0.00008648246,0.00021540732,0.000016979524,0.000009508313,0.008495732,0.000006209948,0.0012101488],"genre_scores_gemma":[0.9945148,0.00010773571,0.00003570838,0.000042447635,0.00001075199,0.000006042062,0.005088211,0.000003897144,0.0001902752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877733,0.00039477358,0.00015429375,0.00020481716,0.0002517349,0.00021701172],"domain_scores_gemma":[0.99717844,0.0006643656,0.0011773438,0.00031053377,0.00032385698,0.0003455138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014913419,0.00025781314,0.00046894766,0.001099884,0.00031601483,0.00092675566,0.0005049497,0.00031536954,0.0022610193],"category_scores_gemma":[0.0054831738,0.0001730928,0.0013863279,0.0023526745,0.00020321025,0.0006608183,0.0012334636,0.00062825717,0.00028485368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013797262,0.000016023283,0.9984382,0.000008066231,0.0002570953,0.000018884488,0.000017381453,0.000075195116,0.000029459947,0.000023649709,0.00029004307,0.00068804435],"study_design_scores_gemma":[0.0000037521634,0.000021552996,0.9993093,0.0000033598526,0.00005854216,0.00003287938,0.000082493454,0.00030178766,0.000013876421,0.000017369313,0.00015260417,0.0000025480676],"about_ca_topic_score_codex":0.02295295,"about_ca_topic_score_gemma":0.034155987,"teacher_disagreement_score":0.02295295,"about_ca_system_score_codex":0.0006005318,"about_ca_system_score_gemma":0.0007247784,"threshold_uncertainty_score":0.04563868},"labels":[],"label_agreement":null},{"id":"W2969655256","doi":"10.1016/j.clbc.2019.07.006","title":"Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Breast cancer; Oncology; Gynecology; Internal medicine; Cancer; Medical physics","score_opus":0.04354266090632091,"score_gpt":0.3739665315014595,"score_spread":0.33042387059513856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969655256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901966,0.00051032397,0.0014143406,0.00027674323,0.000053421776,0.0002658159,0.0005749325,0.000023384518,0.0066844635],"genre_scores_gemma":[0.99615,0.00020621205,0.0017885269,0.0002569419,0.000059311864,0.00013450965,0.0006207771,0.000011282986,0.0007725173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961287,0.0001200469,0.00006306667,0.00005080537,0.000061997605,0.00009134934],"domain_scores_gemma":[0.9992373,0.000299411,0.000119887634,0.000061501945,0.00012103944,0.00016090421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007100374,0.00037756073,0.0005312878,0.0017295395,0.00045789676,0.0006389776,0.0002762198,0.00045867806,0.0030571872],"category_scores_gemma":[0.0020643764,0.00012588382,0.00037767735,0.0010231058,0.00019344046,0.00032961115,0.00029028315,0.00032516324,0.0006533895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056242675,0.00009782921,0.9852658,0.000018479992,0.000012067829,0.0010126656,0.00007885094,0.000101560625,0.002311217,0.00006456958,0.0006054906,0.009869188],"study_design_scores_gemma":[0.00014873629,0.0011943788,0.97869885,0.00006278982,0.00012097976,0.0060903993,0.00096288964,0.001939025,0.0041061947,0.00039728312,0.0062601333,0.000018265162],"about_ca_topic_score_codex":0.001809999,"about_ca_topic_score_gemma":0.002526643,"teacher_disagreement_score":0.0030571872,"about_ca_system_score_codex":0.00019951975,"about_ca_system_score_gemma":0.00046147517,"threshold_uncertainty_score":0.010227263},"labels":[],"label_agreement":null},{"id":"W2972053075","doi":"10.1016/j.clbc.2019.08.008","title":"The Role of CXCL13 and CXCL9 in Early Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Materials Research; Bristol-Myers Squibb Canada; Ipsen Biopharmaceuticals; British Microcirculation Society; Amgen; Boehringer Ingelheim; Roche; European Organisation for Research and Treatment of Cancer; Novartis; Meso Scale Diagnostics; Sanofi; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; CXCL13; Breast cancer; Internal medicine; Chemokine; Hazard ratio; Oncology; Cancer; Immunology; Inflammation; Chemokine receptor","score_opus":0.013339141883159402,"score_gpt":0.33139878025470615,"score_spread":0.31805963837154677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972053075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5247832,0.41009507,0.004143406,0.022304967,0.0010557543,0.000169855,0.0011222154,0.0002099778,0.036115613],"genre_scores_gemma":[0.90970063,0.07292941,0.0026297977,0.0016168272,0.00086820824,0.00009567917,0.00043255504,0.00002951864,0.011697301],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99957114,0.00013654816,0.000027398013,0.000030288338,0.000098187564,0.00013645444],"domain_scores_gemma":[0.9994892,0.00011801413,0.00013135254,0.00002084496,0.000116303556,0.00012436823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000892227,0.00031433307,0.00040484197,0.00081516866,0.00035166316,0.0012210185,0.00040069665,0.00052017655,0.002993351],"category_scores_gemma":[0.0010816292,0.00016547424,0.00022394313,0.000793773,0.0005616412,0.00067394355,0.0005218069,0.0011698378,0.00042436062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052070897,0.00070728944,0.15938075,0.0017624188,0.0001786196,0.003474999,0.0005123302,0.0023348178,0.0936551,0.023559695,0.03058212,0.67864484],"study_design_scores_gemma":[0.00058444525,0.0029138434,0.56934845,0.0017384243,0.0003044651,0.01441035,0.0020335552,0.008911268,0.06623354,0.013055353,0.32027945,0.00018681926],"about_ca_topic_score_codex":0.0025132776,"about_ca_topic_score_gemma":0.0041568475,"teacher_disagreement_score":0.002993351,"about_ca_system_score_codex":0.0012562015,"about_ca_system_score_gemma":0.0017189207,"threshold_uncertainty_score":0.010013759},"labels":[],"label_agreement":null},{"id":"W2972122997","doi":"10.1016/j.clbc.2019.08.009","title":"Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Daiichi Sankyo Europe; Genentech; Daiichi Sankyo Company; Plexxikon; PharmaMar; Eisai; MacroGenics; Amgen; Nippon Kayaku; Astellas Pharma; Mylan; Genomic Health; Novartis Pharma; Novartis; Pfizer; Ontario Brain Institute; Merck; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Internal medicine; Oncology; Placebo; Metastatic breast cancer; Estrogen receptor; Progression-free survival; Odds ratio; Population; Adverse effect; Cancer; Gynecology; Tamoxifen; Chemotherapy; Pathology","score_opus":0.02003432836318951,"score_gpt":0.3391463333567022,"score_spread":0.31911200499351267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972122997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984831,0.0009678196,0.000061191764,0.000054606164,0.0000110921055,0.000039377657,0.00015539955,0.000003622781,0.00022380479],"genre_scores_gemma":[0.9990694,0.00027602134,0.00006455959,0.0000675674,0.00003391895,0.000048072285,0.00028930456,0.0000013216381,0.00014982652],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99942005,0.00028851983,0.00004247109,0.00009149858,0.00007877868,0.00007881595],"domain_scores_gemma":[0.9988869,0.0004513726,0.00037032214,0.000057262747,0.000037396003,0.00019675276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016719279,0.00040513268,0.0009177466,0.00033075068,0.00016585983,0.00049531733,0.00039139352,0.00039857312,0.0013002148],"category_scores_gemma":[0.0014639609,0.00021336022,0.0013047389,0.00027113807,0.00038083512,0.0004332423,0.00027926656,0.0009807821,0.00014591195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59202266,0.0040738233,0.33272377,0.0006475527,0.0051670284,0.00023950633,0.00015621506,0.0019050419,0.0073189223,0.00014282916,0.0009285109,0.05467406],"study_design_scores_gemma":[0.067835756,0.13738818,0.7786402,0.00007595403,0.0058377683,0.00063398294,0.00013817575,0.003926099,0.0028462694,0.0004716769,0.0021522297,0.00005359958],"about_ca_topic_score_codex":0.00036879577,"about_ca_topic_score_gemma":0.0009976836,"teacher_disagreement_score":0.0016719279,"about_ca_system_score_codex":0.00046295804,"about_ca_system_score_gemma":0.00047579128,"threshold_uncertainty_score":0.008842111},"labels":[],"label_agreement":null},{"id":"W3005471759","doi":"10.1016/j.clbc.2020.01.013","title":"Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Celgene; Roche; Novartis; AstraZeneca","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Estrogen receptor; Postmenopausal women; Population; Cancer","score_opus":0.022222844624507913,"score_gpt":0.3124580324885053,"score_spread":0.2902351878639974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005471759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992293,0.00014885206,0.000044390363,0.000017742239,0.0000057578536,0.0000067119463,0.00019113164,0.0000024452563,0.00035378616],"genre_scores_gemma":[0.99941254,0.00006339102,0.000017951315,0.00002120878,0.000009159799,0.000009683214,0.00021838669,0.0000016618054,0.0002460453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948967,0.00017471716,0.000043616183,0.00013334719,0.00006760085,0.00009113613],"domain_scores_gemma":[0.9991424,0.00017510858,0.00025629412,0.0001235118,0.000100261175,0.00020229245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007113995,0.0004769178,0.0005866706,0.00091228593,0.0007838416,0.00090894033,0.00038525774,0.0009741528,0.0019275546],"category_scores_gemma":[0.0017478474,0.0005636165,0.00080916315,0.0013356787,0.00047132914,0.0005680805,0.00054567517,0.0009995031,0.00046436707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00118189,0.00014219896,0.9972199,0.00000759458,0.00020877669,0.000091922695,0.00007990206,0.000022246226,0.00039902562,0.000015649877,0.000054211538,0.0005766769],"study_design_scores_gemma":[0.000060533763,0.00052890513,0.9984226,0.0000028705915,0.00016522195,0.00023218844,0.00023382792,0.00009745018,0.000058388057,0.000030076584,0.00016099335,0.0000068343684],"about_ca_topic_score_codex":0.0059423055,"about_ca_topic_score_gemma":0.0048218006,"teacher_disagreement_score":0.0059423055,"about_ca_system_score_codex":0.0003439757,"about_ca_system_score_gemma":0.00031470336,"threshold_uncertainty_score":0.011815429},"labels":[],"label_agreement":null},{"id":"W3010178347","doi":"10.1016/j.clbc.2020.03.001","title":"Surgical and Oncologic Outcomes of Nipple-Sparing Mastectomy for a Cohort of Breast Cancer Patients, Including Cases with High-Risk Features","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital; Cegep de Saint Jerome; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Cohort; General surgery; Cancer; Surgery; Oncology; Internal medicine","score_opus":0.04764079366895344,"score_gpt":0.351772085054998,"score_spread":0.30413129138604456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010178347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991066,0.0001427385,0.000029058827,0.00003763351,0.0000043071773,0.00000322633,0.00032581747,0.0000017288118,0.00034880106],"genre_scores_gemma":[0.9992168,0.00008169465,0.0000164041,0.000015280782,0.000012349949,0.0000026860318,0.00052273384,0.0000012610012,0.00013081051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997613,0.00003056418,0.000025337968,0.000058089856,0.0000415586,0.00008308064],"domain_scores_gemma":[0.9995203,0.00007763297,0.00018986616,0.000033727225,0.00004007297,0.00013854391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002596925,0.00019900639,0.00023676817,0.00070044573,0.00042492594,0.0005840971,0.0002851575,0.00033124798,0.002156759],"category_scores_gemma":[0.0012195499,0.00017971346,0.000525387,0.00059050834,0.00022734814,0.00044367736,0.00065357384,0.00040449228,0.00026568866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001879013,0.000034087196,0.99782616,0.0000047394333,0.000051309136,0.00015329025,0.000037438247,0.00006264025,0.00023267152,0.000022533935,0.000116178046,0.0012709814],"study_design_scores_gemma":[0.000006874818,0.00008531996,0.9985043,0.000003058378,0.000028887727,0.000738382,0.00026871642,0.0001581546,0.000039556635,0.000034796667,0.00012806295,0.000003819944],"about_ca_topic_score_codex":0.003070079,"about_ca_topic_score_gemma":0.0045336667,"teacher_disagreement_score":0.003070079,"about_ca_system_score_codex":0.00033636673,"about_ca_system_score_gemma":0.00033050103,"threshold_uncertainty_score":0.0072150826},"labels":[],"label_agreement":null},{"id":"W3011736972","doi":"10.1016/j.clbc.2020.03.005","title":"Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Prostate cancer; Oncology; Family history; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Gynecology; Prostate; Incidence (geometry); Confidence interval","score_opus":0.25127705688116014,"score_gpt":0.45284809938464776,"score_spread":0.20157104250348762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011736972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831957,0.00038269983,0.000077446515,0.00008884344,0.00001177014,0.000044922486,0.0004908504,0.000002604603,0.00058120466],"genre_scores_gemma":[0.99866045,0.00013689541,0.00012643778,0.00008134419,0.000019729781,0.00006191994,0.00048810075,0.0000023805048,0.00042277307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854964,0.00086131296,0.00010000323,0.00019781859,0.00014815871,0.00014297872],"domain_scores_gemma":[0.9952318,0.0019932748,0.0016664839,0.00031898843,0.00030987317,0.00047959483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003342937,0.00026906992,0.00029437055,0.0005160713,0.00055438664,0.0005653598,0.000400676,0.00048632466,0.0025863894],"category_scores_gemma":[0.009284276,0.0002340104,0.00054388476,0.00084879785,0.00022619247,0.00048913085,0.00048033867,0.00047757218,0.00020481387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034729464,0.00021422181,0.99183124,0.000052360414,0.00037860117,0.000057944322,0.000092764814,0.00006239569,0.00018411365,0.00003091979,0.0002767413,0.0033457035],"study_design_scores_gemma":[0.0006742302,0.0020537586,0.99410146,0.00003369465,0.0009038913,0.00025171647,0.0002769365,0.00029741507,0.00025059076,0.00009873429,0.0010486683,0.00000888396],"about_ca_topic_score_codex":0.0059113465,"about_ca_topic_score_gemma":0.008493259,"teacher_disagreement_score":0.0059113465,"about_ca_system_score_codex":0.00038601615,"about_ca_system_score_gemma":0.00074392755,"threshold_uncertainty_score":0.017679393},"labels":[],"label_agreement":null},{"id":"W3013629755","doi":"10.1016/j.clbc.2020.03.006","title":"Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Adjuvant; Center (category theory); Adjuvant radiotherapy; Radiation therapy; Cancer; Oncology; Medical physics; Internal medicine","score_opus":0.07963249277138526,"score_gpt":0.3361842361129861,"score_spread":0.2565517433416008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013629755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496,0.0017066144,0.00009857078,0.001020011,0.000026577978,0.000033579327,0.0060505113,0.000013953416,0.0060901633],"genre_scores_gemma":[0.990137,0.0012219447,0.00014491094,0.00022453534,0.000018650982,0.000024803965,0.0024503071,0.0000068885224,0.0057710013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995517,0.000034385877,0.000033190114,0.000053404463,0.00015793234,0.00016937351],"domain_scores_gemma":[0.99872726,0.00007369652,0.00037565036,0.000029081168,0.0004961508,0.00029823277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026300753,0.00013690692,0.00022958987,0.00079196907,0.0011433689,0.00050553586,0.0006612741,0.00029937306,0.0014336789],"category_scores_gemma":[0.0011902868,0.00021411321,0.0002952649,0.0018359831,0.00034553226,0.00031695986,0.0005352688,0.00046387594,0.0001421396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025667888,0.000038726335,0.98364085,0.00010437182,0.000040356983,0.00018386854,0.0014217707,0.00013057643,0.00057386584,0.0001316259,0.0028160703,0.010661283],"study_design_scores_gemma":[0.0000045658307,0.000025788326,0.99449664,0.00003245197,0.000017174862,0.00007683209,0.00082318357,0.00005709622,0.00011873099,0.000009080082,0.0043341657,0.000004251421],"about_ca_topic_score_codex":0.9674768,"about_ca_topic_score_gemma":0.99003816,"teacher_disagreement_score":0.032523215,"about_ca_system_score_codex":0.019693132,"about_ca_system_score_gemma":0.023472153,"threshold_uncertainty_score":0.14288437},"labels":[],"label_agreement":null},{"id":"W3033263543","doi":"10.1016/j.clbc.2020.05.016","title":"Oncoplastic Repair in Breast Conservation: Comprehensive Evaluation of Techniques and Oncologic Outcomes of 937 Patients","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Seroma; Breast cancer; Surgery; Breast-conserving surgery; Ductal carcinoma; Breast surgery; Mastectomy; Oncoplastic Surgery; General surgery; Mammaplasty; Complication; Cancer; Internal medicine","score_opus":0.10171453167683273,"score_gpt":0.40269072572653775,"score_spread":0.300976194049705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033263543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833137,0.000511215,0.00006204013,0.00001604865,0.0000019447734,0.000012434988,0.0004884264,0.000001868573,0.000574729],"genre_scores_gemma":[0.9980476,0.00052003877,0.000089270834,0.00003329835,0.000007035047,0.000018673483,0.0011116442,0.0000023559287,0.00017002407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961025,0.000062717125,0.00005537888,0.000071803166,0.000105025916,0.00009489197],"domain_scores_gemma":[0.9993206,0.00014788673,0.00030964104,0.000041796233,0.000076581186,0.000103537575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039757355,0.00023935412,0.00041131506,0.00095519156,0.00041347847,0.00057058537,0.0002573318,0.0003041351,0.0011870294],"category_scores_gemma":[0.00086744025,0.0002142292,0.0005161008,0.0019338035,0.00028167397,0.0004095809,0.0005138999,0.0003237876,0.00024163586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009444067,0.0000593009,0.99659866,0.000012401797,0.000043579246,0.00011823449,0.00007779257,0.000052475592,0.0001459969,0.000014402686,0.00007056529,0.002712095],"study_design_scores_gemma":[0.000007695481,0.00018007559,0.9981377,0.000012080626,0.00004043388,0.0006232517,0.0005232336,0.00008207136,0.00009104098,0.000016066086,0.0002813421,0.0000050890567],"about_ca_topic_score_codex":0.0037407547,"about_ca_topic_score_gemma":0.0066560498,"teacher_disagreement_score":0.0037407547,"about_ca_system_score_codex":0.000425648,"about_ca_system_score_gemma":0.00050624204,"threshold_uncertainty_score":0.0074379444},"labels":[],"label_agreement":null},{"id":"W3040901621","doi":"10.1016/j.clbc.2020.07.004","title":"Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review","year":2020,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eastern Health","keywords":"Medicine; Breast cancer; Radiology; Pelvis; Metastasis; Bone scintigraphy; Retrospective cohort study; Abdomen; Cancer; Nuclear medicine; Surgery; Internal medicine","score_opus":0.08204565611476444,"score_gpt":0.4735750478685154,"score_spread":0.39152939175375095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040901621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005796016,0.9990134,0.000034744655,0.00007762343,0.000033522,0.000007486035,0.00007122379,0.0000010914332,0.00018121493],"genre_scores_gemma":[0.0031740058,0.99635893,0.00010227511,0.00017017612,0.00005279584,0.000006650476,0.00009203746,0.0000011860001,0.000041865078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991498,0.00014584741,0.00032726253,0.00015513906,0.0001844027,0.00003754387],"domain_scores_gemma":[0.9965432,0.002448533,0.00055502885,0.000057250887,0.00033654616,0.000059425827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015885744,0.0005642879,0.0020628378,0.0037124113,0.00021999596,0.0010916798,0.0009711074,0.0008967094,0.0024736773],"category_scores_gemma":[0.005175837,0.0005050005,0.0016194823,0.0045644757,0.000541001,0.0015338389,0.00050889986,0.00088857295,0.00045906735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005891831,0.00008719457,0.02205433,0.25746718,0.003975813,0.0017580183,0.0003740885,0.00025429853,0.0011415024,0.000861162,0.014702927,0.6967343],"study_design_scores_gemma":[0.00035657536,0.00079537614,0.111434735,0.42360255,0.05078417,0.034950223,0.001947373,0.00031867166,0.0011939862,0.0014710658,0.37290284,0.00024240845],"about_ca_topic_score_codex":0.0025171787,"about_ca_topic_score_gemma":0.0056811883,"teacher_disagreement_score":0.0037124113,"about_ca_system_score_codex":0.0005113622,"about_ca_system_score_gemma":0.001667168,"threshold_uncertainty_score":0.008401275},"labels":[],"label_agreement":null},{"id":"W3092280067","doi":"10.1016/j.clbc.2020.09.014","title":"Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly Japan; Chugai Pharmaceutical; PharmaMar; AstraZeneca Australia; Kyowa Hakko Kirin; Astellas Pharma; Eisai; GlaxoSmithKline Australia; Puma Biotechnology; Genentech; Seattle Genetics; Genomic Health; AbbVie; Mount Sylvia Diatomite; Roche; Daiichi-Sankyo; Teva Pharmaceutical Industries; Pfizer Australia; Celgene; Novartis; Merck; GlaxoSmithKline; British Microcirculation Society; Amgen; Ontario Brain Institute; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Neratinib; Medicine; Breast cancer; Oncology; Hormone receptor; Internal medicine; Stage (stratigraphy); Gynecology; Cancer; Trastuzumab","score_opus":0.12503202366143637,"score_gpt":0.45440523439789093,"score_spread":0.32937321073645454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092280067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94881636,0.020604918,0.0022333937,0.0034278254,0.0007281826,0.0011167198,0.010142043,0.00030081795,0.012629738],"genre_scores_gemma":[0.96435267,0.006381806,0.0018446653,0.002844501,0.000250645,0.00070781895,0.01616977,0.00013202963,0.007316187],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993179,0.00030959942,0.00004464318,0.00008942633,0.00008325598,0.00015513068],"domain_scores_gemma":[0.99919707,0.00024825564,0.00011561057,0.00009314445,0.00008594398,0.00025994325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034017474,0.0013385842,0.0026010035,0.00023454202,0.0002965805,0.0014473654,0.00060939207,0.0007644151,0.003748509],"category_scores_gemma":[0.0022131116,0.00022859866,0.0024360733,0.00030164787,0.00051910395,0.001290692,0.00047481107,0.0029007695,0.0009488712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6076659,0.006986404,0.009828628,0.0033369246,0.0080605885,0.0006703092,0.00036038097,0.014921799,0.02341738,0.001957823,0.037959125,0.28483468],"study_design_scores_gemma":[0.72891045,0.13559486,0.054770987,0.00053514686,0.008507668,0.002195588,0.00030859988,0.006823496,0.011216153,0.00632052,0.04458794,0.00022858431],"about_ca_topic_score_codex":0.00039384188,"about_ca_topic_score_gemma":0.0016143357,"teacher_disagreement_score":0.003748509,"about_ca_system_score_codex":0.0008249446,"about_ca_system_score_gemma":0.00071843667,"threshold_uncertainty_score":0.01799035},"labels":[],"label_agreement":null},{"id":"W3111478139","doi":"10.1016/j.clbc.2020.11.018","title":"A Survey of Breast Pathologists’ Practice in Staging Multiple Foci of Invasive Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer staging; Invasive lobular carcinoma; Stage (stratigraphy); Breast carcinoma; Carcinoma; Lymph node; Cancer; Oncology; Radiology; Pathology; Internal medicine; Invasive ductal carcinoma","score_opus":0.06303935938080452,"score_gpt":0.36418010919487426,"score_spread":0.30114074981406974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111478139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947535,0.0019189802,0.00020949835,0.00076549436,0.000022802431,0.000018254195,0.00019810142,0.000008446891,0.0021050142],"genre_scores_gemma":[0.9970107,0.0015797745,0.00041644165,0.0003694687,0.000040525232,0.000021635522,0.00015603268,0.0000066692933,0.0003986443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993871,0.0029852118,0.0010656512,0.0005878101,0.0011206198,0.00036980747],"domain_scores_gemma":[0.95776844,0.018147035,0.012730063,0.0013021157,0.0071586324,0.0028937547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004906777,0.00013704458,0.00021466882,0.0031451255,0.00061446085,0.0007994868,0.00053686963,0.0007821501,0.0014087189],"category_scores_gemma":[0.0241904,0.00041311915,0.00031068572,0.0028435884,0.0006641311,0.00070413883,0.0009097764,0.00039109233,0.00031576818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008721396,0.0000399474,0.9888465,0.00005521512,0.000026448957,0.00020639715,0.0012461339,0.000052983163,0.00070530054,0.000030341813,0.00030259532,0.008401042],"study_design_scores_gemma":[0.0000048169163,0.00010623708,0.99441683,0.000060382445,0.000015341948,0.0007866539,0.0026157894,0.00011122959,0.00018173626,0.000012025827,0.001682103,0.0000068112404],"about_ca_topic_score_codex":0.0080534695,"about_ca_topic_score_gemma":0.013502855,"teacher_disagreement_score":0.0080534695,"about_ca_system_score_codex":0.0008397935,"about_ca_system_score_gemma":0.0011650216,"threshold_uncertainty_score":0.025949836},"labels":[],"label_agreement":null},{"id":"W3118554446","doi":"10.1016/j.clbc.2021.01.007","title":"Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Michel-Sarrazin","funders":"Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Medicine; Breast cancer; Adjuvant; Oncology; Endocrine system; Gynecology; Adjuvant therapy; Family medicine; Obstetrics; Internal medicine; Cancer; Hormone","score_opus":0.17569329027489405,"score_gpt":0.45231029446857246,"score_spread":0.2766170041936784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118554446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658465,0.0005742511,0.00014101015,0.00016074942,0.000010793269,0.000015115324,0.002193607,0.000010204255,0.0003096098],"genre_scores_gemma":[0.9961255,0.00024309475,0.00016393661,0.000096727024,0.000010507979,0.000030360323,0.0029757645,0.0000058041087,0.00034843673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770004,0.00085200154,0.00024496773,0.00052265916,0.00020124704,0.00047909142],"domain_scores_gemma":[0.99592674,0.00078485697,0.0015775213,0.00047596946,0.0007399993,0.0004949337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029950468,0.00077733456,0.0007430862,0.0021064198,0.0012975804,0.0019984248,0.00095198717,0.0012782344,0.0013615561],"category_scores_gemma":[0.005434923,0.0006063594,0.0018769947,0.0040769298,0.00045213397,0.0010674299,0.0011159967,0.001045346,0.00031235843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008089532,0.00005848349,0.9982869,0.000010062328,0.00023047942,0.0000371485,0.00021011985,0.000052154734,0.000041644675,0.000022148115,0.00022001626,0.00074991415],"study_design_scores_gemma":[0.000008774117,0.000062523104,0.9987526,0.00001366114,0.00007711014,0.00005861544,0.00044160458,0.00023506288,0.00001535111,0.000011195586,0.0003150259,0.000008510917],"about_ca_topic_score_codex":0.31240356,"about_ca_topic_score_gemma":0.27702287,"teacher_disagreement_score":0.31240356,"about_ca_system_score_codex":0.0033043313,"about_ca_system_score_gemma":0.002346415,"threshold_uncertainty_score":0.62117034},"labels":[],"label_agreement":null},{"id":"W3135671961","doi":"10.1016/j.clbc.2021.03.001","title":"Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Epirubicin; Breast cancer; Pharmacogenetics; Oncology; Chemotherapy; Internal medicine; Dosing; Stage (stratigraphy); Glucuronosyltransferase; Cancer; Genotype; Genetics; Gene; Biology","score_opus":0.05108618909565029,"score_gpt":0.42020743389212056,"score_spread":0.3691212447964703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135671961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509466,0.0015996842,0.00081120676,0.00040046967,0.00006624663,0.000039794075,0.00016457844,0.000019753716,0.0018036894],"genre_scores_gemma":[0.9988945,0.00021880012,0.00031021793,0.00012019447,0.000017466415,0.0000178068,0.00008694143,0.0000054640045,0.00032871202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995198,0.00025539333,0.000032204895,0.00007095825,0.0000718266,0.000049855516],"domain_scores_gemma":[0.9996947,0.00013656622,0.00007809171,0.000024305182,0.000024895946,0.000041459643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047532498,0.00021881025,0.0005089714,0.00021291393,0.0001295762,0.00033636883,0.00022697302,0.0004106749,0.0012804498],"category_scores_gemma":[0.0015486245,0.00010928326,0.00031665422,0.0002980343,0.00017037868,0.00021642186,0.00012436,0.0005074704,0.00015659635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08248244,0.002884832,0.48230925,0.00030180567,0.0032146587,0.0008392746,0.00030473515,0.0065087155,0.05094651,0.0016100962,0.0033080347,0.3652897],"study_design_scores_gemma":[0.004051557,0.020283569,0.90535986,0.00017569277,0.0036470238,0.0017937238,0.00026995584,0.027666852,0.019090014,0.0034351915,0.0141491415,0.00007743671],"about_ca_topic_score_codex":0.0006062378,"about_ca_topic_score_gemma":0.0012427222,"teacher_disagreement_score":0.0012804498,"about_ca_system_score_codex":0.00035350464,"about_ca_system_score_gemma":0.00031446465,"threshold_uncertainty_score":0.0042835474},"labels":[],"label_agreement":null},{"id":"W3156978057","doi":"10.1016/j.clbc.2021.04.005","title":"Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Instituto Nacional de Cancerología; Roche; Novartis; Pfizer; Myriad Genetics; AstraZeneca; Eli Lilly and Company","keywords":"Data collection; Medicine; Data quality; Breast cancer; Missing data; Psychosocial; Prospective cohort study; Medical physics; Consistency (knowledge bases); Cohort; Data science; Gynecology; Cancer; Computer science; Internal medicine; Artificial intelligence; Statistics; Psychiatry","score_opus":0.08796769502643914,"score_gpt":0.41264270116469515,"score_spread":0.324675006138256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156978057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788382,0.0013943062,0.0019366139,0.005623042,0.00013723837,0.0005222212,0.009022476,0.000053543597,0.0024723248],"genre_scores_gemma":[0.9721162,0.002128843,0.0092625115,0.0013426763,0.00018974622,0.00091853295,0.012540449,0.0001373256,0.0013637256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98848605,0.0077868495,0.0007707867,0.0008206305,0.001273204,0.0008625012],"domain_scores_gemma":[0.9645304,0.01388378,0.005361139,0.00821627,0.0046222694,0.0033861215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025629414,0.0005846864,0.00051665475,0.0012478473,0.0014806612,0.0031627014,0.0015621039,0.0010313655,0.0015982457],"category_scores_gemma":[0.046849918,0.0005755877,0.00066856184,0.0028849891,0.0007648982,0.0016320476,0.0032841894,0.0012960043,0.00035897817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039275282,0.0003127911,0.9758424,0.00012809246,0.00017642403,0.00033597133,0.0033245292,0.00014885097,0.0004317291,0.0002519791,0.0041485857,0.014505811],"study_design_scores_gemma":[0.00010003914,0.00020597805,0.98123884,0.00019161621,0.00014999692,0.00041442263,0.00762406,0.0006247997,0.00026316015,0.00021599823,0.0089304205,0.00004072223],"about_ca_topic_score_codex":0.06858359,"about_ca_topic_score_gemma":0.103990726,"teacher_disagreement_score":0.06858359,"about_ca_system_score_codex":0.0018016323,"about_ca_system_score_gemma":0.005932849,"threshold_uncertainty_score":0.13636881},"labels":[],"label_agreement":null},{"id":"W3201363474","doi":"10.1016/j.clbc.2021.09.004","title":"Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; Interior Health; BC Cancer Agency","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Genomic Health; Roche; Novartis; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Merck","keywords":"Medicine; Breast cancer; Internal medicine; Estrogen receptor; Prospective cohort study; Estrogen; Oncology; Adjuvant; Chemotherapy; Cancer; Adjuvant therapy; Gynecology","score_opus":0.027367305196067584,"score_gpt":0.3569691101792106,"score_spread":0.32960180498314307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201363474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749243,0.0011818409,0.00013965002,0.00007678778,0.000014099404,0.00004340227,0.00024801557,0.000003153918,0.0008005954],"genre_scores_gemma":[0.9990243,0.00028759424,0.00013039948,0.000045703247,0.000026400508,0.000015547701,0.00026747157,0.0000025820823,0.00020000471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973761,0.0019392177,0.00009868095,0.00018381429,0.00031744153,0.00008472178],"domain_scores_gemma":[0.99375147,0.0037645453,0.0011247416,0.0004198989,0.0005022637,0.0004370819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038627326,0.0006137997,0.00066764717,0.0005236806,0.00022542536,0.0006488424,0.00047160394,0.0005728784,0.0010851083],"category_scores_gemma":[0.008018826,0.0002490342,0.00072030793,0.0006499091,0.0004452946,0.00037231084,0.00025233923,0.0004844093,0.0002297701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04196084,0.0009999158,0.9351908,0.00007237635,0.000777595,0.00010763608,0.000072425646,0.0006213334,0.0024936525,0.00007322705,0.0002275481,0.017402625],"study_design_scores_gemma":[0.0014106142,0.021632662,0.9712034,0.000016782944,0.0013366023,0.00034830676,0.000080845195,0.001503598,0.0015767041,0.000072333074,0.0007968967,0.000021327098],"about_ca_topic_score_codex":0.0015514016,"about_ca_topic_score_gemma":0.0025130108,"teacher_disagreement_score":0.0038627326,"about_ca_system_score_codex":0.0003587385,"about_ca_system_score_gemma":0.0005398099,"threshold_uncertainty_score":0.02042836},"labels":[],"label_agreement":null},{"id":"W3207420121","doi":"10.1016/j.clbc.2021.10.005","title":"Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Anxiety; Breast cancer; Nausea; Physical therapy; Cancer; Radiation therapy; Prospective cohort study; Quality of life (healthcare); Internal medicine; Psychiatry","score_opus":0.010879890797165635,"score_gpt":0.31952372586439803,"score_spread":0.3086438350672324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207420121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980301,0.00061704894,0.000029287592,0.00006628674,0.000007342659,0.000007288646,0.00020039151,0.000002150697,0.0010400543],"genre_scores_gemma":[0.9994837,0.00016751565,0.000028127408,0.00002841365,0.000010684547,0.0000027376614,0.00013115366,9.544808e-7,0.00014670272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972993,0.00008980135,0.000034735804,0.00002938561,0.00005587945,0.000060351333],"domain_scores_gemma":[0.99892575,0.0002145409,0.0005745224,0.000026649663,0.00008769135,0.00017085145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019613813,0.00014762125,0.00038336436,0.0004676587,0.00027444994,0.0005059333,0.00014977569,0.00027338913,0.00242831],"category_scores_gemma":[0.002113539,0.000112587724,0.00046190273,0.0008291067,0.00017074199,0.00024703873,0.00040472293,0.0004014039,0.00015565696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000271885,0.00005367311,0.99638957,0.00002763532,0.00007370466,0.00018544713,0.00008878802,0.000060212296,0.00040653787,0.000012783861,0.00010083749,0.0023288035],"study_design_scores_gemma":[0.0000032475782,0.00006502712,0.99943084,0.00000399494,0.000017863673,0.00020618999,0.00012408567,0.00003846701,0.000019174176,0.000006503645,0.0000826558,0.000001931871],"about_ca_topic_score_codex":0.0024275433,"about_ca_topic_score_gemma":0.0036563117,"teacher_disagreement_score":0.00242831,"about_ca_system_score_codex":0.00025721945,"about_ca_system_score_gemma":0.00025503634,"threshold_uncertainty_score":0.008123577},"labels":[],"label_agreement":null},{"id":"W3211195093","doi":"10.1016/j.clbc.2021.10.006","title":"Current Status and Problems of Breast Cancer Treatment with Schizophrenia","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Breast cancer; Schizophrenia (object-oriented programming); Cancer; Internal medicine; Disease; Oncology; Population; Retrospective cohort study; Guideline; Psychiatry; Pathology","score_opus":0.047065268609711955,"score_gpt":0.3835169114648212,"score_spread":0.33645164285510926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211195093","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4966278,0.35537323,0.0005355933,0.10922186,0.00073092716,0.00009947517,0.0013225452,0.000053250962,0.036035366],"genre_scores_gemma":[0.8295139,0.16360033,0.0005420136,0.0038047256,0.0004664638,0.00006224893,0.00056281197,0.0000064454616,0.0014411091],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991497,0.0002959287,0.00013217986,0.0000595687,0.00020099031,0.00016169334],"domain_scores_gemma":[0.99747616,0.0004046487,0.0010908233,0.000053152464,0.00035675842,0.0006184341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010751581,0.00012583064,0.00022343021,0.0007721323,0.00096500537,0.0009320803,0.00046042042,0.00058983645,0.0038310508],"category_scores_gemma":[0.0046038437,0.00011342176,0.0003521548,0.0011183876,0.0005753384,0.0006858994,0.00067368563,0.0006049777,0.00030387973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002356642,0.00034550444,0.50181895,0.0012474558,0.00009205019,0.0008878332,0.001194454,0.00022661715,0.00035310953,0.0020612278,0.014461855,0.47707522],"study_design_scores_gemma":[0.000062587635,0.0004389383,0.9228488,0.0038004029,0.00018568314,0.005385316,0.010062323,0.00063741324,0.00023639595,0.0030681333,0.05322747,0.00004636066],"about_ca_topic_score_codex":0.02405931,"about_ca_topic_score_gemma":0.037191033,"teacher_disagreement_score":0.02405931,"about_ca_system_score_codex":0.002075246,"about_ca_system_score_gemma":0.004810515,"threshold_uncertainty_score":0.04783851},"labels":[],"label_agreement":null},{"id":"W3216488953","doi":"10.1016/j.clbc.2021.11.011","title":"Primary Care Physicians’ Perspectives in Leading Breast Cancer Follow-Up Care","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Family medicine; Capitation; Remuneration; Breast cancer; Primary care; Receipt; Salary; Nursing; Cancer; Health care; Internal medicine","score_opus":0.08810438922747067,"score_gpt":0.4159483378810889,"score_spread":0.32784394865361827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216488953","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05726217,0.009809113,0.0002777702,0.8977756,0.0032593168,0.000016859532,0.000121847115,0.00001286186,0.031464446],"genre_scores_gemma":[0.7954724,0.0077939187,0.0006886783,0.186769,0.0054987078,0.00003964593,0.0000882839,0.000032035085,0.0036173658],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.97811013,0.011710011,0.0010356326,0.00095074147,0.0030523988,0.0051411623],"domain_scores_gemma":[0.9220312,0.029937023,0.006594356,0.00076396135,0.010344571,0.03032881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013977973,0.0002112157,0.0004327604,0.0010888801,0.010078368,0.010121493,0.0011798717,0.008493459,0.011464511],"category_scores_gemma":[0.053383157,0.00056206214,0.00066440017,0.0013135443,0.0033428832,0.003538419,0.004655638,0.010183313,0.0006618059],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006346126,0.0005994283,0.15171732,0.0013703854,0.00035028474,0.010267967,0.24613263,0.0006166558,0.0010116771,0.048494883,0.42772493,0.11107927],"study_design_scores_gemma":[0.00033629872,0.0004627721,0.10938415,0.0038685328,0.00026820204,0.0042302106,0.4180855,0.00048446836,0.00053909724,0.013508669,0.44864604,0.00018606111],"about_ca_topic_score_codex":0.038150217,"about_ca_topic_score_gemma":0.10358458,"teacher_disagreement_score":0.038150217,"about_ca_system_score_codex":0.010053422,"about_ca_system_score_gemma":0.019978998,"threshold_uncertainty_score":0.07585633},"labels":[],"label_agreement":null},{"id":"W4214522566","doi":"10.1016/j.clbc.2022.02.008","title":"Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital; Algoma University","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Trastuzumab; Cancer; Stage (stratigraphy)","score_opus":0.067916034245382,"score_gpt":0.43671123553147156,"score_spread":0.36879520128608956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214522566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985447,0.00019751018,0.00005287665,0.000048342437,0.000009673274,0.0000055206506,0.0004562817,0.0000024619526,0.00068273896],"genre_scores_gemma":[0.99907744,0.000056624875,0.00001672137,0.000025616935,0.000014799739,0.000007807391,0.0005404974,0.0000015571907,0.00025889935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960357,0.000052288604,0.000050103554,0.00009479356,0.00004732115,0.00015204093],"domain_scores_gemma":[0.99919015,0.00015748334,0.0002850086,0.00003906877,0.00007912992,0.00024916758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003269319,0.00020636422,0.00037879334,0.00074983796,0.00040631407,0.0006506345,0.00027679236,0.00050964765,0.0030339991],"category_scores_gemma":[0.0017100949,0.00014389114,0.00046097662,0.0010933721,0.00031946113,0.0006067508,0.00048640234,0.00055772485,0.00040848833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062459405,0.00006399833,0.99715817,0.00000873575,0.000047316986,0.00012539649,0.00007041924,0.000065587956,0.00036247255,0.000057219877,0.00013464889,0.0012814016],"study_design_scores_gemma":[0.00001979787,0.00018968736,0.99845517,0.000002869111,0.00002304232,0.0003678404,0.00037042165,0.00019124018,0.000044575423,0.000098853685,0.0002307272,0.000005921596],"about_ca_topic_score_codex":0.0024550252,"about_ca_topic_score_gemma":0.0021189284,"teacher_disagreement_score":0.0030339991,"about_ca_system_score_codex":0.00042908124,"about_ca_system_score_gemma":0.0003946439,"threshold_uncertainty_score":0.010149717},"labels":[],"label_agreement":null},{"id":"W4229014874","doi":"10.1016/j.clbc.2021.10.003","title":"Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Thunder Bay Regional Health Sciences Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Randomized controlled trial; Oncology; Cochrane Library; MEDLINE; Internal medicine; Intensive care medicine; Psychiatry; Cancer","score_opus":0.07293141517454359,"score_gpt":0.43453364012296586,"score_spread":0.36160222494842226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229014874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000305226,0.9924305,0.00023859693,0.0049454044,0.0010751026,0.00018638528,0.00043297562,0.000014290498,0.00037166252],"genre_scores_gemma":[0.0053557893,0.9836246,0.0018090758,0.007607645,0.0005429565,0.00036582554,0.00044733015,0.000009205619,0.00023761287],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9885638,0.0039132005,0.004640869,0.00073875155,0.0018461844,0.0002972692],"domain_scores_gemma":[0.9552808,0.027834063,0.009506923,0.0006758445,0.005938488,0.00076391257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017621137,0.0012399968,0.009204886,0.0063106464,0.00057941925,0.0038333118,0.0029842714,0.0040494753,0.0053618164],"category_scores_gemma":[0.06992937,0.0013637987,0.0070961667,0.005509371,0.00085397775,0.004625736,0.0019153256,0.002967636,0.00079037045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047369997,0.000041283507,0.0012726667,0.75704455,0.013066193,0.00017250498,0.000278833,0.00026930962,0.00031081546,0.0010436801,0.033191256,0.19283518],"study_design_scores_gemma":[0.0008209913,0.00013882875,0.0025600584,0.85535973,0.045974374,0.00021165164,0.00031753787,0.00019016331,0.00013930727,0.0014703702,0.092742585,0.000074445015],"about_ca_topic_score_codex":0.0134186,"about_ca_topic_score_gemma":0.04618734,"teacher_disagreement_score":0.017621137,"about_ca_system_score_codex":0.0042822384,"about_ca_system_score_gemma":0.015535551,"threshold_uncertainty_score":0.09319061},"labels":[],"label_agreement":null},{"id":"W4285011880","doi":"10.1016/j.clbc.2022.07.004","title":"Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer","year":2022,"lang":"en","type":"editorial","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Juravinski Hospital; Western University; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Oncology; Breast cancer; Internal medicine; Generalizability theory; Clinical endpoint; Confidence interval; Cancer; Metastatic breast cancer; Brain metastasis; Metastasis","score_opus":0.07960240926807692,"score_gpt":0.4800662895248192,"score_spread":0.4004638802567423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285011880","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012122458,0.023463441,0.00042117047,0.08274288,0.889877,0.00013706603,0.00019603362,0.00009134669,0.002949793],"genre_scores_gemma":[0.0009857288,0.0103075085,0.00039404174,0.076861486,0.9044778,0.00018231352,0.00009537875,0.000067205445,0.006628517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98052514,0.0066594766,0.0036702948,0.0012981918,0.00699831,0.0008486226],"domain_scores_gemma":[0.9067081,0.059055995,0.006568744,0.0020196864,0.019355604,0.00629176],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034496848,0.00393801,0.007096479,0.0033192555,0.0032744748,0.007663753,0.0042547463,0.02448175,0.00874877],"category_scores_gemma":[0.06552795,0.00213291,0.0049612164,0.0018844376,0.002952655,0.004364837,0.0019937428,0.026921885,0.0067169834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034046543,0.00002755027,0.00005874964,0.0010715852,0.00017093167,0.00012433065,0.000015919528,0.000025739573,0.00009625301,0.00026374042,0.9825466,0.01525797],"study_design_scores_gemma":[0.0012997384,0.00016929787,0.0009462135,0.0020030823,0.0009131995,0.0004175437,0.00004226066,0.00025453576,0.00030032799,0.0015327606,0.9920661,0.00005502402],"about_ca_topic_score_codex":0.0016464957,"about_ca_topic_score_gemma":0.0060233707,"teacher_disagreement_score":0.96550316,"about_ca_system_score_codex":0.004686713,"about_ca_system_score_gemma":0.005082995,"threshold_uncertainty_score":0.18243891},"labels":[],"label_agreement":null},{"id":"W4285046055","doi":"10.1016/j.clbc.2022.07.003","title":"Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Taxane; Anthracycline; Mastectomy; Radiation therapy; Chemotherapy; Breast-conserving surgery; Triple-negative breast cancer; Neoadjuvant therapy; Population; Cancer","score_opus":0.028358492020909336,"score_gpt":0.3302457103527544,"score_spread":0.30188721833184506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285046055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985783,0.0008695283,0.00006863153,0.00003841895,0.0000031425113,0.0000023254997,0.00016988524,0.0000014721745,0.00026836962],"genre_scores_gemma":[0.999411,0.0002478704,0.000023574885,0.000018767469,0.00001027066,0.0000035672335,0.00022780403,0.0000014976157,0.00005560586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955386,0.00016796493,0.00003854258,0.00012747207,0.00005830856,0.000053900072],"domain_scores_gemma":[0.99925774,0.00020034717,0.00030143413,0.000094522664,0.00005970824,0.000086329055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059580134,0.00018321087,0.00042822884,0.00074848044,0.0003440836,0.0006060139,0.0003039255,0.00038957543,0.0009150347],"category_scores_gemma":[0.0014199655,0.00023840777,0.000594336,0.0017570156,0.00038047077,0.0005308783,0.00040868818,0.0005269402,0.00010914122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024410414,0.000026494894,0.9976943,0.0000073587066,0.00021438803,0.000035781326,0.0000535085,0.000041601146,0.000224347,0.000028666367,0.00005498798,0.0013744931],"study_design_scores_gemma":[0.000008884338,0.00006368468,0.99920434,0.0000028481102,0.00011927813,0.00013501373,0.00013093396,0.00008386936,0.00004220137,0.000026696478,0.00017944317,0.0000029915964],"about_ca_topic_score_codex":0.00361801,"about_ca_topic_score_gemma":0.004106683,"teacher_disagreement_score":0.00361801,"about_ca_system_score_codex":0.0003179159,"about_ca_system_score_gemma":0.0002710918,"threshold_uncertainty_score":0.0071938634},"labels":[],"label_agreement":null},{"id":"W4287511610","doi":"10.1016/j.clbc.2022.07.010","title":"Clinical Breast Examination is Important in Surveillance After Mastectomy","year":2022,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Breast examination; General surgery; Mammography; Internal medicine; Cancer","score_opus":0.08916666850516008,"score_gpt":0.41121106323506224,"score_spread":0.32204439472990215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287511610","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018032235,0.0011793516,0.000070722774,0.98435265,0.007173114,0.000011867641,0.000047004,0.000015346886,0.0053466586],"genre_scores_gemma":[0.012456078,0.0013811908,0.00031206638,0.9452416,0.03487656,0.00003442971,0.00004771074,0.00002168156,0.0056287223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954847,0.0012963924,0.00087486254,0.00041221135,0.0009685702,0.00096331624],"domain_scores_gemma":[0.98257554,0.0091685895,0.0018412952,0.0005636424,0.0021930241,0.0036578686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046121306,0.0006571806,0.0012304334,0.0010880687,0.004782942,0.00391708,0.0016401963,0.05248346,0.006574718],"category_scores_gemma":[0.029348057,0.0010537017,0.0010316642,0.0012654709,0.0024078165,0.0030214752,0.0019172125,0.036112066,0.003182541],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015974857,0.00015052801,0.025762834,0.00016492537,0.00003557229,0.009874448,0.00077894266,0.0001550569,0.00090932933,0.002556533,0.9232183,0.03623377],"study_design_scores_gemma":[0.00027474292,0.00046020086,0.052146137,0.0020032371,0.00015546221,0.021284668,0.0033961397,0.0011911854,0.0008061217,0.010660104,0.9074157,0.0002063259],"about_ca_topic_score_codex":0.019324679,"about_ca_topic_score_gemma":0.05616232,"teacher_disagreement_score":0.05248346,"about_ca_system_score_codex":0.004164769,"about_ca_system_score_gemma":0.0075878804,"threshold_uncertainty_score":0.038424432},"labels":[],"label_agreement":null},{"id":"W4293927079","doi":"10.1016/j.clbc.2022.08.004","title":"High Risk Breast Cancer Screening is a Double Edged Sword: A Qualitative Study of Patient Perspectives on the Ontario High Risk Breast Cancer Screening Program","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Mammography; Distress; Breast cancer screening; Qualitative research; Family medicine; Breast MRI; Cancer; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.1006526776267866,"score_gpt":0.4288519155018461,"score_spread":0.3281992378750595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293927079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494047,0.0005397252,0.00028138835,0.008256518,0.00008615785,0.00013045028,0.00018769226,0.000008934583,0.0055685975],"genre_scores_gemma":[0.99425524,0.00046866425,0.00027089927,0.0028119348,0.000021312166,0.00012165927,0.0000626844,0.000021399415,0.001966231],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9890906,0.006667968,0.0003399846,0.00042341478,0.0011465135,0.002331585],"domain_scores_gemma":[0.97103226,0.01726174,0.0026487592,0.00052452064,0.003076199,0.00545648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010349195,0.00047944093,0.00078564347,0.0011586441,0.02262995,0.0053403955,0.0024964735,0.0024317906,0.003359919],"category_scores_gemma":[0.022820132,0.0010188571,0.0005124891,0.0022717642,0.009907143,0.0033075963,0.006594643,0.0058740396,0.00018665081],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026992226,0.000032128886,0.0063614845,0.000043464664,0.000004671702,0.00016042766,0.9912634,0.000007951677,0.00013926053,0.00029356574,0.00064828893,0.0010184452],"study_design_scores_gemma":[0.0000039710576,0.00001795383,0.0038749534,0.000055103057,0.000004181086,0.000036793117,0.99298626,0.000015770165,0.00003466095,0.000046518402,0.0029138024,0.000010076729],"about_ca_topic_score_codex":0.6497315,"about_ca_topic_score_gemma":0.86345065,"teacher_disagreement_score":0.35026848,"about_ca_system_score_codex":0.038411953,"about_ca_system_score_gemma":0.04862636,"threshold_uncertainty_score":0.70466256},"labels":[],"label_agreement":null},{"id":"W4309269762","doi":"10.1016/j.clbc.2022.11.003","title":"The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Providence Health Care","funders":"","keywords":"Medicine; Interquartile range; Angiosarcoma; Context (archaeology); Mammography; Breast cancer; Radiology; Magnetic resonance imaging; Retrospective cohort study; Breast imaging; Cancer; Internal medicine","score_opus":0.013635804386185373,"score_gpt":0.3014781439902644,"score_spread":0.287842339604079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309269762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973605,0.00048142503,0.00013135384,0.00019843808,0.000009197919,0.000013437747,0.000037444843,0.000008824901,0.0017594034],"genre_scores_gemma":[0.9978399,0.00067426,0.00051940395,0.00008118556,0.00002047277,0.0000041934163,0.000060404465,0.000011288554,0.0007888524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908364,0.00027666066,0.000083009596,0.000067848865,0.00017774767,0.00031109978],"domain_scores_gemma":[0.99587905,0.0010233998,0.00063194946,0.00017326282,0.000973608,0.0013186956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019891663,0.00031317753,0.00018362868,0.00096267054,0.0015685814,0.0009174988,0.0008395371,0.00058063463,0.0017949543],"category_scores_gemma":[0.006738731,0.000442888,0.00030584334,0.00075839786,0.001030571,0.00041031584,0.0013928773,0.0005910032,0.00048167983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031681446,0.00039911608,0.95507294,0.00005298895,0.00003102229,0.010513178,0.006626845,0.00038967744,0.002950461,0.00006535373,0.00062591635,0.022955643],"study_design_scores_gemma":[0.00003722749,0.0014088762,0.9282566,0.0000889205,0.00006965659,0.04162342,0.019162718,0.000992194,0.0025223927,0.00011730399,0.0056459573,0.000074675605],"about_ca_topic_score_codex":0.04206692,"about_ca_topic_score_gemma":0.10199611,"teacher_disagreement_score":0.04206692,"about_ca_system_score_codex":0.0018031665,"about_ca_system_score_gemma":0.002834951,"threshold_uncertainty_score":0.08364415},"labels":[],"label_agreement":null},{"id":"W4321793442","doi":"10.1016/j.clbc.2023.02.011","title":"Characteristics Assessment of Online YouTube Videos on Radiotherapy for Breast Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Medical physics; Oncology; Internal medicine","score_opus":0.30104063096543826,"score_gpt":0.6468970359415411,"score_spread":0.34585640497610287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321793442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05558837,0.92777216,0.00028824495,0.00092825876,0.00023376515,0.0010565283,0.0072096884,0.00001820925,0.0069046803],"genre_scores_gemma":[0.17810458,0.811502,0.0012356808,0.0013614317,0.00018915148,0.0011007371,0.0037655835,0.0000151755685,0.0027257798],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989423,0.0002969907,0.0002883547,0.00008801302,0.00031306577,0.000071270704],"domain_scores_gemma":[0.9951527,0.0029422364,0.0010801799,0.00004118713,0.00067823945,0.00010550212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014872334,0.00036262692,0.0012123563,0.0031989738,0.00030493,0.000845245,0.00046383045,0.0004981789,0.008939484],"category_scores_gemma":[0.0104284305,0.00019385073,0.0020847905,0.004838202,0.00017793031,0.0010265533,0.0006264019,0.00059422385,0.00051248306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010876353,0.0004050479,0.06755848,0.29407886,0.008398469,0.0003440626,0.0016836664,0.0001653929,0.00040186013,0.0004793022,0.018408727,0.6069885],"study_design_scores_gemma":[0.0010177615,0.0014949524,0.47413877,0.31896478,0.040841874,0.0016255621,0.006275569,0.0005465806,0.0006269948,0.00069636735,0.15356888,0.00020195363],"about_ca_topic_score_codex":0.018011156,"about_ca_topic_score_gemma":0.076318644,"teacher_disagreement_score":0.018011156,"about_ca_system_score_codex":0.0010203685,"about_ca_system_score_gemma":0.0022878882,"threshold_uncertainty_score":0.035812616},"labels":[],"label_agreement":null},{"id":"W4380743011","doi":"10.1016/j.clbc.2023.06.003","title":"Low Serum Vitamin D Associated With Increased Tumor Size and Higher Grade in Premenopausal Canadian Women With Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Manitoba","funders":"Alberta Cancer Foundation; Alberta Health Services","keywords":"Medicine; Breast cancer; Vitamin D and neurology; Prospective cohort study; Internal medicine; Cancer; Risk factor; Vitamin; Cohort; Population; vitamin D deficiency; Gynecology; Physiology; Gastroenterology; Oncology","score_opus":0.025822437989258526,"score_gpt":0.33577728468462187,"score_spread":0.30995484669536333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380743011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961604,0.0029752576,0.000082163715,0.00084960245,0.00004349738,0.000026242824,0.0018295503,0.000009277356,0.0045683375],"genre_scores_gemma":[0.99702877,0.00082614843,0.000081757506,0.0001408129,0.000013573994,0.000007892482,0.00045124613,0.0000029252917,0.0014469657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996032,0.000046083736,0.000023050123,0.00005730354,0.00010761519,0.00016287559],"domain_scores_gemma":[0.99862456,0.0001657418,0.000324032,0.00004599807,0.00056083204,0.0002788037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047915653,0.00034397357,0.00035701215,0.001421414,0.0020772486,0.0010964778,0.00085224013,0.0006329275,0.003350788],"category_scores_gemma":[0.002598087,0.00034799016,0.00065206044,0.003429648,0.0007107191,0.0002483397,0.0003984882,0.0008604349,0.00017466022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029492629,0.000034454162,0.99591535,0.000035782614,0.000080633974,0.000109263114,0.0003515791,0.00003185113,0.00028930936,0.00010151376,0.0006092824,0.0021460631],"study_design_scores_gemma":[0.000014422257,0.00002366099,0.9981517,0.00002343094,0.000064104635,0.0000882289,0.0007353019,0.000055531928,0.00005429827,0.000034286044,0.0007470272,0.000007935749],"about_ca_topic_score_codex":0.9804648,"about_ca_topic_score_gemma":0.975848,"teacher_disagreement_score":0.019535184,"about_ca_system_score_codex":0.008462467,"about_ca_system_score_gemma":0.011550286,"threshold_uncertainty_score":0.061399817},"labels":[],"label_agreement":null},{"id":"W4385252052","doi":"10.1016/j.clbc.2023.07.005","title":"Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Aging","keywords":"Menstrual cycle; Medicine; Follicular phase; Luteal phase; Parenchyma; Body mass index; Breast cancer; Menstruation; Gynecology; Physiology; Internal medicine; Pathology; Hormone; Cancer","score_opus":0.1740580846854266,"score_gpt":0.4689678883820856,"score_spread":0.294909803696659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385252052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885976,0.00046478427,0.00008054502,0.000026215459,0.00000681691,0.000006439789,0.00008503039,0.000002626983,0.0004677145],"genre_scores_gemma":[0.9994481,0.0001715789,0.00009221739,0.000013279957,0.000012650499,0.0000054138313,0.00007273239,0.000002101491,0.00018193031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998154,0.00007365534,0.000019400499,0.000031703457,0.00002322011,0.0000365985],"domain_scores_gemma":[0.9988716,0.00051419483,0.00037982568,0.00005245322,0.000064458654,0.000117432115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004402234,0.00020164205,0.00018233898,0.0006898377,0.00018604864,0.00034439782,0.00018283323,0.0002818736,0.0010595577],"category_scores_gemma":[0.0028668833,0.00018848196,0.0001775522,0.0005980842,0.0001783218,0.00020971926,0.00019048141,0.00023812336,0.0001216568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009885156,0.00004103142,0.9948436,0.000014696684,0.00004499403,0.0002017358,0.00006147398,0.000025958478,0.0014014677,0.000019133426,0.000025522999,0.0023319414],"study_design_scores_gemma":[0.000005500193,0.00020075313,0.99905056,0.0000025945094,0.000027487042,0.000276187,0.00008591491,0.00009433711,0.00013179267,0.0000120918585,0.00011092977,0.0000018818732],"about_ca_topic_score_codex":0.0012822308,"about_ca_topic_score_gemma":0.002031248,"teacher_disagreement_score":0.0012822308,"about_ca_system_score_codex":0.00015298277,"about_ca_system_score_gemma":0.00020301851,"threshold_uncertainty_score":0.003544569},"labels":[],"label_agreement":null},{"id":"W4386200239","doi":"10.1016/j.clbc.2023.08.005","title":"Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Breast-conserving surgery; Breast cancer; Retrospective cohort study; Cohort; Adjuvant; Adjuvant therapy; Radiation therapy; Internal medicine; Oncology; Cohort study; Randomized controlled trial; Mastectomy; Cancer; Surgery","score_opus":0.05005409503406344,"score_gpt":0.34008860490730886,"score_spread":0.2900345098732454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386200239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806467,0.013773999,0.00023275732,0.00053610257,0.00002701633,0.000023775685,0.00244082,0.0000031850732,0.00231555],"genre_scores_gemma":[0.9958496,0.00311666,0.00009474292,0.000110950605,0.000014782963,0.000012033236,0.00071493245,0.0000033186811,0.00008295904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799025,0.0008559364,0.0003396405,0.0003897226,0.00024781516,0.00017664736],"domain_scores_gemma":[0.986521,0.005013962,0.0059662033,0.0011788943,0.00083441683,0.00048558018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027420707,0.00028046142,0.0005352887,0.0015049808,0.000426469,0.0010431336,0.00049901323,0.0005742457,0.0020530713],"category_scores_gemma":[0.012535756,0.0004000438,0.0010977299,0.0033203093,0.0006305973,0.0004271863,0.00048286837,0.00051933504,0.00012890174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115826704,0.000019969753,0.9974648,0.000095616524,0.00037299466,0.00005045686,0.0001323883,0.000021368895,0.00009526382,0.00005805439,0.00006373644,0.001509567],"study_design_scores_gemma":[0.000028828745,0.00009411259,0.99703693,0.00014771435,0.00066376093,0.00028288423,0.0005428808,0.000065219174,0.000060476792,0.000055111712,0.0010141818,0.000007893827],"about_ca_topic_score_codex":0.031499837,"about_ca_topic_score_gemma":0.03683652,"teacher_disagreement_score":0.031499837,"about_ca_system_score_codex":0.00078263326,"about_ca_system_score_gemma":0.001103939,"threshold_uncertainty_score":0.06263298},"labels":[],"label_agreement":null},{"id":"W4386645518","doi":"10.1016/j.clbc.2023.09.006","title":"Factors Influencing Recurrence in Medial Breast Cancer Tumors After Skin Sparing Mastectomy and Immediate Breast Reconstruction","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; University of British Columbia; University of Calgary","funders":"University of British Columbia","keywords":"Medicine; Breast cancer; Mastectomy; Breast reconstruction; Radiation therapy; Surgery; Stage (stratigraphy); Rectus abdominis muscle; Retrospective cohort study; Cancer; Internal medicine","score_opus":0.037666733097456655,"score_gpt":0.32966291518386787,"score_spread":0.2919961820864112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386645518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991239,0.00038784518,0.0000411456,0.00003613117,0.000007359783,0.0000029121459,0.00004289987,0.0000023747014,0.00035544677],"genre_scores_gemma":[0.9995977,0.00007404775,0.000027427526,0.000018591449,0.000016022337,0.000003340251,0.000056412722,0.0000019507681,0.00020450096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996828,0.00008273619,0.0000447794,0.000032216507,0.000063421816,0.000094110255],"domain_scores_gemma":[0.99774146,0.0008584498,0.00078814104,0.000094715746,0.00012237295,0.00039495484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041891687,0.00013746666,0.0002963027,0.00046644924,0.0003002297,0.00044834233,0.00029485533,0.00038752027,0.0024533607],"category_scores_gemma":[0.0042318627,0.000119876946,0.0005847349,0.00062450924,0.0002863087,0.00027601654,0.00024281484,0.0004102681,0.00021795467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218685,0.000057768695,0.99651587,0.000011188297,0.000031315783,0.00027106475,0.00008380674,0.000043384924,0.00028778406,0.000013217579,0.000053774293,0.0021090333],"study_design_scores_gemma":[0.000007174646,0.00024715092,0.99814236,0.000004668364,0.000042579275,0.0009140824,0.00024778274,0.00013221873,0.000105819985,0.000019182466,0.00013323934,0.0000037604125],"about_ca_topic_score_codex":0.0020692449,"about_ca_topic_score_gemma":0.003950233,"teacher_disagreement_score":0.0024533607,"about_ca_system_score_codex":0.00020818302,"about_ca_system_score_gemma":0.00035726375,"threshold_uncertainty_score":0.008207321},"labels":[],"label_agreement":null},{"id":"W4388996953","doi":"10.1016/j.clbc.2023.11.008","title":"Brain Metastases in the Setting of Stable Versus Progressing Extracranial Disease Among Patients With Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Disease; Oncology; Internal medicine; Clinical trial; Cohort; Metastatic breast cancer; Cancer; Retrospective cohort study; Brain metastasis; Metastasis","score_opus":0.04573150718103655,"score_gpt":0.38631829801391615,"score_spread":0.34058679083287957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388996953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979588,0.00055030343,0.000024516248,0.00016072638,0.000011148837,0.000007058418,0.00012478851,0.0000014666592,0.0011612469],"genre_scores_gemma":[0.99954456,0.00016610284,0.000013237057,0.000047099507,0.000026003278,0.0000030921221,0.00010387146,9.792219e-7,0.000095032716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958795,0.00010323197,0.00003952494,0.000064758955,0.00007233594,0.00013215639],"domain_scores_gemma":[0.9991941,0.00020313208,0.00030023267,0.000019931193,0.00007645896,0.00020607766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002839245,0.00020459136,0.00041266216,0.00063591235,0.00047407617,0.00089359167,0.0003486277,0.0005607463,0.002203865],"category_scores_gemma":[0.0027337852,0.00017691543,0.00029352756,0.00087462564,0.0005107282,0.0007383782,0.00053483585,0.0008099527,0.00018635845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076223066,0.000051832867,0.9952743,0.000018777242,0.00004335712,0.0008100728,0.00012599587,0.00006025674,0.00033626656,0.000051283154,0.00020810324,0.0022575308],"study_design_scores_gemma":[0.00003468274,0.00026412567,0.99566615,0.000015715443,0.000059561473,0.0021644759,0.0010576419,0.00023016192,0.00009500376,0.00014366524,0.00025995765,0.0000089047335],"about_ca_topic_score_codex":0.006603461,"about_ca_topic_score_gemma":0.01422419,"teacher_disagreement_score":0.006603461,"about_ca_system_score_codex":0.0006081707,"about_ca_system_score_gemma":0.00053055555,"threshold_uncertainty_score":0.013130009},"labels":[],"label_agreement":null},{"id":"W4389822986","doi":"10.1016/j.clbc.2023.12.001","title":"Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Hamilton Health Sciences Foundation","keywords":"Medicine; Breast cancer; Meta-analysis; Oncology; Triple-negative breast cancer; Internal medicine; Cancer; Triple negative","score_opus":0.20917259294176682,"score_gpt":0.45381579388930104,"score_spread":0.24464320094753422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389822986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075032823,0.9915245,0.00018976245,0.00009536196,0.00009773333,0.00004202841,0.00038731328,0.00001056519,0.00014943197],"genre_scores_gemma":[0.21227303,0.7843379,0.0010468558,0.00081697915,0.00020695865,0.00016975286,0.00076058874,0.000016515916,0.0003714689],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9980731,0.00067241455,0.0005970133,0.00032941604,0.00020892861,0.000119032695],"domain_scores_gemma":[0.997471,0.0015963763,0.0005660723,0.00010699443,0.0001917389,0.00006781652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002462584,0.0014368589,0.008875038,0.0017388676,0.00034493968,0.0015282327,0.0010953445,0.0015112888,0.0024388],"category_scores_gemma":[0.0063489703,0.0008917565,0.017443899,0.003544497,0.000329466,0.00090035226,0.0009256151,0.0014595794,0.00023442354],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058437195,0.00006469876,0.019074427,0.25067687,0.6930053,0.00021410162,0.00010829177,0.0005961469,0.00060354377,0.00013455669,0.0013578979,0.028320309],"study_design_scores_gemma":[0.0009218111,0.00023497037,0.014661629,0.009180694,0.9720282,0.000119699405,0.00006924282,0.00016374895,0.0001194923,0.00016019736,0.002301992,0.000038365106],"about_ca_topic_score_codex":0.007360904,"about_ca_topic_score_gemma":0.02388201,"teacher_disagreement_score":0.008875038,"about_ca_system_score_codex":0.0009295639,"about_ca_system_score_gemma":0.001489172,"threshold_uncertainty_score":0.014636099},"labels":[],"label_agreement":null},{"id":"W4395469260","doi":"10.1016/j.clbc.2024.04.011","title":"The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons’ Perspectives","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pandemic; Breast cancer; Coronavirus disease 2019 (COVID-19); Health care; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Qualitative research; Cancer; Disease; Pathology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.1288651069566403,"score_gpt":0.5887012954384878,"score_spread":0.4598361884818475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395469260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9410062,0.0017846251,0.0017165453,0.033060517,0.00048131534,0.0001890471,0.0005690074,0.000017971168,0.021174695],"genre_scores_gemma":[0.9904018,0.00090334995,0.00064163946,0.005462613,0.00007189641,0.00016731182,0.0001297655,0.000041679392,0.0021799488],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.96385527,0.027070958,0.0011922328,0.00088688364,0.0026213306,0.004373378],"domain_scores_gemma":[0.88966775,0.086595215,0.0056140446,0.0012146237,0.007265038,0.0096434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030549552,0.00037468004,0.0006336213,0.0018181292,0.010989358,0.007834893,0.001919272,0.0024247344,0.0051604873],"category_scores_gemma":[0.06337159,0.0007461857,0.0005629231,0.0025322228,0.010830503,0.0050934977,0.014434679,0.007506232,0.00041078022],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004723033,0.00002404636,0.0058237747,0.00017967801,0.000008959694,0.00029111153,0.9856367,0.00003835637,0.00025071605,0.002837081,0.0014571704,0.0034051856],"study_design_scores_gemma":[0.000003320015,0.000014544387,0.0013754239,0.00017544189,0.0000032206258,0.00006701752,0.9889326,0.000025912697,0.00008384928,0.00030210923,0.009004581,0.000012016302],"about_ca_topic_score_codex":0.023568675,"about_ca_topic_score_gemma":0.03914432,"teacher_disagreement_score":0.030549552,"about_ca_system_score_codex":0.014635695,"about_ca_system_score_gemma":0.021487154,"threshold_uncertainty_score":0.1615634},"labels":[],"label_agreement":null},{"id":"W4401832653","doi":"10.1016/j.clbc.2024.08.010","title":"Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Pathological; Internal medicine; Complete response; Cancer","score_opus":0.02265700414410472,"score_gpt":0.3211083829367441,"score_spread":0.2984513787926394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401832653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934286,0.00024463184,0.00003231702,0.000026919319,0.0000030671592,0.000003422241,0.000049892064,7.686136e-7,0.00029604745],"genre_scores_gemma":[0.9996742,0.00006065018,0.000027275617,0.000013389924,0.000007306099,0.000004798563,0.0001065177,6.4587704e-7,0.00010518441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973553,0.00013915815,0.00002708934,0.00002652736,0.000033188844,0.00003856996],"domain_scores_gemma":[0.99870706,0.0007049212,0.00028313385,0.000057442103,0.00007486363,0.0001726098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004559057,0.00014449927,0.00028838968,0.00032589037,0.00021743121,0.00031735777,0.00015512978,0.0002789318,0.0009483095],"category_scores_gemma":[0.0021407064,0.0001020767,0.0002585181,0.0005318982,0.00019968685,0.00021004086,0.00013077105,0.0003449214,0.00011046594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019869525,0.00008121022,0.99462163,0.000011934677,0.000046767116,0.00010760229,0.000037363632,0.00008147553,0.001137469,0.000016065314,0.000048235932,0.0018232224],"study_design_scores_gemma":[0.000022515744,0.0005199841,0.998483,0.000002329526,0.000037718604,0.0002347349,0.00010120858,0.00015060243,0.0002491917,0.000014943065,0.00018183212,0.0000019224594],"about_ca_topic_score_codex":0.0010013016,"about_ca_topic_score_gemma":0.0011579347,"teacher_disagreement_score":0.0010013016,"about_ca_system_score_codex":0.00021803904,"about_ca_system_score_gemma":0.0002850955,"threshold_uncertainty_score":0.0031723976},"labels":[],"label_agreement":null},{"id":"W4403541257","doi":"10.1016/j.clbc.2024.10.008","title":"Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, Canada","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; AstraZeneca (Canada); University of Calgary","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Incidence (geometry); Stage (stratigraphy); Oncology; Health care; Family medicine; Cancer; Internal medicine; Environmental health; Gynecology; Economic growth","score_opus":0.07110996056037043,"score_gpt":0.4306683173923992,"score_spread":0.35955835683202875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403541257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83787864,0.07717934,0.00072199997,0.0034892217,0.00026787244,0.001136664,0.06920354,0.000050663017,0.0100720385],"genre_scores_gemma":[0.9763442,0.010456403,0.0009748321,0.0010420416,0.000057558336,0.00028363484,0.0097577525,0.0000108825025,0.0010725869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99215627,0.0024819023,0.0012065123,0.0005861014,0.0025288558,0.0010404268],"domain_scores_gemma":[0.981475,0.0036245685,0.005022334,0.0006846126,0.0075567025,0.0016366622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006380876,0.0006337563,0.00150014,0.0028808399,0.0015282705,0.002687653,0.0020673797,0.0010195888,0.0023649458],"category_scores_gemma":[0.018428715,0.0005774287,0.0021429637,0.011471749,0.0010488818,0.0005259597,0.0012308077,0.0011514325,0.00015465582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00303372,0.00028049405,0.9562664,0.0047829705,0.009521185,0.00019521434,0.000501366,0.0011728599,0.00012716341,0.00074247055,0.007811202,0.015565002],"study_design_scores_gemma":[0.0014474305,0.0003246388,0.9810441,0.0028978456,0.006137361,0.00012808361,0.0013346319,0.0007259026,0.00008089102,0.0001515498,0.0056608375,0.00006672125],"about_ca_topic_score_codex":0.9883422,"about_ca_topic_score_gemma":0.9914615,"teacher_disagreement_score":0.04096048,"about_ca_system_score_codex":0.04096048,"about_ca_system_score_gemma":0.070633024,"threshold_uncertainty_score":0.29719043},"labels":[],"label_agreement":null},{"id":"W4403909260","doi":"10.1016/j.clbc.2024.10.017","title":"Another Biosignature for Ductal Carcinoma In Situ—Have We Moved the Needle?","year":2024,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; In situ; Ductal carcinoma; Breast cancer; Carcinoma in situ; Surgery; Pathology; Carcinoma; Cancer; Internal medicine","score_opus":0.031110235486006967,"score_gpt":0.3331387168952305,"score_spread":0.30202848140922356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403909260","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004283711,0.00233468,0.00010479636,0.98471224,0.011092277,0.000008273657,0.000020681866,0.000009395781,0.0012892841],"genre_scores_gemma":[0.004246067,0.0018109754,0.00035980888,0.954623,0.035056766,0.000028612421,0.000023137149,0.0000127371795,0.0038389147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938257,0.002527727,0.00076888927,0.00056589785,0.0016174744,0.00069431594],"domain_scores_gemma":[0.98070544,0.012204649,0.0009733982,0.0008133481,0.0021723013,0.0031308983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008747013,0.0007365605,0.0019269593,0.0009123594,0.0037902438,0.002995898,0.0020939321,0.051927075,0.0061607123],"category_scores_gemma":[0.029985266,0.0006567339,0.0014383785,0.0007568561,0.005613144,0.0053505115,0.0019431296,0.041700743,0.0026669367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039354636,0.00023506652,0.0034911311,0.0001894293,0.000095985735,0.0033354887,0.0002356573,0.00012357744,0.0010038246,0.015769886,0.9380724,0.037054066],"study_design_scores_gemma":[0.000575914,0.0004800457,0.0037918347,0.00057021575,0.00014666493,0.004059886,0.000931075,0.00052631483,0.0008584552,0.042990297,0.94491035,0.0001588693],"about_ca_topic_score_codex":0.0061578434,"about_ca_topic_score_gemma":0.012375744,"teacher_disagreement_score":0.051927075,"about_ca_system_score_codex":0.0049430933,"about_ca_system_score_gemma":0.0071525923,"threshold_uncertainty_score":0.046259165},"labels":[],"label_agreement":null},{"id":"W4404600357","doi":"10.1016/j.clbc.2024.11.010","title":"Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era","year":2024,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Health Research Board","keywords":"Breast cancer; Medicine; Health care; Anthropocene; Poverty; Climate change; Sustainability; Cancer; Economic growth; Environmental ethics; Ecology; Internal medicine","score_opus":0.08803724021212457,"score_gpt":0.5510367534266708,"score_spread":0.46299951321454624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404600357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052412026,0.9973127,0.00009755002,0.0011436001,0.00030699588,0.00000252286,0.000013510138,0.0000059709287,0.0010647408],"genre_scores_gemma":[0.0006746555,0.99798054,0.00014388621,0.00052939216,0.00024405427,0.000003496643,0.000017644183,0.0000018631644,0.0004044668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997136,0.00007959259,0.000026620291,0.000040417504,0.000103819395,0.00003596913],"domain_scores_gemma":[0.99915767,0.00053680583,0.00007406529,0.000017161223,0.00016198636,0.000052282427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011643597,0.00072312023,0.0011557093,0.0015984236,0.0003551326,0.0014704822,0.0008693558,0.0016593073,0.0075288867],"category_scores_gemma":[0.001433397,0.00016471076,0.0005581995,0.0021884972,0.0006754336,0.0017148603,0.0012674181,0.0025735875,0.0016157558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038461803,0.00005391956,0.00017110175,0.018930418,0.000079872,0.00008896694,0.000100299614,0.00054035516,0.0006759331,0.013906635,0.04153398,0.9238801],"study_design_scores_gemma":[0.000008202137,0.000033034317,0.0004384054,0.0072314865,0.00005835174,0.00022501717,0.00011197877,0.000078070676,0.0001399823,0.004674512,0.9869888,0.0000122341635],"about_ca_topic_score_codex":0.002196119,"about_ca_topic_score_gemma":0.005449319,"teacher_disagreement_score":0.0075288867,"about_ca_system_score_codex":0.0012382882,"about_ca_system_score_gemma":0.0025398943,"threshold_uncertainty_score":0.025186658},"labels":[],"label_agreement":null},{"id":"W4404958104","doi":"10.1016/j.clbc.2024.11.020","title":"Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment","year":2024,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Oncology; Estrogen; Internal medicine; Expression (computer science); Cancer research; Gynecology; Cancer","score_opus":0.04153391169801477,"score_gpt":0.37359940888585663,"score_spread":0.33206549718784184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404958104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069042726,0.999506,0.000040645726,0.00011906804,0.00005146197,0.0000018631104,0.00002014861,0.0000019802824,0.00018972206],"genre_scores_gemma":[0.000582665,0.99891984,0.00009463121,0.00012718013,0.00009072768,0.0000039847037,0.000040162337,6.820835e-7,0.00014021444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998172,0.00003860863,0.000029177694,0.000038553397,0.000059195634,0.00001725042],"domain_scores_gemma":[0.99966073,0.00019128657,0.000049777882,0.000010078253,0.000065468994,0.000022696275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008249234,0.00080834085,0.002027641,0.0016107108,0.00016783892,0.0008869269,0.0008487846,0.00072635326,0.0019302047],"category_scores_gemma":[0.0010399801,0.00022015627,0.0006165263,0.0025261957,0.00036688466,0.0006378857,0.0004602765,0.0013575422,0.00089221844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001815242,0.00005612556,0.0006941314,0.015482452,0.00022251713,0.000113917245,0.000022021675,0.00036841774,0.0005577731,0.0012305239,0.022082645,0.95898783],"study_design_scores_gemma":[0.00013927293,0.00030453387,0.0073654265,0.014174503,0.0013773518,0.0026903779,0.00013341173,0.00024451042,0.0005996716,0.0030700858,0.9698445,0.000056295397],"about_ca_topic_score_codex":0.0017443035,"about_ca_topic_score_gemma":0.003605689,"teacher_disagreement_score":0.002027641,"about_ca_system_score_codex":0.0006492495,"about_ca_system_score_gemma":0.0009847775,"threshold_uncertainty_score":0.0064572096},"labels":[],"label_agreement":null},{"id":"W4405663958","doi":"10.1016/j.clbc.2024.12.012","title":"Evaluation of the Impact of Breast Radiation Therapy on Quality of Life Requires Appropriate Instruments at Relevant Timepoints","year":2024,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Breast cancer; Medical physics; Quality of life (healthcare); Radiation therapy; Quality (philosophy); Intensive care medicine; Cancer; Internal medicine; Nursing","score_opus":0.12088703593966212,"score_gpt":0.44470427840901094,"score_spread":0.32381724246934884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405663958","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056335493,0.0009068088,0.0003104883,0.9791767,0.0037932685,0.000038892198,0.00008212986,0.000019042907,0.010039072],"genre_scores_gemma":[0.07085027,0.0038603682,0.0029194346,0.8808925,0.02594263,0.00030030348,0.00018321296,0.000039038394,0.015012283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962315,0.001689105,0.0005885727,0.00017113847,0.0008503176,0.00046929898],"domain_scores_gemma":[0.98721737,0.0077550667,0.0006810337,0.0003847301,0.0024651003,0.0014965861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00286456,0.00026350952,0.0008675684,0.00036826407,0.001965518,0.0023322916,0.00081271114,0.01144155,0.005443094],"category_scores_gemma":[0.020571515,0.00022671974,0.00072398945,0.00065932394,0.0011434556,0.0015940237,0.0009676859,0.01019639,0.003209502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021036692,0.0003924978,0.031409428,0.0001802885,0.00003353487,0.0071402416,0.00060999824,0.00032473973,0.0009907681,0.0052255443,0.8333496,0.12013312],"study_design_scores_gemma":[0.0002742862,0.00089934166,0.063403785,0.0018356134,0.000086081185,0.02094275,0.007189459,0.0020830685,0.0010627662,0.03125326,0.87080455,0.00016516581],"about_ca_topic_score_codex":0.0058230124,"about_ca_topic_score_gemma":0.014837245,"teacher_disagreement_score":0.01144155,"about_ca_system_score_codex":0.0026700103,"about_ca_system_score_gemma":0.004470835,"threshold_uncertainty_score":0.019372344},"labels":[],"label_agreement":null},{"id":"W4408165416","doi":"10.1016/j.clbc.2025.03.002","title":"Development of Machine Learning Models for Predicting Radiation Dermatitis in Breast Cancer Patients Using Clinical Risk Factors, Patient-Reported Outcomes, and Serum Cytokine Biomarkers","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"Temerty Faculty of Medicine, University of Toronto; Institute of Biomedical Science; Princess Margaret Cancer Foundation; University of Toronto; AstraZeneca","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.03289625724407347,"score_gpt":0.35754594014717733,"score_spread":0.32464968290310386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408165416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76085216,0.0021937555,0.23095861,0.0015610331,0.00012337264,0.00033097295,0.0015233943,0.0012107706,0.001245916],"genre_scores_gemma":[0.9594678,0.00030674573,0.03807957,0.00013404,0.00005416894,0.0003051509,0.0011316828,0.0000237848,0.00049699866],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99927074,0.00040713063,0.000058269925,0.00011706791,0.00008004249,0.00006681649],"domain_scores_gemma":[0.9947649,0.004003975,0.00047936296,0.00009813842,0.00053729187,0.000116355906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004459931,0.0011148109,0.0009724901,0.0015370519,0.00027055008,0.0008972124,0.0008199957,0.00078156457,0.001002213],"category_scores_gemma":[0.007830768,0.00035922445,0.0011032652,0.0006507706,0.00021484983,0.0004904914,0.00048731564,0.001389851,0.00040679445],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007709495,0.00080157886,0.22420779,0.00014992677,0.00069265626,0.00019358311,0.000109302186,0.6546532,0.0011012475,0.0004495232,0.0023484575,0.11452182],"study_design_scores_gemma":[0.000023087363,0.00014341607,0.007090057,0.000027987415,0.00005677668,0.00004136907,0.000017870569,0.9917663,0.00025785735,0.0004106548,0.00015661975,0.000008045207],"about_ca_topic_score_codex":0.0052000675,"about_ca_topic_score_gemma":0.0032960481,"teacher_disagreement_score":0.0052000675,"about_ca_system_score_codex":0.00074212055,"about_ca_system_score_gemma":0.0014184626,"threshold_uncertainty_score":0.02358663},"labels":[],"label_agreement":null},{"id":"W4409254738","doi":"10.1016/j.clbc.2025.04.007","title":"Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Relay Therapeutics; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Breast cancer; Bridging (networking); Cancer; Internal medicine","score_opus":0.009842488139956453,"score_gpt":0.32730691804731155,"score_spread":0.3174644299073551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409254738","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023130313,0.048487436,0.00043942707,0.9239346,0.02568735,0.000014459189,0.000040324845,0.00002061944,0.0011444893],"genre_scores_gemma":[0.01626154,0.13391708,0.0064248634,0.6937768,0.14601123,0.00017782034,0.00022650992,0.00006947871,0.0031346492],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.97160393,0.014585619,0.0033091502,0.0019556207,0.0062714857,0.0022741351],"domain_scores_gemma":[0.7032552,0.202424,0.010558306,0.0042710057,0.053421862,0.02606962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0914671,0.0014715686,0.0028362533,0.0041828654,0.0059736837,0.014350467,0.0044405055,0.026750933,0.011752756],"category_scores_gemma":[0.15023404,0.0009589919,0.0026086026,0.0033775193,0.007723616,0.014887848,0.010089849,0.032773767,0.0020846901],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013269343,0.000092513015,0.00060026784,0.0021603245,0.00013638509,0.00058734545,0.0019699482,0.0001917236,0.00030570856,0.012751471,0.8924621,0.088609524],"study_design_scores_gemma":[0.0001256502,0.000056974637,0.00097543915,0.01105132,0.00022878531,0.00077674806,0.0068674358,0.00029892122,0.00020424665,0.046591334,0.93270296,0.000120139244],"about_ca_topic_score_codex":0.0044258325,"about_ca_topic_score_gemma":0.009864986,"teacher_disagreement_score":0.0914671,"about_ca_system_score_codex":0.0071668965,"about_ca_system_score_gemma":0.02873919,"threshold_uncertainty_score":0.48373002},"labels":[],"label_agreement":null},{"id":"W4409257721","doi":"10.1016/j.clbc.2025.04.001","title":"High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.009806990534439437,"score_gpt":0.31580114123425934,"score_spread":0.3059941506998199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409257721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972004,0.00012793636,0.000028074666,0.000011722195,0.0000020693428,0.0000014683343,0.00003892005,0.0000011132256,0.00006866912],"genre_scores_gemma":[0.99976426,0.000048803948,0.000025543934,0.000006560863,0.000004245232,0.0000017570535,0.00008207796,6.6486444e-7,0.000066031986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998864,0.000024928044,0.000011523417,0.000023494771,0.000026087073,0.000027555228],"domain_scores_gemma":[0.99938285,0.00009453775,0.00034289903,0.000030920008,0.000047697777,0.00010118576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023348579,0.00019852766,0.00020379448,0.0004351346,0.00020603157,0.00029065035,0.00020993514,0.00027800738,0.0011800252],"category_scores_gemma":[0.0010412843,0.00018615564,0.00020543505,0.00030909627,0.00016328135,0.00012882432,0.00019314833,0.0003043033,0.0001793037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011265662,0.000012686628,0.99882716,0.0000034214047,0.000012848507,0.00006077821,0.000009210646,0.000014195969,0.00027480623,0.0000024962615,0.000030391553,0.0006394645],"study_design_scores_gemma":[0.0000073575684,0.00007039054,0.9991033,0.00000261686,0.000019806075,0.0004991003,0.000029802386,0.000097333585,0.00009309504,0.000006354057,0.000069444985,0.0000014487027],"about_ca_topic_score_codex":0.002014229,"about_ca_topic_score_gemma":0.0026803457,"teacher_disagreement_score":0.002014229,"about_ca_system_score_codex":0.00015709376,"about_ca_system_score_gemma":0.000158552,"threshold_uncertainty_score":0.004005015},"labels":[],"label_agreement":null},{"id":"W4409316409","doi":"10.1016/j.clbc.2025.04.006","title":"Patient Reported Outcomes in Breast Cancer: A Plea for the Silent and Forgotten","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Medicine; Plea; Breast cancer; Cancer; Family medicine; Oncology; Gynecology; Internal medicine; Law","score_opus":0.03351985211653033,"score_gpt":0.3741289316235006,"score_spread":0.3406090795069703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409316409","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15803008,0.23944819,0.0035159036,0.5728824,0.00942764,0.00009301618,0.001618418,0.000084965875,0.014899435],"genre_scores_gemma":[0.8205508,0.07069504,0.003959158,0.085150145,0.016819827,0.00020698126,0.00096949073,0.00011340815,0.0015352605],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851275,0.0077806492,0.00234561,0.00085024786,0.0033087332,0.0005872814],"domain_scores_gemma":[0.89124495,0.07778312,0.012628454,0.0048420546,0.009420668,0.0040807156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031033635,0.00038347198,0.0014388128,0.0015226789,0.0011397011,0.0041086045,0.0018885343,0.003264227,0.0027178403],"category_scores_gemma":[0.10911853,0.00036435275,0.0012841247,0.0022773177,0.003156517,0.0067754067,0.0030951765,0.0074593443,0.00044941137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010615897,0.0006904447,0.5166188,0.0035869884,0.00094415917,0.00089902786,0.0059761824,0.0005834975,0.0004678058,0.0102643315,0.06577154,0.39313564],"study_design_scores_gemma":[0.00024874028,0.0016102577,0.8272274,0.01558025,0.00092541083,0.0037013255,0.014454355,0.0016361263,0.00054164324,0.0357172,0.09797637,0.0003810144],"about_ca_topic_score_codex":0.00217337,"about_ca_topic_score_gemma":0.0056566326,"teacher_disagreement_score":0.031033635,"about_ca_system_score_codex":0.0017899913,"about_ca_system_score_gemma":0.001939844,"threshold_uncertainty_score":0.16412354},"labels":[],"label_agreement":null},{"id":"W4409879700","doi":"10.1016/j.clbc.2025.04.017","title":"Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; McGill University; Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Medicine; Trastuzumab; Breast cancer; Regimen; Oncology; Anthracycline; Internal medicine; Discontinuation; Neoadjuvant therapy; Cancer","score_opus":0.005940179759944021,"score_gpt":0.2996759952733951,"score_spread":0.29373581551345107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409879700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646336,0.002257658,0.0000902103,0.00009775999,0.000042118252,0.00009398609,0.00012567533,0.000010367385,0.0008189056],"genre_scores_gemma":[0.99805707,0.0008958511,0.000109737266,0.000075562355,0.000076854536,0.00006804787,0.00018226904,0.000004868677,0.00052970095],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990727,0.0006827131,0.00004005449,0.00007026645,0.00005024193,0.00008405976],"domain_scores_gemma":[0.99862444,0.00059961673,0.00020696534,0.00018102558,0.000059117003,0.000328741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015246796,0.00056048506,0.0013957774,0.0003560922,0.00034238532,0.00053911365,0.0005455054,0.0007178597,0.0013146676],"category_scores_gemma":[0.001966639,0.00025171277,0.0005752742,0.00050277525,0.00078282016,0.0005492263,0.00015931837,0.0013019039,0.00021862506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8665636,0.01736592,0.0101261595,0.00028573655,0.00047484372,0.00019100402,0.00013388,0.0016138498,0.021768296,0.0001874176,0.0004516682,0.08083754],"study_design_scores_gemma":[0.09280402,0.79913837,0.08456167,0.00009432776,0.0008814382,0.00055030687,0.00014966047,0.0015773296,0.016664235,0.00027225466,0.0032516292,0.00005474287],"about_ca_topic_score_codex":0.0012429559,"about_ca_topic_score_gemma":0.0024844797,"teacher_disagreement_score":0.0015246796,"about_ca_system_score_codex":0.0007579882,"about_ca_system_score_gemma":0.00094646413,"threshold_uncertainty_score":0.008063436},"labels":[],"label_agreement":null},{"id":"W4409973230","doi":"10.1016/j.clbc.2025.04.019","title":"Navigating Endocrine Sensitivity Assessment in Nonmetastatic Breast Cancer Through Early On-Treatment Ki67 Understanding","year":2025,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Ministério da Saúde; Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Department of Science and Technology, Ministry of Science and Technology, India; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Instituto Nacional de Ciência e Tecnologia em Teranóstica e Nanobiotecnologia; Ministry of Health","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Oncology; Endocrine system; Internal medicine; Cancer; Gynecology; Hormone","score_opus":0.1112746711518572,"score_gpt":0.48301769329686145,"score_spread":0.37174302214500426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409973230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053731994,0.99936324,0.000054825843,0.00020424194,0.000060464437,0.0000026047314,0.00001446697,0.0000024329015,0.00024395791],"genre_scores_gemma":[0.00068337127,0.9985605,0.00017416928,0.00027922084,0.00008272152,0.0000056580275,0.000030970823,0.000001020456,0.00018240881],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997614,0.00006636507,0.00003463105,0.00004265684,0.000071619994,0.000023264116],"domain_scores_gemma":[0.9992434,0.00049373205,0.00007850139,0.000013115534,0.00014221952,0.000029105686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012173599,0.00071027636,0.0017139962,0.0014765377,0.00015173556,0.0011011095,0.0009259793,0.00096572697,0.0028183453],"category_scores_gemma":[0.0019450855,0.0002794991,0.0008898133,0.0012244665,0.0003661652,0.000981739,0.0006723285,0.002019801,0.000943603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012936968,0.000049905917,0.00035677222,0.01854885,0.00023857011,0.00007727383,0.000031260744,0.00023959088,0.00044079256,0.0014980816,0.015679665,0.96270984],"study_design_scores_gemma":[0.00017334666,0.00027869802,0.00387896,0.030840073,0.0016241212,0.0013311519,0.00017024094,0.00028156646,0.0007342442,0.005107111,0.9555228,0.0000575975],"about_ca_topic_score_codex":0.0023397605,"about_ca_topic_score_gemma":0.0063192584,"teacher_disagreement_score":0.0028183453,"about_ca_system_score_codex":0.00076556904,"about_ca_system_score_gemma":0.0013169622,"threshold_uncertainty_score":0.009428322},"labels":[],"label_agreement":null},{"id":"W4412974461","doi":"10.1016/j.clbc.2025.07.013","title":"Appropriate Treatment for Stage 1 and 2 Her2-Positive and Triple-Negative Breast Cancer by Immigration Status in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Institute for Clinical Evaluative Sciences; Industrial Research and Consultancy Centre; Ontario Ministry of Health and Long-Term Care; Johns Hopkins University","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Immigration; Triple negative; Oncology; Triple-negative breast cancer; Cancer; Internal medicine; Gynecology; Demography","score_opus":0.042806962429829294,"score_gpt":0.3755415888982367,"score_spread":0.3327346264684074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412974461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991581,0.0015193911,0.00008982568,0.0010647218,0.000024108653,0.000039508017,0.003049355,0.000008429562,0.0026235168],"genre_scores_gemma":[0.9975631,0.0006632396,0.00009814782,0.00019351138,0.0000075779462,0.000015207529,0.00079315,0.000003827395,0.00066214823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993285,0.000045061042,0.000048951795,0.000095866,0.00018214148,0.00029948828],"domain_scores_gemma":[0.9983158,0.00008606831,0.00057131925,0.00003068705,0.0004453485,0.0005507723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003545139,0.00020494183,0.0002661724,0.00064647617,0.001906278,0.0006588776,0.00074493495,0.00031093313,0.0017728135],"category_scores_gemma":[0.0016061951,0.00018329859,0.0004595415,0.001767352,0.00061987527,0.00026772494,0.00067996373,0.0005098267,0.000112099966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084163716,0.00002006547,0.99271303,0.000058591344,0.000032947763,0.000119944154,0.00078970636,0.00007555158,0.00015246695,0.000075717624,0.0013409334,0.00453692],"study_design_scores_gemma":[0.0000067708684,0.000015493662,0.9970266,0.000062657185,0.000021115495,0.00007507012,0.0014781923,0.000109097695,0.000032435484,0.000016889657,0.0011488729,0.0000068131067],"about_ca_topic_score_codex":0.99120075,"about_ca_topic_score_gemma":0.99677414,"teacher_disagreement_score":0.026121657,"about_ca_system_score_codex":0.026121657,"about_ca_system_score_gemma":0.034226287,"threshold_uncertainty_score":0.1895268},"labels":[],"label_agreement":null},{"id":"W620273790","doi":"10.1016/j.clbc.2015.06.003","title":"Timing of Postmastectomy Reconstruction Does Not Impair Breast Cancer-Specific Survival: A Population-Based Study","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Nova Scotia Health Authority; Izaak Walton Killam Health Centre","funders":"Canadian Cancer Society","keywords":"Breast reconstruction; Medicine; Mastectomy; Breast cancer; Hazard ratio; Proportional hazards model; Population; Survival analysis; Confidence interval; Oncology; Adjuvant therapy; Internal medicine; Cancer; Surgery","score_opus":0.08730859380808599,"score_gpt":0.3764642661218802,"score_spread":0.28915567231379424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W620273790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987136,0.00042078714,0.0001168189,0.000033296812,0.000017134254,0.000007983175,0.00021395639,0.000003859646,0.0004725164],"genre_scores_gemma":[0.99930346,0.00016018451,0.00004309245,0.0000297946,0.00002338556,0.0000075223716,0.00022935704,0.00000483299,0.0001985147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989907,0.0002662872,0.00009880122,0.00032434377,0.00010167605,0.0002181016],"domain_scores_gemma":[0.9967445,0.00070025795,0.0015093762,0.00045807756,0.00016560436,0.00042209338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009454114,0.00066920597,0.00074317685,0.0006769181,0.0006992905,0.001171948,0.00081291137,0.0012886991,0.0035776277],"category_scores_gemma":[0.0036913622,0.00071478885,0.0016221947,0.0014599201,0.00062353956,0.0010134011,0.00054369145,0.0011397402,0.00048690336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017579527,0.00023360952,0.9955836,0.000020430549,0.00044930298,0.00015658663,0.00006743653,0.000050650215,0.00036300733,0.00002861227,0.000095138304,0.0011936284],"study_design_scores_gemma":[0.0000755966,0.0013691663,0.996736,0.0000097368675,0.00040906147,0.0005685954,0.0002460821,0.00017849308,0.00006799727,0.00006642681,0.0002605454,0.00001227758],"about_ca_topic_score_codex":0.0031455187,"about_ca_topic_score_gemma":0.003272662,"teacher_disagreement_score":0.0035776277,"about_ca_system_score_codex":0.00036434928,"about_ca_system_score_gemma":0.0005217696,"threshold_uncertainty_score":0.011968315},"labels":[],"label_agreement":null},{"id":"W7117512937","doi":"10.1016/j.clbc.2025.12.009","title":"Canadian Women’s Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Ministère de la Santé et des Services Sociaux (Québec); Université Laval; McMaster University; Cancer Care Ontario; Women's College Hospital; University Health Network; University of Toronto; Public Health Ontario","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; Centre Hospitalier Universitaire de Québec; Génome Québec; Fondation du cancer du sein du Québec; Ontario Research Foundation; Fondation CHU de Québec; Cancer Research UK; Ministère de l'Économie, de la Science et de l'Innovation - Québec; Canadian Institutes of Health Research; Genome Canada; Université Laval","keywords":"Perspective (graphical); Breast cancer; Health care; Breast cancer screening; Adaptation (eye); Risk assessment; MEDLINE","score_opus":0.023976090620450412,"score_gpt":0.35556392115808116,"score_spread":0.33158783053763075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117512937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794836,0.00085143966,0.00014434993,0.005553768,0.00003907398,0.00016158934,0.001606214,0.000013441753,0.012146573],"genre_scores_gemma":[0.99225384,0.0011405199,0.000331462,0.0012939762,0.000018103123,0.00010104548,0.000786524,0.000012267271,0.0040623425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977496,0.00036688018,0.000050995444,0.00016878251,0.0009879579,0.0006757452],"domain_scores_gemma":[0.99502003,0.00078085816,0.0006981314,0.000113480295,0.0019109665,0.0014764509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002911659,0.00043317105,0.00038212683,0.0010577071,0.009710521,0.0023106006,0.0013440127,0.0008293699,0.005016307],"category_scores_gemma":[0.007171726,0.00033404824,0.0005836719,0.0028693392,0.0014333206,0.0006853868,0.0016240985,0.0013910155,0.00038507945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000360775,0.00051018724,0.79438823,0.00021487563,0.00006979963,0.00044562027,0.11775965,0.00015537738,0.00039990369,0.0009987514,0.023506895,0.0611899],"study_design_scores_gemma":[0.00006169657,0.00019967454,0.8650244,0.00028874617,0.00007076178,0.00014781886,0.1123005,0.00044937187,0.00014425743,0.00021859715,0.021003462,0.000090785004],"about_ca_topic_score_codex":0.99567395,"about_ca_topic_score_gemma":0.9965245,"teacher_disagreement_score":0.047014594,"about_ca_system_score_codex":0.047014594,"about_ca_system_score_gemma":0.07437886,"threshold_uncertainty_score":0.34111637},"labels":[],"label_agreement":null},{"id":"W955520680","doi":"10.1016/j.clbc.2015.06.010","title":"Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations","year":2015,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lobular carcinoma; Medicine; Invasive lobular carcinoma; Pathology; Breast cancer; Estrogen receptor; Carcinoma; Breast carcinoma; Oncology; Cancer; Disease; Internal medicine; Ductal carcinoma; Invasive ductal carcinoma","score_opus":0.22140273591805448,"score_gpt":0.4444355650434185,"score_spread":0.22303282912536404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W955520680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011019361,0.99926513,0.000052965945,0.00019222671,0.00005482579,0.0000019440506,0.000012476675,0.0000024625685,0.00030781198],"genre_scores_gemma":[0.0009166041,0.9985153,0.00012365637,0.00017084983,0.000115378636,0.000001990253,0.000021336391,5.629716e-7,0.00013432812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977547,0.000036632377,0.000048022193,0.00004092604,0.000080292,0.000018639532],"domain_scores_gemma":[0.99948764,0.00027757106,0.00008816459,0.0000119243405,0.000102751364,0.00003198181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005218061,0.00064394483,0.0016334832,0.0028564064,0.00027787406,0.001111152,0.0009149527,0.0007385756,0.0018179994],"category_scores_gemma":[0.0010403611,0.00027724347,0.0005591881,0.0026434388,0.00053228333,0.0013277713,0.00058185344,0.0012188618,0.00067143585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005959567,0.000044953522,0.0008904988,0.018720662,0.0001468045,0.00076151616,0.00006240447,0.00036268475,0.0011159503,0.0014855454,0.022026576,0.9543228],"study_design_scores_gemma":[0.00003702448,0.000115948336,0.004997474,0.014808453,0.0008042486,0.014071645,0.00027903565,0.00023056574,0.0005809815,0.0025740804,0.9614419,0.000058683818],"about_ca_topic_score_codex":0.0014004543,"about_ca_topic_score_gemma":0.0039006376,"teacher_disagreement_score":0.0028564064,"about_ca_system_score_codex":0.00056714134,"about_ca_system_score_gemma":0.0011345537,"threshold_uncertainty_score":0.0060818195},"labels":[],"label_agreement":null}]}